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Abstract  
Gold complexes can increase the electrophilicity of alkynes by coordination and facilitate 
smooth nucleophilic addition to make a new bond. In general, the reaction of enyne-containing 
substrates with gold catalysts, called cycloisomerization, is well developed because it gives a cyclic 
structure by C-C bond formation in high atom efficiency under mild conditions. Among these reac-
tions, there are many reports where part of an aromatic ring acts as an ene moiety, and this trans-
formation is hydroarylation. In particular, 6-endo-dig type hydroarylation is most popular. However, 
examples of medium-sized ring construction by gold-catalyzed hydroarylation is rare. In addition, 
nitrogen-containing medium-sized ring compounds are known to exhibit interesting biological ac-
tivities. 
Another synthetic use of gold complexes is the preparation of gold carbenoid species, which un-
dergo cyclopropanation, C-H insertion and Büchner reaction, etc. The gold carbenoid species is 
commonly prepared from gold(I) complexes and diazo compounds. New strategies for the genera-
tion of the gold carbenoid species without the use of diazo compounds were successively developed. 
The first example is gold-catalyzed rearrangement of propargylic esters. The second strategy is ret-
ro-Büchner reaction of 7-substituted 1,3,5-cycloheptatrienes. The third method is the generation 
from cyclopropenes. The fourth method is the reaction of alkynes with an oxidant. Against this 
background, the author paid attention to ynamides as attractive precursors of gold carbenoid species, 
because their reactivity can be tuned by the nitrogen-protecting group, and the highly polarized al-
kyne leads to regioselective transformations. 
This thesis consists of four chapters. 
In Chapter 1, general introduction was described. 
In Chapter 2, the author explained the construction of nitrogen-containing medium-sized rings by 
gold(I)-catalyzed hydroarylation of alkynes. The hydroarylation of 2-alkynyldiphenylamine deriva-
tives by cationic gold(I)-catalyst gave 7-endo-dig products selectively. The resonance effect of ni-
trogen was important for high reactivity, and hexacyclic compounds as well as simple 
N-methyldibenzazepine were synthesized by this protocol. On the other hand, the gold(I)-catalyzed 
reaction of 2-propargylaminotriphenylamine derivatives proceeded via 8-exo-dig cyclization to 
provide dibenzodiazocines selectively. The control experiment of o-aminophenol tethered sub-
strates indicated that o-diaminobenzene tether was crucial for the 8-exo-dig selective hydroarylation. 
For the reaction of internal alkynes, the use of the IPr ligand was important to obtain high yields. 
In Chapter 3, the author described dearomative spirocyclization of phenol derivatives via gold 
carbenoid species derived from ynamides. The reaction of ynamides derived from 
p-methoxybenzylamine in the presence of a gold catalyst and N-oxide proceeded to give azaspiro-
 cyclic compounds. By-product formation was suppressed by using IPr as the ligand and water as 
the co-solvent. One of the products was efficiently transformed to a gabapentin lactam derivative. 
In Chapter 4, summary of this thesis was presented. 
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List of Abbreviations  
Ac  acetyl  
AcOH  acetic acid  
aq aqueous 
Ar  aryl  
Bn  benzyl  
br  broad  
BTMS 3,5-bis(trimethylsilyl)phenyl 
Bu  butyl  
ca. circa 
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C-H  carbon-hydrogen  
cod  1,5-cyclooctadiene  
conc  concentrated  
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HPLC  high performance liquid chromatography  
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J  coupling constant  
LED light emitting diode 
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M  molar, mol/L  
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m  meta  
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Me  methyl  
Mes  mesityl  
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NMR  nuclear magnetic resonance  
NOE  nuclear Overhauser effect  
NOESY  NOE correlated spectroscopy  
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Ns 2-nitrobenzenesulfonyl 
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1,3-dioxolane-4,5-dimethanol 
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Backgrounds  
Gold complexes can increase the electrophilicity of alkynes by coordination and nucleophilic 
addition proceeds smoothly to make a new bond.1 In particular, the reaction of enyne-containing 
substrate with gold catalysts, called cycloisomerization, is well developed because it can give a cy-
clic structure by C-C bond formation in high atom efficiency under mild conditions.2  
For the pioneering works, in 2004, Echavarren and co-workers reported a cationic 
gold(I)-catalyzed cycloisomerization of 1,6-enyne to give a 5-exo-dig type product (Scheme 1a).3 
This reaction was considered to provide conjugated dienes via gold carbenoid species. The reaction 
pathway was changed by the tether moiety and/or substituents on the alkene and alkyne. The reac-
tion of dimethyl-substituted substrate gave a 6-endo-dig type product selectively under the same 
reaction conditions (Scheme 1b).3 In contrast, the combination of internal alkyne and gold catalyst 
possessing a bulky ligand gave a cyclobutene derivative by formal [2+2] cycloaddition (Scheme 
1c).4  
 
Scheme 1. Examples of the reactions of 1,6-enynes 
PhO2S
PhO2S
Ph3PAuCl
+ AgSbF6 (2 mol%)
DCM, r.t.
PhO2S
PhO2S
quant.
PhO2S
PhO2S
[Au]+
(a) 5-Exo-dig type reaction
(b) 5-Endo-dig type reaction
TsN
Me
Me
Ph3PAuCl
+ AgSbF6 (2 mol%)
DCM, r.t. TsN
Me
Me
96%
(c) [2+2] Cycloaddition
MeO2C
MeO2C
Me
Ph CyJohnphosAuCl
+ AgSbF6 (2 mol%)
DCM, r.t.
Ph
Me
MeO2C
MeO2C
77%  
 In 2004, Toste and co-workers reported cationic gold(I)-catalyzed cycloisomerization of 
1,5-enynes (Scheme 2).5 This reaction proceeded via gold carbenoid species to give bicy-
clo[3.1.0]hexenes under mild conditions.  
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Scheme 2. Example of the reactions of 1,5-enynes 
Ph
Ph3PAuCl
+ AgSbF6 (1 mol%)
DCM, r.t.
[Au]
Ph
Ph
99%  
 After these pioneering works, various 1,n-enynes were subjected to gold(I)-catalyzed cycloisom-
erization and a variety of ring structures were constructed under similar reaction conditions.2 
Gold-catalyzed cycloisomerization was also used as a key step in total synthesis.1b Among these 
reactions, there are many reports where part of an aromatic ring acts as an ene moiety, and this 
transformation is hydroarylation. In particular, 6-endo-dig type hydroarylation is most popular.6 
There are two types of substrates for 6-endo-dig hydroarylation; heteroatom-tethered and or-
tho-phenylene-tethered alkynes. 
As for the heteroatom-tethered substrates, in 2000, Fujiwara and co-workers reported palladi-
um-catalyzed 6-endo-dig-selective hydroarylation of phenyl phenylpropiolate, and coumarins (Z = 
O) and quinolinones (Z = NH) were obtained (Scheme 3).6a,6b This report was the first example of 
6-endo-dig-selective hydroarylation. However, this transformation required the use of TFA as a 
co-solvent. 
 
Scheme 3. Palladium-catalyzed 6-endo-dig-selective hydroarylation 
Z O
R2
Pd(OAc)2 (3 mol%)
TFA/DCM, r.t.
Z O
R2
R1 R
1
Z = O, NH  
 In 2004, He and co-workers reported cationic gold(III)-catalyzed 6-endo-dig-selective hydroary-
lation to provide coumarin derivatives (Scheme 4).6c This transformation was the first example of 
gold-catalyzed reaction, but heated conditions were required. The deuterium experiments indicated 
the presence of arylgold(III) species which was generated by the direct metalation of electron-rich 
arene, but the possibility of alkyne activation by gold(III) catalyst as a Lewis acid could not be ex-
cluded. 
 
Scheme 4. Gold(III)-catalyzed 6-endo-dig-selective hydroarylation 
O O
Ph
t-Bu
AuCl3 (5 mol%)
AgOTf (15 mol%)
DCE, 50 °C
O O
t-Bu
Ph
92%  
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 In 2009, Banwell and co-workers achieved gold(I)-catalyzed 6-endo-dig-selective hydroarylation 
of terminal alkynes (Scheme 5).6d The reaction was catalyzed by an isolated cationic 
gold(I)-monophosphine complex and proceeded under mild conditions to yield coumarins, 
chromenes, and dihydroquinolines. In the reactions of some propargyl ether-containing substrates, 
benzofurans were also obtained by the fragmentation of vinyl-gold species, which were formed by 
the 6-endo-dig hydroarylation. 
 
Scheme 5. Gold(I)-catalyzed 6-endo-dig-selective hydroarylation of terminal alkynes 
Z O
JohnphosAu(MeCN)SbF6
(1-5 mol%)
DCM, r.t. Z O
and/or
O
MeR R R
O
Au
OH O
Me
Z = O, NTs, NNs
 
 The main problems of hydroarylation are poor regioselectivity and tolerability of elec-
tron-deficient aromatic ring-containing substrates. In 2016, Jiang and co-workers overcame these 
problems by the ligand tuning of gold(I)-catalysts and the use of directing groups (DG) (Scheme 
6).6f When they used an electron-deficient phosphite ligand, which enables the coordinations of 
both alkyne and DG to the metal center, the reaction at sterically hindered ortho-position with an 
alkyne moiety proceeded (Scheme 6a, right). In contrast, the use of rigid and bulky electron-rich 
phosphine ligand prevented the coordinations and generated steric repulsion with DG, and cycliza-
tion proceeded at sterically less hindered para-position (Scheme 6a, left). In addition, when the 
substrates were subjected to hydroarylation using an electron-deficient phosphite ligand, the use of 
both gold and silver catalysts enabled successive hydroarylation and hydroamination with DG to 
provide a tricyclic product selectively (Scheme 6b). The first hydroarylation was catalyzed by a 
cationic gold(I)-catalyst, then the second hydroamination to alkene was catalyzed by a silver cata-
lyst. It is noteworthy that internal alkynes and electron-deficient substrates were also applicable for 
this reaction. 
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Scheme 6. Gold(I)-catalyzed regioselective 6-endo-dig hydroarylation and cascade reactions 
Z
DG
R1
Z = O, NPG
PG: protecting group
DG = CONHOMe
R2
[(2,4-t-Bu2C6H3O)3P]AuOTf
(5 mol%)
DCE, 80 °C
Z
DG R1
R2
XPhosAuNTf2 (5 mol%)
DCE, 80 °CZ
R1
DG
R2
(a) Regioselective  6-endo-dig hydroarylation
(b) Cascade reaction catalyzed by gold and silver catalysts
Z
NHO
OMe
R1
R2
[(2,4-t-Bu2C6H3O)3P]AuCl
(5 mol%)
AgOTf (10 mol%)
PhCl, 110 °C R2
Z
N
O OMe
R1
 
 Another gold(I)-catalyzed hydroarylation of internal alkynes was achieved by Vadola and 
co-workers in 2017 (Scheme 7).6g They used a rigid and sterically hindered phosphine ligand to 
synthesize various quinolinone derivatives. 
 
Scheme 7. Gold(I)-catalyzed 6-endo-dig hydroarylation of internal alkynes 
N
R
O
R'
XPhosAu(MeCN)SbF6
(5 mol%)
DCE, 50 °C
N
R
O
R'
 
 Some enantioselective hydroarylations were also reported. In 2011, Tanaka and coworkers 
achieved gold(I)-catalyzed enantioselective synthesis of axially chiral heterobiaryls using chiral 
biaryl bisphosphine as a chiral ligand (Scheme 8).6e They also reported atropselective synthesis of 
all-benzenoid biaryls by a gold(I)-catalyst.7h,7j However, the enantioselectivity was low to moderate 
in both reactions. 
 
Scheme 8. Gold(I)-catalyzed enantioselective 6-endo-dig hydroarylation 
R4
Z
R1
R2
R3 O
Z = NBn, O, CHR
Me2SAuCl (20 mol%)
AgX (20 mol%)
Ligand (10 mol%)
DCE, r.t.
X = BF4, OTf
Ligand: (R)-DTBM-SEGPHOS
              (R)-BINAP
              (R)-xyl-BINAP
R4
N
Bn
O
R1
R2
R4
R1
R2
R3 R3
R
up to 61% ee up to 70% ee
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 Next, the examples of ortho-phenylene-tethered alkynes, namely 2-alkynylbiphenyls are listed.7 
In 2006, our group reported that cationic gold(I)-catalyzed cycloisomerization of 
2-(1-hexynyl)biphenyl gave a phenanthrene derivative as major product (Scheme 9).7a This report 
was the first example of gold(I)-catalyzed 6-endo-dig hydroarylation. However, the selectivity was 
not perfect and a 5-exo-dig product was also formed. 
 
Scheme 9. Previous work by our group 
n-Bu
Ph3PAuCl (10 mol%)
AgSbF6 (12 mol%)
DCE, 40 °C
n-Bu n-Bu
6-endo-dig
product
5-exo-dig
product
57%
(6-endo/5-exo = 5/1)  
 In 2008, Yang and coworkers reported that the gold(I)-catalyzed hydroarylation of phe-
nyl-substituted 2-alkynylbiphenyl realized 6-endo-dig-selective transformation (Scheme 10).7b The 
catalytic systems were almost the same as Scheme 8, but the selectivity was perfect. These results 
imply that substituent on alkyne have a significant effect on the selectivity of cyclization fashion.  
 
Scheme 10. Hydroarylation of phenyl-substituted 2-alkynylbiphenyl 
Ph
Ph3PAuCl
+ AgSbF6 (10 mol%)
toluene, 110 °C
Ph
63%  
 In 2013, Alcarazo and coworkers reported the 6-endo-dig-selective hydroarylation of sterically 
hindered 4 and/or 5-substituted 2-alkynylbiphenyls using an extremely π-acidic catalyst (Scheme 
11).7e They developed new positively charged electron-poor phosphines, (dialkyla-
mino)cyclopropenium-substituted phosphines, which are bench-stable crystalline solids. The new 
phosphine ligands have the same donor ability as P(CF3)3, which is a liquid with low boiling point 
and difficult to handle. They synthesized new extremely π-acidic gold catalysts with the new elec-
tron poor phosphines and subjected them to the hydroarylation of 4 and/or 5-substituted 
2-alkynylbiphenyls, which were less reactive because of steric repulsion. As a result, 
4,5-substituted non-planar phenanthrenes were obtained in high yields. They also used this trans-
formation as a key step in total synthesis of calaquinone C and calahydroquinone A by modifying 
the structure of ligand.7g 
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Scheme 11. Synthesis of 4,5-substituted non-planar phenanthrene by extremely π-acidic gold cat-
alyst 
P
Au
Ph
Cl
(i-Pr)2N N(i-Pr)2
N(i-Pr)2
N(i-Pr)22BF4
-
(2 mol%)
AgSbF6 (2 mol%)
DCM, r.t.
R1
R2
R1
R2
 
 An extremely π-acidic phosphine was modified to a chiral ligand.7h,7i In 2017, Alcarazo and 
coworkers reported enantioselective synthesis of [6]carbohelicenes via 6-endo-dig-selective double 
hydroarylation using a Au(I)-TADDOL-derived cationic phosphonite catalyst (Scheme 12).7i 
 
Scheme 12. Enantioselective synthesis of [6]carbohelicene via hydroarylation 
P
N
NO
O
MeO
MeO
Ar Ar
Ar Ar
Mes
Mes
Au
Cl
SbF6
-
Ar = 4-CF3C6H4
(5 mol%)
AgSbF6 (5 mol%)
C6H5F, -20 °C
R2 R
2
R1 R1
R2R2
R1 R1
 
Another synthetic use of gold complexes is the preparation of gold carbenoid species which un-
dergo cyclopropanation, C-H insertion, and Büchner reaction.8,9 The gold carbenoid species is 
commonly prepared from Au(I) complexes and diazo compounds (Scheme 13).8  
 
 
 
 
 
 
 
 
 
 
Chapter 1 
 8 
Scheme 13. Generation of gold carbenoid species from diazo compounds and their reactivity 
R1 R2
N2
R1 R2
Au Nu
Product
Nu: Nucleophile
X H
Product
R1 R2
R1 R2
X H
R1 R2
R2
R1
R1 R2
Au
X = C, O, N
Au
 
New strategies for the generation of gold carbenoid species without the use of diazo compounds 
were successively developed. The first example is gold-catalyzed rearrangement of propargylic es-
ters (Scheme 14a).9 5-Exo-dig pathway gave the gold carbenoid species by 1,2-shift. On the other 
hand, 6-endo-dig pathway provided allene intermediates by 1,3-shift. Allene intermediates could be 
converted to gold-carbenoid species through cyclic intermediates. In 2009, Toste and co-workers 
reported cationic gold(I)-catalyzed enantioselective intramolecular cyclopropanation via in-situ 
generated gold carbenoid species with rearrangement of propargylic esters (Scheme 14b).10 
 
Scheme 14. Generation of gold carbenoid species from propargylic esters 
O
O
5-exo-dig
O
O
Au
Au
1,2-shift
O
Au
O
O
O
Au
O
O
1,3-shift
6-endo-dig
AuO O
Au
(a) Possible pathways
(b) Cyclopropanation
Me OAc
(R)-xyl-BINAP(AuCl)2
(2.5 mol%)
AgSbF6 (5 mol%)
MeNO2, -25 °C
Me OAc
Me
OAc
[Au]
Au
1 2 3
1 3
1 2
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 The second strategy is retro-Büchner reaction of 7-substituted 1,3,5-cycloheptatrienes (Scheme 
15). In 2011, Echavarren and coworkers reported that the reaction of 7-substituted 
1,3,5-cycloheptatriene with alkene in the presence of cationic gold(I)-catalysts gave cyclopropanes, 
which indicates the generation of gold carbenoid species by retro-Büchner reaction of 7-substituted 
1,3,5-cycloheptatriene.11 This method can provide new gold carbenoid species, which were difficult 
to prepare from diazo compounds. 
 
Scheme 15. Generation of gold carbenoid species by retro-Büchner reaction 
R
Au
R
Au
H
R
R1
R2
JohnphosAu(MeCN)SbF6
(5 mol%)
DCE, 120 °C
R
R1 R2
retro-Büchner
reaction
 
 The third method is the generation from cyclopropenes (Scheme 16). The release of the ring 
strain of cyclopropene is the driving force for the generation of vinyl carbenoid species. In 2011, 
Hadfield and Lee demonstrated the reaction of cyclopropenes with furans in the presence of a gold 
catalyst to give conjugated trienones (Scheme 16).12 The mechanism of this reaction was consid-
ered to be Friedel-Crafts type pathway or cyclopropanation. 
 
Scheme 16. Generation of gold carbenoid species from cyclopropenes 
Au
Au
Au
H
Au
R1 R2 LAu
R2R1
AuL
cyclopropanation
Friedel-Crafts
OR3
O
AuL
R2
R1
R3
OR3
R2
R1
R2R1
R3
O
 
 The forth method is the reaction of alkynes with oxidants (Scheme 17a).13 The alkynes are at-
tacked by nucleophiles to form a negatively charged vinyl-gold complex. This complex releases 
leaving group to form gold carbenoid species. There are many combinations of alkynes and nucle-
ophiles. In particular, ynamides are attractive precursors of gold carbenoid species because their 
reactivity could be tuned by the protecting group, and the highly polarized alkyne leads to regiose-
lective transformations.13d For example, Ye and co-workers achieved intramolecular C-H insertion 
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via α-oxo-gold carbenoid species derived from ynamide by using N-oxide as the oxidant (Scheme 
17b).14 Davies and co-workers used this ynamide strategy for intramolecular Büchner reaction 
(Scheme 17c).15 In both examples, the reactivity could be changed by the ynamides and N-oxides. 
 
Scheme 17. Generation of gold carbenoid species from alkyne and oxidant 
R1 R2
Au
LG X
LG: Leaving group
X: Nucleophile
R1
X
R2
Au
LG
R1
X
R2
Au
-LG
(a) General mechanism
NMs
Ph
Me
XPhosAuNTf2 (5 mol%)
Methyl picolinate N-oxide
(1.1 eq.)
MeNO2, 80 °C NMs
OPh
Me
NMs
Me
O
[Au]
Ph
N
Ph
PGR1
R2
BrettPhosAuNTf2 (5 mol%)
8-ethylquinoline N-oxide
(2.0 eq.)
DCE, 80 °C
R1
R2
[Au]
N
O
PG
Ph
N
O
PG
Ph
R1 R2
H
(b) C-H insertion
(c) Büchner reaction
 
 
Purpose of this thesis  
As mentioned above, there are many examples of 6-endo-dig-selective hydroarylation of alkynes. 
However, examples of medium-sized ring construction by gold-catalyzed hydroarylation are rare, 
which are shown in the introduction of Chapter 2. Therefore, the atom-economical construction of 
7-membered dibenzazepines and 8-membered dibenzodiazocines by gold-catalyzed hydroarylation 
of alkynes is attractive.  
In Chapter 2, the author explained the construction of nitrogen-containing medium-sized rings by 
gold(I)-catalyzed hydroarylation of alkynes (Scheme 18). The hydroarylation of 
2-alkynyldiphenylamine derivatives by cationic gold(I)-catalysts gave a 7-endo-dig product selec-
tively (Scheme 18a). The resonance effect of nitrogen was important for high reactivity, and hexa-
cyclic compounds and simple N-methyldibenzazepine were synthesized by this protocol. On the 
other hand, the gold(I)-catalyzed reaction of 2-propargylaminotriphenylamine derivatives proceed-
ed via 8-exo-dig selectivity to provide dibenzodiazocines (Scheme 18b). The control experiment of 
o-aminophenol tethered substrates indicated that o-diaminobenzene tether was crucial for the 
8-exo-dig-selective hydroarylation. For the reaction of internal alkynes, the use of IPr ligand was 
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important for the high reactivity. 
 
Scheme 18. Gold(I)-catalyzed construction of nitrogen-containing medium-sized ring 
N
R
cationic Au(I) cat.
7-endo-dig-selective
N
R
up to >99%
N
NTs
N
NTs
Ph
Ph
R
cationic Au(I) cat.
8-exo-dig-selective
R
up to >99%
(a) Synthesis of dibenzazepines by 7-endo-dig-selective hydroarylation
(b) Synthesis of dibenzodiazocines by 8-exo-dig-selective hydroarylation
 
In Chapter 3, the author described dearomative spirocyclization of phenol derivatives via gold 
carbenoid species derived from ynamides (Scheme 19). The reaction of ynamide derived from 
p-methoxybenzylamine in the presence of a gold catalyst and N-oxide proceeded to give an azaspi-
rocyclic compound. By-product formation was suppressed by using IPr as a ligand and water as a 
co-solvent. The product was efficiently transformed to a gabapentin lactam derivative. 
 
Scheme 19. Dearomative spirocyclization of phenol derivatives via gold carbenoid species 
R2O
N
Ts
R1
N
O
O
Ts
R1
IPrAuCl (10 mol%)
quinoline (10 mol%)
quinoline N-oxide (2.0 eq.)
DCE/H2O = 1/4, 80 °C
up to 98%
R3
R3
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Backgrounds  
Nitrogen-containing heterocyclic structures are attractive for synthetic chemists because they are 
confirmed in many biologically active compounds and functional materials.1 For an example of a 
medium-sized ring system, the dibenzazepine skeleton, which has one nitrogen atom in a sev-
en-membered ring fused with two benzene rings, is a substructure of tricyclic antidepressants.2 In 
addition, the diazocine skeleton, which has two nitrogen atoms in an eight-membered ring, is in-
cluded in antibacterial agents and HIV-1 integrase inhibitors.3 
As mentioned in Chapter 1, there are many reports of 6-endo-dig-selective hydroarylation, but 
only a few examples for construction of medium-sized rings by hydroarylation have been reported. 
In 2006, Echavarren and co-workers reported the 7-exo-dig- and 8-endo-dig-selective hydroaryla-
tion of alkynes using an indole moiety as a nucleophile (Scheme 1).4 The use of a gold(I)-catalyst 
induced 7-exo-dig-selective hydroarylation. On the other hand, the use of a gold(III)-catalyst selec-
tively provided an 8-endo-dig product. In both cases, the reaction initially proceeded at the 
C3-position of indole in a 6-exo-dig and 7-endo-dig fashions to give spirocyclic intermediates. 
These spirocyclic intermediates were readily rearranged to give the formal 7-exo-dig and 
8-endo-dig products, respectively. This strategy was used for the total synthesis of various indole 
alkaloids.4d 
 
Scheme 1. 7-Exo-dig- and 8-endo-dig-selective hydroarylation of alkynes by using indoles 
N
H
N
CO2Me
DNBSJohnPhosAu(MeCN)SbF6
N
H
N
DNBS
CO2Me
N
H
N
DNBSMeO2C
AuCl3
DCM, r.t. DCM, r.t.
N
H
N
[Au]
MeO2C
DNBS
via
N
H
N
DNBS
MeO2C
[Au]
via
 
In 2011, Fujii, Ohno, and co-workers reported a cascade reaction of hydroamination and 
7-endo-dig-selective hydroarylation (Scheme 2).5 They synthesized various or-
tho-1,6-diyne-substituted anilines and subjected them to gold(I)-catalyzed reactions. The first reac-
tion was hydroamination of alkyne to provide a C2-substituted indole intermediate. The 
C3-position of the indole was highly nucleophilic and successive reaction with the remaining al-
kyne moiety selectively gave 7-endo-dig products by hydroarylation (Scheme 2a). When me-
thyl-substituted alkyne was subjected to the gold(I)-catalyzed cascade reaction, a 
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6-exo-dig-selective hydroarylation proceeded (Scheme 2b). These results indicated that the substit-
uents on alkyne affected the selectivity of hydroarylation. 
 
Scheme 2. Cascade reaction of hydroamination and hydroarylation 
NH2
Z
Ph
N
H
Z
Ph
N
H
Z
Ph
(a) 7-Endo-dig-selective hydroarylation with indole
(b) 6-Exo-dig-selective hydroarylation with indole
NH2
Me
CO2Me
CO2Me
same as above
N
H
Me
CO2Me
CO2Me
N
H
Me
CO2Me
CO2Me
XPhosAuCl
+ AgOTf (5 mol%)
MeCN, 80 °C
Z = NTs, O, C(CO2Me)2
 
While indole moieties have been used as a nucleophile in hydroarylations, Hashmi and 
co-workers reported gold(I)-catalyzed 7-exo-dig-selective hydroarylation of alkynes by using a 
3,5-dimethoxyphenyl group as a nucleophile. Dibenzocycloheptatriene was obtained after complete 
isomerization of exo-olefin using Tf2NH as a strong acid (Scheme 3).
6 This reaction was promoted 
by an electron-deficient phosphite ligand. 
 
Scheme 3. 7-Exo-dig-selective hydroarylation of alkyne 
OMeMeO
[(2,4-di-t-Bu-C6H3O)3PAu(PhCN)]SbF6
Tf2NH
DCM, r.t.
OMe
MeO
 
 As for the construction of eight-membered rings, there are some examples of ene-yne cycloi-
somerization. In 2009, Toste and co-workers disclosed an intramolecular cyclopropanation of 
1,8-enynes via in situ generated gold carbenoid species, which was prepared by the rearrangement 
of propargylic esters, and cyclopropane-fused eight-membered ring compounds were obtained 
(Scheme 4).7 Enantioselective reaction was also achieved by using a chiral ligand.  
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Scheme 4. Construction of eight-membered ring by cyclopropanation 
R1
OAc
[Au]
R1 OAc
R2
(R)-xyl-BINAP(AuCl)2
(2.5 mol%)
AgSbF6 (5 mol%)
R1 OAc
R2
MeNO2, -25 °C
R2
 
In 2011, Kumar, Waldmann and a co-worker reported 8-endo-dig-selective cycloisomerization of 
o-propargyloxy styrenes for the synthesis of benzoxocines (Scheme 5).8 The reaction was consid-
ered to proceed via a cationic eight-membered ring intermediate which was initiated by an elec-
tron-donating resonance effect of the oxygen atom. 
 
Scheme 5. 8-Endo-dig-selective cycloisomerization 
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 In 2013, Sawamura and co-workers reported 8-exo-dig-selective cycloisomerization of silyl enol 
ethers possessing an alkynyl side chain, and a bridged bicyclic system containing an 
eight-membered ring was constructed (Scheme 6).9 Their originally developed semihollow tri-
ethynylphosphane ligands enabled the cyclization of the highly flexible substrate. In particular, this 
methodology could also be used for acyclic substrates (Scheme 6b). 
 
Scheme 6. 8-Exo-dig-selective cycloisomerization 
DTBM: 3,5-t-Bu2-4-MeOC6H2
BTMS: 3,5-bis(trimethylsilyl)C6H3
LAuNTf2 (5 mol%)
t-BuOH
4Å MS
DCE, 85 °C O
H
CO2Et
OTBS
CO2Et L = P CAr3)3(
Ar = DTBM or BTMS
Ph
OTBS
Ph
O
(a) Reaction of cyclic substrate
(b) Reaction of acyclic substrate
same as above
 
 While an intramolecular gold(I)-catalyzed [2+2] cycloaddition had been developed for the con-
struction of seven-membered ring and macrocycles,10 Sawamura and co-workers reported the con-
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struction of cyclobutene-fused eight-membered ring by intramolecular gold(I)-catalyzed [2+2] cy-
cloaddition (Scheme 7).11 The dehydrated condition was important for high reactivity.12 
 
Scheme 7. Construction of eight-membered ring by [2+2] cycloaddition 
MeO2C CO2Me
Me
Me Me
Me
CO2Me
MeO2C
LAuNTf2 (5 mol%)
4Å MS
DCM, r.t.
L = P CAr3)3(
Ar = DTBM  
Against this background, the author considered that the construction of a nitrogen-containing 
medium-sized ring could be achieved by using diphenylamine possessing an alkyne moiety as a 
substrate of cationic gold(I)-catalyzed hydroarylation (Scheme 8). When the reaction of 
2-(1-alkynyl)-N-phenylanilines proceeded in a 7-endo-dig-selective fashion, dibenzazepines would 
be obtained (Scheme 8a).13 When the reaction of 2-propargylaminodiphenylamines proceeded in a 
8-exo-dig-selective manner, dibenzodiazocines would be obtained (Scheme 8b).14  
 
Scheme 8. Concept of this work 
N
R'
R
cationic gold cat.
7-endo-dig-selective
hydroarylation
N
R'
R
N
R'
NPG
R
cationic gold cat.
8-exo-dig-selective
hydroarylation
N
R'
NPG
R
(a) Synthesis of dibenzazepines
(b) Synthesis of dibenzodiazocines
 
 
Results and Discussion  
2.1. Synthesis of Dibenzazepines by 7-endo-dig-Selective Cycloisomerization 
2.1.1. Reactions of Carbazole-Containing Substrates 
First, the author subjected triphenylamine derivative 1 to gold(I)-catalyzed cycloisomerization, 
but no reaction proceeded (Scheme 9a). The author considered that the reactivity of the ortho posi-
tion of amino group was too low to react due to free rotation of the phenyl ring. Therefore, the au-
thor designed carbazole-containing substrate 2 because the planarity of carbazole was expected to 
increase the nucleophilicity by the electron-donating resonance effect of nitrogen atom as well as 
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the accessibility to an alkyne moiety (Scheme 9b). Moreover, the formation of undesired 6-exo-dig 
product 3’ would be suppressed by the effect of substituents on alkyne. 
 
Scheme 9. Preliminary result and design of substrate 
Ph3PAuCl (10 mol%)
AgSbF6 (10 mol%)
DCE, 80 °C, 23 h
N
p-Tol
NR
1
p-Tol = 4-Me-C6H4
N
R
2
cationic gold(I) cat.
High reactivity
7-endo-dig-selective
N
R
(a) Reaction of a triphenylamine derivative
(b) Design of substrate
3
N
R
3'
 
 p-Tolyl-substituted alkyne 2a was used for the optimization of reaction conditions (Table 1). 
When the reaction of 2a was conducted in the presence of chloro(triphenylphosphine)gold(I) and 
silver hexafluoroantimonate in DCE at 80 °C, the desired 7-endo-dig product 3a was obtained se-
lectively in high yield (Entry 1). Its structure was confirmed by single-crystal X-ray analysis (Fig-
ure 1) and the undesired 6-exo-dig product 3a’ was not obtained. Hexafluoroantimonate and tri-
fluoromethanesulfonate exhibited almost the same reactivity, but the use of tetrafluoroborate gave a 
poor result and the yield of 3a was low (Entries 1-3). In the absence of silver salt, only a trace 
amount of 3a was obtained (Entry 4). This result indicated that the cationic character of gold cata-
lysts was important for this reaction. Drastic decrease of yield was observed at lower reaction tem-
peratures (Entries 5 and 6). When a more electrophilic gold(I) catalyst possessing an elec-
tron-deficient phosphine ligand was used, the reaction proceeded even at room temperature, albeit 
in moderate yield along with the remaining of the substrate (Entries 7-10). The author determined 
Entry 1 as the best conditions for 2a. 
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Table 1. Screening of reaction conditions for 2a 
N
p-Tol
Catalyst
+ Additive (10 mol%)
DCE, Temp., 24 h
N
p-Tol
2a 3a
N
p-Tol
3a'
 
Entry Catalyst Additive Temp. /°C Yield /% 
1 Ph3PAuCl AgSbF6 80 90 
2 Ph3PAuCl AgOTf 80 88 
3 Ph3PAuCl AgBF4 80 12 
4 Ph3PAuCl None 80 Trace 
5 Ph3PAuCl AgSbF6 60 27 
6 Ph3PAuCl AgSbF6 40 14 
7 [(4-CF3C6H4)3P]AuCl AgSbF6 r.t. 58 
8 [(4-CF3C6H4)3P]AuCl AgOTf r.t. 65 
9 [(C6F5)3P]AuCl AgSbF6 r.t. 33 
10 [(C6F5)3P]AuCl AgOTf r.t. 42 
 
 
Figure 1. ORTEP diagram of 3a (thermal ellipsoids shown at 50% probability) 
 
 Under the optimized conditions, the author subjected various alkynes to the cycloisomerization 
(Table 2). The reaction of sterically hindered o-tolyl-substituted alkyne 2b proceeded to give 3b in 
good yield (Entry 1). p-Anisyl-substituted alkyne 2c showed high reactivity: the reaction concluded 
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within 6 h and product 3c was obtained in excellent yield (Entry 2). Naphthyl- and 
thienyl-substituted alkynes 2d-2f could also be used as substrates to provide cycloadducts 3d-3f in 
high yields (Entries 3-5). Terminal alkyne 2g was completely consumed within 2 h at room tem-
perature and high yield was achieved (Entry 6). In contrast, the reactivity of phenyl-substituted al-
kyne 2h was low under these conditions (Entry 7).  
 
Table 2. Substrate scope of alkyne terminus 
N
R
N
R
Ph3PAuCl (10 mol%)
AgSbF6 (10 mol%)
DCE, 80 °C, 24 h
 
Entry R Yield /% 
1 2-MeC6H4 (2b) 75 (3b) 
2[a] 4-MeOC6H4 (2c) 98 (3c) 
3 1-Naphthyl (2d) 92 (3d) 
4 3-Thienyl (2e) 86 (3e) 
5 2-Thienyl (2f) 91 (3f) 
6[b] H (2g) 82 (3g) 
7 Ph (2h) 20 (3h) 
[a] The reaction was conducted for 6 h. [b] AgOTf was used instead of AgSbF6. The reaction was 
conducted at r.t. for 2 h. 
 
 To improve the yield of the reaction of 2h, the author conducted condition screening again (Ta-
ble 3). When more electrophilic gold(I) catalyst, chloro(tris(4-trifluoromethylphenyl)phosphine)- 
gold(I), was used at 80 °C, the desired product 3h was obtained in low yield and most of the sub-
strate 2h remained (Entry 1). Since the author considered that the reason for the low conversion 
might be the instability of electrophilic gold(I) catalysts at high temperature, the reaction was con-
ducted at room temperature (Entry 2). Gratifyingly, the yield improved to 45% as expected. After 
screening of various counteranions, trifluoromethanesulfonate was found to be best (Entry 3). 
When the more electrophilic chloro(tris(pentafluorophenyl)phosphine)gold(I) catalyst was used, 
the reaction proceeded quantitatively within 3 h (Entry 4). 
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Table 3. Screening of reaction conditions for 2h 
N
Ph
Catalyst
+ Additive (10 mol%)
DCE, Temp., 24 h
N
Ph
2h 3h  
Entry Catalyst Additive Temp. /℃ Yield /% 
1 [(4-CF3C6H4)3P]AuCl AgSbF6 80 7 
2 [(4-CF3C6H4)3P]AuCl AgSbF6 r.t. 45 
3 [(4-CF3C6H4)3P]AuCl AgOTf r.t. 98 
4[a] [(C6F5)3P]AuCl AgOTf r.t. >99 
[a] The reaction was conducted for 3 h. 
 
 Under the optimized conditions in Entry 4 of Table 3, other alkynes were subjected to the cy-
cloisomerization (Table 4). The reaction of m-tolyl, m-anisyl, and p-biphenyl-substituted alkynes 2i, 
2j, 2k proceeded smoothly to give the desired products 3i, 3j, and 3k, respectively in high to ex-
cellent yields (Entries 1-3). Alkynes possessing electron-withdrawing group-substituted aryl groups 
2l and 2m could also be used as substrates to give 3l and 3m in high yields (Entries 4 and 5). The 
reaction of 2a under these conditions gave 3a in lower yield (42%, see entry 10 in Table 1). 
 
Table 4. Substrate scope of alkyne terminus 
[(C6F5)3P]AuCl (10 mol%)
AgOTf (10 mol%)
N
R
N
R
DCE, r.t., 3 h
 
Entry R Yield /% 
1 3-MeC6H4 (2i) 86 (3i) 
2 3-MeOC6H4 (2j) 93 (3j) 
3 4-PhC6H4 (2k) 98 (3k) 
4 4-ClC6H4 (2l) 85 (3l) 
5 4-CF3C6H4 (2m) 97 (3m) 
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 Next, the author subjected substrates possessing a substituent on the carbazole ring to the cy-
cloisomerization (Scheme 10). The reaction of 4-methoxycarbazole-containing substrate 2n pro-
ceeded selectively at the methoxy-substituted aromatic ring with the slightly remaining of the sub-
strate to provide 3n in good yield, but it was lower than that of 3a (Scheme 10a). The author con-
sidered that 2a had two possible reactive carbons in its symmetrical structure, but 2n had only one 
possible reactive carbon, which resulted in lower yield of 3n. To synthesize -extended polycyclic 
compounds, benzocarbazole-containing substrates were examined (Scheme 10b and 10c). The re-
action of benzo[c]carbazole-based substrate 2o gave cycloadducts 3o and 3o’ as an inseparable 
mixture (Scheme 10b). The reactivity of substrate 2p possessing a benzo[a]carbazole moiety was 
extremely low and only a trace amount of 3p was obtained (Scheme 10c). The steric repulsion be-
tween naphthalene ring and 2-alkynylphenyl group of 3p was responsible for the low reactivity. 
 
Scheme 10. Scope of substrates possessing substituent on carbazole moiety 
N
MeO
p-Tol
3n
77%
N
p-Tol
N
p-Tol
88% (3/2)
+
N
p-Tol
Ph3PAuCl (10 mol%)
AgSbF6 (10 mol%)
DCE, 80 °C, 24 h
2n
same as above
N
p-Tol
2o
MeO
(a)
(b)
3o 3o'
same as above
N
p-Tol
2p
(c)
N
p-Tol
3p
<5%  
 In place of phenylene-tethered substrates, naphthylene-tethered substrate 2q was subjected to the 
cycloisomerization to synthesize a hexacyclic compound (Scheme 11). The reaction of 2q gave the 
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desired π-extended product 3q in high yield. 
 
Scheme 11. Synthesis of hexacyclic compound 3q 
N
p-Anisyl
3q
85%
N
p-Anisyl
Ph3PAuCl (10 mol%)
AgSbF6 (10 mol%)
DCE, 80 °C, 24 h
2q
p-Anisyl = 4-MeOC6H4  
 When the reaction of alkyl substituted alkyne 2r was conducted, the cyclization proceeded, but 
the desired 7-endo-dig product 3r was minor product while the undesired 6-exo-dig product 3r’ 
was major product (Scheme 12). In this reaction, the starting material remained and could not be 
separated from the product.  
 
Scheme 12. Reaction of alkyl-substituted alkyne 2r 
N
pent
Ph3PAuCl (10 mol %)
AgOTf (10 mol %)
DCE, 80 °C, 24 h
N
pent
N
pent
ca. 37%
endo/exo = 1/12
2r 3r 3r'
pent = n-C5H11
 
 The author speculated the endo/exo selectivity as follows (Figure 2). In the case of ar-
yl-substituted alkynes, the gold catalyst would be ligated to distal carbon because of the steric re-
pulsion with bulky aryl group, which resulted in 7-endo-dig cyclization. In the case of al-
kyl-substituted alkyne, when the reaction proceeded in 6-exo-dig manner, the partial positive 
charge would be at distal carbon of alkyne from alkyl group and stabilized by resonance effect of 
aromatic ring. 
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N
Ar
N
Ar
N
Ar Au+ +
Au+
N
R
N
R
N
R
Au+ Au+
+
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6-exo-dig
Steric Effect Electronic Effect7-endo-dig
 
Figure 2. Explanation of endo/exo selectivity 
 
2.1.2. Reactions of Indoline-Containing Substrates 
To further investigate the substrate scope of this 7-endo-dig-selective cycloisomerization, the 
author subjected indole-containing substrate 4 to gold(I)-catalyzed reaction (Scheme 13). While the 
desired 7-endo-dig cyclization did not proceed, 5-exo-dig product 5 was obtained in moderate yield. 
This result indicated the reactivity of the C2 position of indole is higher than the C7 position. 
 
Scheme 13. Reaction of indole-containing substrate 
Ph3PAuCl (10 mol%)
AgOTf (10 mol%)
DCE, 80 °C, 5.5 h
5
62%
N
p-Tol
N
p-Tol
4
N
p-Tol
not obtained
2
7
 
 To suppress the 5-exo-dig cycloisomerization, an indoline-containing substrate possessing a sp3 
carbon at the C2 position was examined. The author subjected p-tolyl-substituted alkyne 6a to the 
cycloisomerization (Table 5). The desired product 7a was obtained in good NMR yield under the 
conditions of Entry 2 in Table 1 and 5-exo-dig cycloadduct could not be detected as expected, but 
alkyne 6a was not completely consumed after 24 h (Entry 1). The author considered that the cati-
onic gold catalyst was deactivated during the progress of the reaction. To stabilize the catalyst, a 
catalytic amount of pyridine was added. As a result, alkyne 6a was completely consumed and the 
NMR yield exceeded 90% (Entry 2). The reaction did not proceed without a gold catalyst or a sil-
ver salt (Entries 3 and 4). These results indicated that the cationic character of gold species was 
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important for high reactivity. After screening of various counteranions, trifluoromethanesulfonate 
gave the best result (Entries 2, 5, and 6). Unlike the reaction of carbazole-based substrates, tetra-
fluoroborate also realized a high yield. The reaction temperature could be decreased to room tem-
perature without drastic decrease of yield and the reaction proceeded quantitatively at 40 °C, which 
was determined to be the best conditions (Entries 2, 7-9). To compare the reactivity of carbazole- 
and indoline-containing substrates, the reaction under the conditions of Entry 6 in Table 1 was ex-
amined (Entry 10). The starting material 6a slightly remained, but the yield (79%) was higher than 
that of carbazole-containing substrate (14%). These results indicated that indoline-containing sub-
strates had higher reactivity than the carbazole-containing ones. 
 
Table 5. Screening of reaction conditions for 6a 
N
p-Tol Catalyst
+ Silver salt
+ Additive (10 mol%)
DCE, Temp., 24 h
N
p-Tol
6a 7a  
Entry Catalyst Silver salt Additive Temp. /℃ NMR yield /%[a] 
1 Ph3PAuCl AgOTf None 80 75 
2 Ph3PAuCl AgOTf Pyridine 80 93 
3 None AgOTf Pyridine 80 N.R. 
4 Ph3PAuCl None Pyridine 80 N.R. 
5 Ph3PAuCl AgBF4 Pyridine 80 89 
6 Ph3PAuCl AgSbF6 Pyridine 80 92 
7 Ph3PAuCl AgOTf Pyridine 60 93 
8 Ph3PAuCl AgOTf Pyridine 40 >99 
9 Ph3PAuCl AgOTf Pyridine r.t. 83 
10 Ph3PAuCl AgSbF6 None 40 79 
[a] NMR yields was measured using 1,1,2,2-tetrachloroethane as an internal standard. 
 
 Under the optimized conditions of Entry 8 in Table 5, substituent scope of the alkyne moiety was 
examined (Table 6). Compounds 7 were generally unstable and part of the obtained compound was 
oxidized to indole 8 during purification by preparative TLC. Therefore, products were isolated and 
fully characterized as indole derivatives 8 after DDQ oxidation.15 The oxidation of compound 7a 
yielded the indole derivative 8a and the two-step yield was high (Entry 1). Tolyl, anisyl, and phe-
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nyl-substituted alkynes 6b-6g gave indole-containing dibenzazepines 8b-8g in high to excellent 
yields (Entries 2-7). In particular, sterically hindered alkynes 6c and 6f could also be used for this 
reaction. Electron-deficient chlorophenyl-substituted alkynes 6h and 6i provided cyclcoadducts 8h 
and 8i in high yields (Entries 8 and 9). The reaction of 4-(trifluoromethyl)phenyl-substituted alkyne 
6j yielded cyclcoadduct 8j in moderate yield due to low conversion (Entry 10). The use of more 
electrophilic gold catalysts slightly improved the yield, but the substrate still remained after 24 h 
(Entry 11). 1-Naphthyl- and 4-biphenyl-substituted alkynes 6k and 6l were transformed into 8k and 
8l in good to high yields (Entries 12 and 13). When terminal alkyne 6m was subjected to the cy-
cloisomerization, more electrophilic gold catalysts were effective and indoline-containing cy-
cloadduct 7m was obtained in 80% NMR yield. But the oxidation gave several unidentified prod-
ucts and the isolated yield of 8m was moderate (Entry 14). 
 
Table 6. Scope of substituents on alkyne for indoline-containing substrate 
N
R
Ph3PAuCl
+ AgOTf
+ pyridine (10 mol%)
DCE, 40 °C, 24 h
N
R
6 7
DDQ (1.0 eq.)
benzene, r.t., 1-3 h
N
R
8  
Entry R Yield /%[a] Entry R Yield /%[a] 
1 4-MeC6H4 (6a) 93 (8a) 8 4-ClC6H4 (6h) 88 (8h) 
2 3-MeC6H4 (6b) 98 (8b) 9 3-ClC6H4 (6i) >99 (8i) 
3 2-MeC6H4 (6c) 87 (8c) 10 4-CF3C6H4 (6j) 51 (8j) 
4 4-MeOC6H4 (6d) 86 (8d) 11
[b] 4-CF3C6H4 (6j) 64 (8j) 
5 3-MeOC6H4 (6e) 96 (8e) 12 1-Naphthyl (6k) 98 (8k) 
6 2-MeOC6H4 (6f) 88 (8f) 13 4-PhC6H4 (6l) 76 (8l) 
7 Ph (6g) >99 (8g) 14[b] H (6m) 56 (8m) 
[a] Isolated yield. [b] [(C6F5)3P]AuCl and AgBF4 were used. 
 
 Next, the author examined the substituent on the indoline moiety (Scheme 14). Both elec-
tron-withdrawing and -donating groups could be used, and fluoro-substituted cycloadduct 8n and 
methoxy-substituted cycloadduct 8o were obtained in moderate yields. 
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Scheme 14. Reaction of substrates possessing a substituent on indoline moiety 
N
p-Tol
same as Table 6
6n (R1 = F, R2 = H)
6o (R1 = H, R2 = OMe)
DDQ (1.5 eq.)
benzene, r.t., 3 h
N
p-Tol
8n: 71%
8o: 63%
R1
R2
R1
R2
N
p-Tol
R1
R2
 
 The cycloisomerization of pyridine-containing substrate 6p proceeded smoothly at 80 °C without 
addition of external pyridine. Indoline-containing cycloadduct 8p was isolated in high yield with-
out further oxidation (Scheme 15). 
 
Scheme 15. Reaction of pyridine-containing substrate 
N N
p-Tol
Ph3PAuCl
+ AgOTf (10 mol%)
DCE, 80 °C, 2 h
6p
N N
p-Tol
8p
97%  
 To evaluate the effect of ring structure in the substrate, tetrahydroquinoline-based substrate 9 
was subjected to the cycloisomerization (Scheme 16). As a result, the reaction proceeded at lower 
reaction temperature and tetracyclic product 10 was obtained in high yield. This result implies that 
the flexibility of nitrogen-containing ring in the substrate does not affect the reactivity. 
 
Scheme 16. Reaction of tetrahydroquinoline-containing substrate 
p-Tol Ph3PAuCl
+ AgOTf
+ pyridine (10 mol%)
DCE, 40 °C, 24 h
9 10
94%
N N
p-Tol
 
 Finally, the author examined more flexible substrate 11 without fused ring structure (Scheme 17). 
At 40 °C, the conversion was low but the desired dibenzazepine derivative 12 was obtained.16,17 
The yield was improved to 82% at higher reaction temperature of 80 °C. 
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Scheme 17. Reaction of acyclic substrate 
Ph3PAuCl
+ AgOTf
+ pyridine (10 mol%)
DCE, Temp., 24 h
11 12
12% (40 °C)
82% (80 °C)
N
Me
p-Tol
N
Me
p-Tol
 
 The author speculated higher reactivity of indoline-containing substrates than carba-
zole-containing ones as follows (Figure 3). In the case of carbazole-containing substrate, there were 
two reactive carbons for cyclization. The lone pair of nitrogen atom delocalized to two aromatic 
rings of carbazole moiety. In contrast, indoline-containing substrate had only one reactive carbon 
and the lone pair delocalized to one aromatic ring of indoline moiety. As a result, the resonance ef-
fect of nitrogen atom of indoline-containing substrate would be stronger than that of carba-
zole-containing substrate. In addition, the alkyl moiety of indoline moiety acted as elec-
tron-donating group to increase the nucleophilicity. 
N
R
N
R
alkyl group
EDG
two reactive carbons
resonance effect of nitrogen: weak
one reactive carbon
resonance effect of nitrogen: strong  
Figure 3. Higher reactivity of indoline-containing substrates than carbazole-containing ones 
 
 While the reaction of triphenylamine derivative 1 did not proceed (Scheme 1a), the reaction of 
2-alkynyl-N-methyldiphenylamine derivative 11 proceeded. The author speculated the strikingly 
different reactivity of phenyl and methyl groups as follows (Figure 4). In the case of triphenyla-
mine derivative 1, the steric repulsion of two phenyl groups made the phenyl group and the lone 
pair of nitrogen atom difficult to occupy the same plane. As a result, the resonanace effect of nitro-
gen atom was small, and phenyl group acted as an electron-withdrawing group. In contrast, in the 
case of less bulky methyl-substituted substrate 11, phenyl group and the lone pair of nitrogen atom 
occupy the same plane and resonance effect of nitrogen was large, moreover, methyl group acted as 
an electron-donating group. 
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N
p-Tol
Me
N
p-Tol
resonance effect of nitrogen atom
weak
resonance effect of nitrogen atom
strong  
Figure 4. Effect of substituent for the reactivity 
 
2.2. Synthesis of Dibenzodiazocines by 8-exo-dig-Selective Cycloisomerization 
 In the previous section, the 7-endo-dig cycloisomerization of 2-alkynyldiphenylamine was ex-
plained. In this section, the author describes the 8-exo-dig-selective cycloisomerization of 
2-propargylaminotriphenylamines. 
First, tosyl-protected 2-(propargylamino)triphenylamine 13a was subjected to the 
gold(I)-catalyzed cycloisomerization (Table 7). The reaction of 13a proceeded smoothly in the 
presence of chloro(triphenylphosphine)gold(I) and silver hexafluoroantimonate in DCM at room 
temperature, and the desired 8-exo-dig product 14a was selectively obtained (Entry 1). Other cy-
cloadducts, such as 6-endo-dig product 14a’ and 9-endo-dig product 14a’’, were not obtained. After 
screening of silver salts, silver hexafluoroantimonate was found to be the best (Entries 1-3). In the 
absence of a gold catalyst or a silver salt, the reaction was totally deterred (Entries 4 and 5). The 
use of toluene as a solvent improved the yield, and the reaction proceeded quantitatively in chloro-
benzene (Entries 6 and 7). The amount of catalyst loading could be reduced to 5 mol% without 
drastic decrease of yield (Entry 8). 
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Table 7. Screening of reaction conditions for 13a 
N
TsN
N
NTsPh3PAuCl  (10 mol%)
Ag salt  (10 mol%)
Solvent, r.t., 1 h
Ph
Ph
13a 14a
TsN
Ph2N
14a'
NTs
N
Ph
14a''
 
Entry Ag salt Solvent Yield of 14a /%[a] 
1 AgSbF6 DCM 90 
2 AgOTf DCM (47)[b] 
3 AgBF4 DCM (52)
[b] 
4 None DCM N.R. 
5[c] AgSbF6 DCM N.R. 
6 AgSbF6 toluene 97 
7 AgSbF6 PhCl 99 
8[d] AgSbF6 PhCl 79 
[a] Isolated yield. NMR yield was shown in parentheses. [b] NMR yields was measured using 
1,1,2,2-tetrachloroethane as an internal standard. [c] The reaction was conducted without gold cat-
alyst. [d] Gold complex and Ag salt (5 mol%) was used. 
 
 Under the reaction conditions of Entry 7 in Table 7, substrates possessing substituents on aro-
matic rings were subjected to the cycloisomerization (Scheme 18). The reaction of 
N-(3,5-dimethoxyphenyl)-substituted substrate 13b proceeded quantitatively to give the product 
14b, where more electron-rich arene was selectivity involved in the transformation [Equation (1)]. 
In contrast, N-(4-fluorophenyl)-substituted substrate 13c was selectively converted into 14c, where 
the electron-poor arene was untouched [Equation (2)]. The substituents on the o-diaminobenzene 
moiety were also examined [Equation (3)]. While the reaction of methyl-substituted substrate 13d 
gave the desired product 14d in high yield, that of trifluoromethyl-substituted substrate 13e af-
forded the corresponding cycloadduct 14e in low yield, even after a longer reaction time. The rea-
son for the low reactivity of 13e could be explained by the strong electron-withdrawing effect of 
the trifluoromethyl group. Therefore, the author used the more electrophilic gold catalyst to make 
the alkyne moiety more electrophilic. As a result, the yield was dramatically improved to 95%. 
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Scheme 18. Reactions of substrates possessing substituents on the aromatic rings 
N
TsN
N
NTsPh3PAuCl (10 mol%)
AgSbF6 (10 mol%)
PhCl, r.t., 1 h
Ph
Ph
OMe
MeO MeO
MeO
(1)
N
Ph
TsN
N
NTs
same as above
14b
>99%
(2)
14c
99%
(3)
N
TsN
N
NTs
LAuCl (10 mol%)
AgSbF6 (10 mol%)
PhCl, r.t., 1 h
Ph
Ph
14d: 82% (L = PPh3)
14e: 36% (L = PPh3, 20 h)
        95% (L = P(p-CF3C6H4)3)
R
R
F
13b
13c
13d (R = Me)
13e (R = CF3)
4-FC6H4
 
 Next, the author examined the reaction of internal alkyne 13f (Table 8). Under the optimized 
conditions for terminal alkynes as above, the reaction sluggishly proceeded and only a trace 
amount of the desired product 14f was detected even at high temperature (Entry 1). After screening 
of phosphine ligands, the more sterically hindered and electron-rich phosphine ligand, tBuXPhos, 
gave 14f in low yield (Entry 2). Various ligands were examined and IPr type ligands were found 
more effective for this transformation (Entries 3, 6 and 7). IMes type ligands were ineffective in the 
present reaction and the formation of 14f was not detected (Entries 3 and 4). These results sug-
gested that the bulkiness around the gold catalyst and the strong σ-donation of the NHC ligand 
were crucial for this reaction of internal alkyne.18 The olefin moiety of 14f was confirmed to be E 
isomer by NOESY analysis. 
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Table 8. Screening of reaction conditions for internal alkyne 13f 
N
TsN
N
NTs
LAuCl (10 mol%)
AgSbF6 (10 mol%)
PhCl, 80 °C, 24 h
Ph
Ph
Ph
Ph
14f13f  
Entry L Isolated yield /% 
1 PPh3 trace 
2 tBuXPHOS 8 
3 IPr 94 
4 IMes N.D. 
5 SIMes N.D. 
6 SIPr 88 
7 IPrMe 71 
 
 Under the optimized conditions of Entry 3 in Table 8, various internal alkynes were subjected to 
the cycloisomerization (Table 9). Anisyl-substituted alkynes 13g-13i were not completely con-
sumed and the yields of cycloadducts 14g-14i were moderate (Entries 1-3).19 In contrast, elec-
tron-withdrawing group-substituted arylalkynes 13j-13l were completely consumed and the desired 
products 14j-14l were obtained in high yields (Entries 4-6). Ethoxycarbonyl-substituted alkyne 
13m was the best substrate and gave cycloadduct 14m in 98% (Entry 7). 
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Table 9. Substrate scope for internal alkynes 
N
TsN
N
NTs
IPrAuCl (10 mol%)
AgSbF6 (10 mol%)
PhCl, 80 °C, 24 h
Ph
Ph
R
R
 
Entry R Yield /% 
1 4-MeOC6H4 (13g) 41 (14g) 
2 3-MeOC6H4 (13h) 53 (14h) 
3 2-MeOC6H4 (13i) 50 (14i) 
4 4-CF3C6H4 (13j) 85 (14j) 
5 4-FC6H4 (13k) 87 (14k) 
6 4-ClC6H4 (13l) 93 (14l) 
7 CO2Et (13m) 98 (14m) 
 
 During the screening of NHC ligands, ICy ligand showed different regioselectivity (Scheme 19). 
In the reactions of electron-donating group-substituted arylalkynes 13g and 13o, 6-endo-dig prod-
ucts 14g’ and 14o’ were selectively obtained in moderate yields and 8-exo-dig products 14g and 
14o were not be detected. In Entry 1 of Table 9, 6-endo-dig product 14g’ was obtained as a by-
product.19 The author considered that the combination of electron-donating group-substituted arene 
and less bulky ligand changed the regioselectivity. 
 
Scheme 19. Undesired 6-endo-dig cyclization for the internal alkynes 
N
Ph
TsN
ICyAuCl (20 mol%)
AgSbF6 (20 mol%)
PhCl, 80 °C, 24 h
(4)
13g (R = 4-MeOC6H4)
13o (R = 4-MeC6H4)
R
14g': 50%
14o': 43%
N
Ph
NTs
R
14g: N.D.
14o: N.D.
TsN
Ph2N
R
 
 To investigate the effect of nitrogen atoms for this selective transformation, the author examined 
the reactions of o-aminophenol-tethered substrates 15 and 17 (Scheme 20). In the case of propargyl 
ether-containing substrate 15, the reaction proceeded in selective 6-endo-dig fashion to give 16’ in 
low yield without formation of 8-exo-dig product 16 [Equation (5)]. These results indicated that the 
propargyl moiety and the diphenylamino group could be readily accessible because of the steric 
repulsion between the tosyl and diphenylamino groups (Figure 5). Moreover, the elec-
tron-withdrawing effect of the tosyl group decreased the nucleophilicity of its ortho position and 
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6-endo-dig cycloisomerization hardly proceeded. On the other hand, the reaction of phe-
noxy-substituted substrate 17 did not provide any cycloadducts, but gave hydration product 18’ 
[Equation (6)]. This result suggested that the arene moiety was hardly accessible to the alkyne 
moiety due to the flexible phenoxy group (Figure 6). In addition, tosyl and phenoxy groups acted as 
electron-withdrawing ones to lower the nucleophilicity for 6-endo-dig cycloisomerization.  
 
Scheme 20. Effect of heteroatom-tether 
O
TsN
same as above
O
NTs
O
TsN
O
18'
51%
18
N.D.
N
O Ph3PAuCl (10 mol%)
AgSbF6 (10 mol%)
PhCl, r.t., 1 h
N
Ph
O
16
N.D.
N
Ph
O
16'
23%
(5)
(6)
15
17
 
  
N N Ph
PhTs
LAu
O N Ph
Ph
LAu
Conformations for 6-endo-dig cyclization
large steric repulsion
low nucleophilicity
small steric repulsion
high nucleophilicity  
Figure 5. Effect of propargylamino group 
 
N O
Ph
Ts
LAu
N O Ph
Ts
LAu
8-exo-dig 6-endo-dig
large steric repulsion low nucleophilicity
two EWGs: NTs and PhO  
Figure 6. Explanation of low reactivity of phenoxy-containing substrate 
 
 6-Endo-dig-selective cycloisomerization was observed in the reaction of electron-donating 
group-substituted alkynes with less bulky NHC ligand (see, Scheme 18). The author speculated the 
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reason for this selectivity as follows (Figure 7). First, the electron-donating group at alkyne termi-
nus stabilized more the proximal partial positive charge in the transition state for 6-endo-dig cy-
cloisomerization than distal one in the transition state for 8-exo-dig cycloisomerization (Figure 7a). 
Second, the use of bulky NHC ligand (IPr) induced propargyl moiety to approach diphenylamine 
group by the steric repulsion between tosyl group and gold catalyst coordinated to alkyne (Figure 
7b). 
N
Ph
NTs
EDG
TsN
Ph2N
EDG
AuL AuL
+ +
N N Ph
Ph
Ts
LBAu
R
N N Ph
Ph
Ts
LBAu
LB: bulky ligand
R
(a) Effect of electron-donating group for 6-endo-dig selectivity
(b) Effect of bulky NHC ligand for 8-endo-dig selectivity
A B
transition state
for 6-endo-dig
transition state
for 8-exo-dig
 
Figure 7. Explanation of selectivity of the reaction of internal alkyne 
 
Conclusion  
 The author developed gold(I)-catalyzed 7-endo-dig- and 8-exo-dig-selective cycloisomerizations 
for the synthesis of dibenzazepines and dibenzodiazocines. The 7-endo-dig-selective cycloisomeri-
zation proceeded when 2-(1-alkynyl)diphenylamine derivatives were used as substrates. The flexi-
bility around the nitrogen atom affected the reactivity, which meant more rigid structure exhibited 
higher reactivity. The author speculated the reason as follows. The fixed structure led to the lone 
pair of nitrogen atom and reactive aromatic ring aligned in the same plane and increased the nucle-
ophilicity by resonance effect. In addition, the use of indoline moiety increased the nucleophilicity 
compared to carbazole-derived substrate by eletron-donating effect of alkyl group. The 
8-exo-dig-selective cycloisomerization was achieved by using 2-propargylaminotriphenylamine 
derivatives as substrates. ortho-Diaminobenzene tether was important for the selective cycloisom-
erization. The steric repulsion between N-tosyl group and diphenylamine group might make the 
substrate conformation such that the propargyl moiety is only accessible from the reaction site 
8-exo-dig cyclization. The electron-withdrawing effect of Ts group might also make the 
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6-endo-dig-selective reaction site less nucleophilic. For the reaction of internal alkynes, the use of 
IPr as a ligand and electron-withdrawing substituents on alkyne terminus were crucial for the 
8-exo-dig selective cycloisomerization. The use of less bulky NHC ligand (ICy) and elec-
tron-donating group on alkyne terminus promoted 6-endo-dig-selective cycloisomerization. The 
author speculated that the bulky NHC ligand (IPr) caused steric repulsion with tosyl group to in-
duce the propargyl moiety approaching diphenylamine group and electron-donating group on al-
kyne terminus made the transition state of 6-endo-dig cycloisomerization more stable than that of 
8-exo-dig. 
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Experimental Section  
General information: 1H NMR spectra were recorded on JEOL ECX-500 (500 MHz) spectrome-
ters. The chemical shifts were reported in parts per million (δ) relative to internal standard TMS (0 
ppm) for CDCl3. The peak patterns are indicated as follows: s, singlet; d, doublet; dd, doublet of 
doublets; t, triplet; td, triplet of doublets; m, multiplet; q, quartet. The coupling constants, J, are 
reported in Hertz (Hz). 13C NMR spectra were obtained by JEOL ECX-500 (125 MHz) spectrome-
ters and referenced to the internal solvent signals (central peak is 77.16 ppm in CDCl3). CDCl3 was 
used as a NMR solvent. High-resolution mass spectra (HRMS) were measured on a JMS-T100CS 
with ESI (Electro Spray Ionization) method. Preparative thin-layer chromatography (PTLC) was 
performed with silica gel-precoated glass plates (Wakogel B-5F) prepared in our laboratory, Flash 
silica gel column chromatography was performed over silica gel 200-300. All reagents were 
weighed and handled in air and backfilled under argon at room temperature. Unless otherwise not-
ed, all reactions were performed under an argon atmosphere. All reagents were purchased from 
Wako, Kanto, Aldrich, TCI and Strem and used without further purification. Compounds 2h20, S121 
and S222 are known. 4-methoxy-9H-carbazole, 7H-benzo[c]carbazole, 11H-benzo[a]carbazole, and 
1-bromo-2-[2-(4-methylphenyl)ethynyl]benzene were synthesized by reported protocol.23-26 
 
Synthetic schemes of substrates in 2.1.1. 
diphenylamine
Pd(OAc)2 + Xantphos
NaOtBu N
Br
S1
PdCl2(PPh3)2, CuI
TEA, 80 °C
p-Tolyl
N p-Tolyl
I
Br
1
toluene, 100 °C
 
Preparation of 2-(4-methylphenyl)ethynyl-N,N,-diphenyl-benzenamine (1): 
A dry Schlenk tube was charged 1-bromo-2-iodobenzene (1.0 mmol), Pd(OAc)2 (0.030 mmol), 
Xantphos (0.050 mmol), NaOtBu (1.5 mmol), diphenylamine (1.2 mmol) and toluene (1.4 mL). 
The solution was stirred at 110 °C (bath temperature) for 1 h. After cooling, it was filtered by silica 
gel and the solvents were removed. Then the residue was purified by flash silica gel column chro-
matography on silica gel (hexane/EtOAc = 92/8) to give S1, 74%.26 The next step was the same as 
the second step of following synthesis of 2. 
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PdCl2(PPh3)2, CuI
TEA, 80 °C
R
N RN
I
1,2,-diiodobenzene
CuI, K2CO3
xylene, reflux
N
H
S2 2  
Preparation of 9-(2-alkynylphenyl)-9H-carbazole derivatives (2): 
A 50 mL dry two-necked pear-shaped flask equipped with a rubber septum, Allihn condenser and 
argon balloon was charged with carbazole or derivatives (5.5 mmol), CuI (3.5 mmol), K2CO3 (9.0 
mmol) and xylene (12.0 mL). The solution was stirred at room temperature, and 1,2,-diiodobenzene 
(6.0 mmol) was added. The reaction mixture was stirred at 150 °C for 72 h. The solution was 
cooled to room temperature, 1N HCl (10 mL) was added. The aqueous layer was extracted with 
DCM, and the organic extract was dried over Na2SO4, filtered, and evaporated under reduced 
pressure. After removal of solvent, it was purified by flash silica gel column chromatography 
(hexane/DCM = 9/1) and compound S2 was obtained, 61%.27 
A dry Schlenk tube was charged compound S1 (0.25 mmol), PdCl2(PPh3)2 (0.020 mmol), CuI (1 
0.023 mmol) and distilled Et3N (TEA, 0.50 mL) and stirred at room temperature. Alkynes (0.50 
mmol) was added to the reaction vessel. The solution was then stirred at 80 °C (bath temperature) 
for 16 h. After cooling, the solvents were removed, and the residue was purified by flash silica gel 
column chromatography on silica gel (hexane/DCM = 9/1) to give 2.28 
 
N TMS N H
TBAF
THF, 0 °Cr.t.
S3 2g
PdCl2(PPh3)2, CuI
TEA, 80 °C
TMS
N
I
S1  
Preparation of 9-(2-((trimethylsilyl)ethynyl)phenyl)-9H-carbazole (2g): 
First step was the same as the synthesis protocol of 2, to give S2, and the second step was exam-
ined without complete purification. A dry Schlenk tube was charged compound S2 (0.40 mmol) and 
THF 1.5 mL and stirred at 0 ℃. 1 M TBAF in THF (0.8 mL) was added to the reaction mixture, 
and it was stirred at room temperature. After 1 h, sat.NH4Cl 2.0 mL was added and extracted by 
EtOAc (5.0 mL×3). The organic layer was washed H2O and brine, and dried over Na2SO4. After 
removal of solvent, it was purified by column chromatography on silica gel (hexane/DCM = 9/1) to 
give 2g, 72%.28 
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PdCl2(PPh3)2, CuI
TEA, 80 °C
p-Tol
NN
1,2,-diiodobenzene
CuI, K2CO3
xylene, reflux
N
H
2n or 2o
OMe
OMe OMe
Br
p-Tol
 
Preparation of 9-(2-iodophenyl)-9H-carbazole derivatives (2n, 2o): 
The reaction was the same as the synthesis protocol of 2 using 4-methoxy-9H-carbazole or 
7H-benzo[c]carbazole instead of carbazole. The second step was examined without purification. 
 
N p-Tol
CuI, K2CO3
xylene, refluxN
H
2p
Br p-Tol
 
Preparation of benzo[1,2]-9-(2-((4-methylphenyl)ethynyl)phenyl)-11H-carbazole (2p): 
The reaction was the same as the first step of synthesis protocol of 2 using 11H-benzo[a]carbazole 
and 1-bromo-2-[2-(4-methylphenyl)ethynyl]-benzene. 
 
p-ethynylanisole
PdCl2(PPh3)2, CuI
(i-Pr)2NH, 80 °C
N PMPN
Br
carbazole
CuI, K2CO3
xylene, reflux
Br
Br
2q  
Preparation of 9-(2-(3-(4-methoxyphenyl)ethynyl)naphthalenyl)-9H-carbazole (2q): 
The reaction was the same as the synthesis protocol of 2 by using 2,3,-dibromonaphthalene in-
stead of 1,2,-diiodobenzene. The second step was examined without purification, and (i-Pr)2NH 
was used as the solvent instead of TEA. 
 
General procedure for cycloisomerization in Tables 2 and Table 4: 
Table 2: Ph3PAuCl (0.0050 mmol), AgSbF6 (0.0050 mmol), and 9-(2-ethynylphenyl)-9H-carbazole 
derivatives 2 (0.050 mmol) were placed in a Schlenk tube, which was then evacuated and back-
filled with argon (×3). To the reaction vessel was added anhydrous DCE (0.50 mL). The solution 
was then stirred at 80 °C (bath temperature). The reaction mixture was cooled to room temperature 
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and the solvent was evaporated. The obtained crude product was purified by PTLC to give products 
3. 
Table 4: (C6F5)3PAuCl (0.0050 mmol), AgOTf (0.0050 mmol), and 
9-(2-ethynylphenyl)-9H-carbazole derivatives 2 (0.050 mmol) were placed in a Schlenk tube, 
which was then evacuated and backfilled with argon (×3). To the reaction vessel was added anhy-
drous DCE (0.50 mL). The solution was then stirred at room temperature. After removal of solvent, 
the crude product was purified by PTLC to give products 3. 
 
Characterization data for new compounds in 2.1.1. 
2-(4-Methylphenyl)ethynyl-N,N,-diphenylbenzenamine (1) 
Isolated by PTLC (hexane/DCM = 8/1 x2). The title compound was obtained as a pale yellow solid, 
20%; mp 79 °C; 1H NMR δ 7.55-7.51 (m, 1H), 7.29-7.24 (m, 1H, overlapped with CHCl3), 
7.24-7.19 (m, 4H), 7.16-7.11 (m, 2H), 7.06-7.03 (m, 4H), 7.02-6.98 (m, 2H), 6.97-6.92 (m, 4H), 
2.29 (s, 3H); 13C NMR δ 148.5, 147.9, 138.2, 134.2, 131.6, 129.5, 129.1, 128.9, 128.9, 124.9, 123.0, 
122.1, 122.1, 120.3, 95.4, 86.8, 21.6; HRMS (DART, positive): m/z calcd. for C27H22N [M + H]
+ 
360.1746, found 360.1747. 
 
9-(2-((4-Methylphenyl)ethynyl)phenyl)-9H-carbazole (2a) 
Isolated by flash silica gel column chromatography (hexane/DCM = 9/1). The title compound was 
obtained as a white solid, 77%; mp 107 °C; 1H NMR δ 8.16 (dd, J = 7.4, 1.3 Hz, 2H), 7.76 (dd, J = 
7.7, 1.6 Hz, 1H), 7.59-7.51 (m, 2H), 7.48 (ddd, J = 7.4, 7.4, 1.6 Hz, 1H), 7.40-7.35 (m, 2H), 7.27 
(dd, J = 7.4, 7.4 Hz, 4H), 6.86 (d, J = 8.0 Hz, 2H), 6.49 (d, J = 8.3 Hz, 2H), 2.20 (s, 3H); 13C NMR 
δ 140.9, 138.9, 138.4, 133.3, 131.2, 129.2, 129.0, 128.7, 128.0, 125.7, 123.3, 123.2, 120.1, 119.7, 
119.4, 110.6, 95.7, 85.5, 21.4; HRMS (DART, positive): m/z calcd. for C27H20N [M + H]
+ 358.1591, 
found 358.1590. 
 
9-(2-((2-Methylphenyl)ethynyl)phenyl)-9H-carbazole (2b) 
Isolated by flash silica gel column chromatography (hexane/DCM = 9/1). The title compound was 
obtained as a white solid, 86%; mp 125-126 °C; 1H NMR δ 8.14 (d, J = 7.8 Hz, 2H), 7.83-7.79 (m, 
1H), 7.56-7.48 (m, 3H), 7.39-7.35 (m, 2H), 7.28-7.21 (m, 4H, overlapped with CHCl3), 7.02 (dd, J 
= 7.8, 7.8 Hz, 1H), 6.90 (dd, J = 7.5, 7.5 Hz, 2H), 6.73 (d, J = 7.7 Hz, 1H), 1.58 (s, 3H); 13C NMR δ 
141.1, 140.2, 138.6, 133.7, 131.9, 129.4, 129.2, 128.3, 128.2, 125.8, 125.2, 123.7, 123.4, 122.3, 
120.1, 119.7, 110.4, 110.6, 93.8, 89.6, 19.5; HRMS (DART, positive): m/z calcd. for C27H20N [M + 
H]+ 358.1591, found 358.1590. 
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9-(2-((4-Methoxylphenyl)ethynyl)phenyl)-9H-carbazole (2c) 
Isolated by flash silica gel column chromatography (hexane/DCM = 9/1). The title compound was 
obtained as a white solid, 88%; mp 82 °C; 1H NMR δ 8.16 (dd, J = 7.5, 1.3 Hz, 2H), 7.74 (dd, J = 
7.6, 1.6 Hz, 1H), 7.59-7.50 (m, 2H), 7.50-7.46 (m, 1H), 7.38 (ddd, J = 7.6, 7.6, 1.3 Hz, 2H), 7.28 
(dd, J = 7.6, 7.6 Hz, 4H), 6.58 (d, J = 9.0 Hz, 2H), 6.52 (d, J = 9.0 Hz, 2H), 3.69 (s, 3H); 13C NMR 
δ 159.6, 140.9, 138.7, 133.1, 132.8, 128.9, 128.0, 125.7, 123.3, 123.3, 120.1, 119.7, 114.6, 114.2, 
113.6, 110.6, 95.6, 84.9, 55.1; HRMS (DART, positive): m/z calcd. for C27H19NNaO [M + Na]
+ 
396.1360, found 396.1359. 
 
9-(2-((1-naphthyl)ethynyl)phenyl)-9H-carbazole (2d) 
Isolated by flash silica gel column chromatography (hexane/DCM = 9/1). The title compound was 
obtained as a white solid, 87%; mp 149 °C; 1H NMR δ 8.21 (d, J = 7.8 Hz, 2H), 7.91 (d, J = 7.2 Hz, 
1H), 7.63 ( dd, J = 8.2, 2.6 Hz, 2H), 7.58-7.52 (m, 3H), 7.38 (dd, J = 7.1, 7.1 Hz, 2H), 7.34-7.26 (m, 
5H), 7.21 (dd, J = 7.4, 7.4 Hz, 1H), 7.12-7.05 (m, 2H), 6.95 (d, J = 8.2 Hz, 1H); 13C NMR δ 141.2, 
138.7, 133.9, 132.8, 130.5, 129.6, 129.3, 128.8, 128.3, 127.8, 126.6, 126.1, 125.9, 125.8, 124.9, 
123.6, 123.4, 120.2, 119.9, 110.4, 93.1, 90.6 (two pairs of peaks at the aromatic region were over-
lapped); HRMS (DART, positive): m/z calcd. for C30H20N [M + H]
+ 394.1591, found 394.1591. 
 
9-(2-((3-Thienyl)ethynyl)phenyl)-9H-carbazole (2e) 
Isolated by flash silica gel column chromatography (hexane/DCM = 9/1). The title compound was 
obtained as a brown solid, 77%; mp 109 °C; 1H NMR δ 8.16 (d, J = 7.9 Hz, 2H), 7.74 (dd, J = 7.7, 
1.4 Hz, 1H), 7.61-7.52 (m, 2H), 7.49 (ddd, J = 7.5, 7.5, 1.4 Hz, 1H), 7.42-7.36 (m, 2H), 7.32-7.25 
(m, 4H), 7.00 (dd, J = 4.9, 3.0 Hz, 1H), 6.63 (dd, J = 2.8, 1.1 Hz, 1H), 6.32 (dd, J = 4.9, 1.1 Hz, 
1H); 13C NMR δ 140.9, 139.0, 133.0, 129.3, 129.2, 129.0, 128.9, 128.0, 125.7, 124.9, 123.3, 123.0, 
121.6, 120.1, 119.8, 110.6, 90.8, 85.7; HRMS (DART, positive): m/z calcd. for C24H16NS [M + H]
+ 
350.0999, found 350.0998. 
 
9-(2-((2-Thienyl)ethynyl)phenyl)-9H-carbazole (2f) 
Isolated by flash silica gel column chromatography (hexane/DCM = 9/1). The title compound was 
obtained as a brown solid, 75%; mp 123-124 °C; 1H NMR δ 8.16 (d, J = 7.8 Hz, 2H), 7.74 (dd, J = 
7.7, 1.4 Hz, 1H), 7.60-7.52 (m, 2H), 7.48 (ddd, J = 7.5, 7.5, 1.5 Hz, 1H), 7.42-7.35 (m, 2H), 
7.31-7.24 (m, 4H), 7.06 (dd, J = 5.1, 1.1 Hz, 1H), 6.73 (dd, J = 5.1, 3.8 Hz, 1H), 6.42 (dd, J = 3.8, 
1.1 Hz, 1H); 13C NMR δ 140.9, 138.8, 132.9, 132.1, 129.4, 129.0, 128.0, 127.7, 126.8, 125.7, 123.4, 
122.7, 122.4, 120.2, 119.8, 110.5, 89.8, 88.8; HRMS (DART, positive): m/z calcd. for C24H16NS [M 
+ H]+ 350.0999, found 350.0998. 
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9-(2-Ethynylphenyl)-9H-carbazole (2g) 
Isolated by flash silica gel column chromatography (hexane/DCM = 9/1). The title compound was 
obtained as a white solid, 66% (2 steps); mp 64 °C; 1H NMR δ 8.14 (d, J = 7.8 Hz, 2H), 7.78 (dd, J 
= 7.6, 1.5 Hz, 1H), 7.56 (ddd, J = 7.6, 7.6, 1.6 Hz, 1H), 7.51-7.46 (m, 2H), 7.42-7.37 (m, 2H), 7.28 
(dd, J = 7.4, 7.4 Hz, 2H), 7.19 (d, J = 8.2 Hz, 2H), 2.79 (s, 1H); 13C NMR δ 141.2, 139.8, 134.6, 
130.3, 129.3, 128.3, 125.8, 123.5, 122.4, 120.3, 120.0, 110.5, 82.8, 79.9; HRMS (DART, positive): 
m/z calcd. for C20H14N [M + H]
+ 268.1121, found 268.1121. 
 
9-(2-((3-Methylphenyl)ethynyl)phenyl)-9H-carbazole (2i) 
Isolated by flash silica gel column chromatography (hexane/DCM = 9/1). The title compound was 
obtained as a white solid, 86%; mp 106 °C; 1H NMR δ 8.17 (d, J = 7.8 Hz, 2H), 7.76 (dd, J = 7.6, 
1.5 Hz, 1H), 7.61-7.52 (m, 2H), 7.49 (ddd, J = 7.6, 7.6, 1.5 Hz, 1H), 7.41-7.35 (m, 2H), 7.31-7.25 
(m, 4H), 6.97-6.91 (m, 2H), 6.49-6.44 (m, 1H), 6.28 (s, 1H), 3.69 (s, 3H); 13C NMR δ 141.1, 139.2, 
137.7, 133.4, 132.2, 129.4, 129.3, 129.1, 128.3, 128.2, 127.9, 125.9, 123.5, 123.3, 122.4, 120.3, 
119.9, 110.7, 95.9, 85.9, 21.2; HRMS (DART, positive): m/z calcd. for C27H20N [M + H]
+ 358.1590, 
found 358.1590. 
 
9-(2-((3-Methoxylphenyl)ethynyl)phenyl)-9H-carbazole (2j) 
Isolated by flash silica gel column chromatography (hexane/DCM = 9/1). The title compound was 
obtained as a white solid, 63%; mp 78 °C; 1H NMR δ 8.15 (d, J = 7.5 Hz, 2H), 7.77 (dd, J = 7.6, 
1.5 Hz, 1H), 7.60-7.53 (m, 2H), 7.50 (ddd, J = 7.4, 7.4, 1.6 Hz, 1H), 7.42-7.36 (m, 2H), 7.30-7.25 
(m, 4H), 6.97 (dd, J = 8.0, 8.0 Hz, 1H), 6.70-6.66 (m, 1H), 6.35 (d, J = 7.7 Hz, 1H), 5.99 (dd, J = 
2.1, 1.1 Hz, 1H), 3.59 (s, 3H); 13C NMR δ 159.1, 141.1, 139.2, 133.5, 129.6, 129.1, 128.2, 125.9, 
125.9, 123.8, 123.6, 123.4, 123.1, 120.2, 119.9, 115.9, 115.4, 110.7, 95.5, 85.9, 55.4; HRMS 
(DART, positive): m/z calcd. for C27H20NO [M + H]
+ 374.1540, found 374.1539. 
 
9-(2-((4-Biphenyl)ethynyl)phenyl)-9H-carbazole (2k) 
Isolated by flash silica gel column chromatography (hexane/DCM = 9/1). The title compound was 
obtained as a white solid,  65%; mp 133-134 °C; 1H NMR δ 8.18 (d, J = 7.1 Hz, 2H), 7.79 (dd, J = 
7.7, 1.4 Hz, 1H), 7.62-7.54 (m, 2H), 7.50 (ddd, J = 7.4, 7.4, 1.6 Hz, 1H), 7.48-7.44 (m, 2H), 
7.42-7.35 (m, 4H), 7.32-7.27 (m, 7H), 6.65 (d, J = 8.3 Hz, 2H); 13C NMR δ 141.1, 140.4, 139.2, 
133.5, 131.8, 129.5, 129.2, 128.9, 128.2, 127.7, 127.1, 126.8, 125.9, 123.5, 123.2, 121.5, 120.3, 
119.9, 110.7, 95.5, 86.9 (a pair of peaks at the aromatic region was overlapped); HRMS (DART, 
positive): m/z calcd. for C32H22N [M + H]
+ 420.1745, found 420.1747. 
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9-(2-((4-Chlorophenyl)ethynyl)phenyl)-9H-carbazole (2l) 
Isolated by flash silica gel column chromatography (hexane/DCM = 9/1). The title compound was 
obtained as yellow oil, 87%; 1H NMR δ 8.17 (d, J = 7.8 Hz, 2H), 7.76 (d, J = 7.7 Hz, 1H), 
7.63-7.55 (m, 2H), 7.51 (ddd, J = 7.3, 7.3, 1.6 Hz, 1H), 7.41-7.36 (m, 2H), 7.32-7.22 (m, 4H, over-
lapped with CHCl3), 7.03 (dd, J = 8.4, 1.4 Hz, 2H), 6.52-6.44 (m, 2H); 
13C NMR δ 141.0, 139.3, 
134.4 133.4, 132.6, 129.8, 129.2, 128.4, 128.2, 125.9, 123.5, 122.8, 121.1, 120.3, 120.0, 110.7, 94.4, 
87.1; HRMS (DART, positive): m/z calcd. for C26H17ClN [M + H]
+ 378.1045, found 378.1044. 
 
9-(2-((4-Trifluoromethylphenyl)ethynyl)phenyl)-9H-carbazole (2m) 
Isolated by flash silica gel column chromatography (hexane/DCM = 9/1). The title compound was 
obtained as yellow oil, 89%; 1H NMR δ 8.17 (d, J = 7.7 Hz, 2H), 7.78 (d, J = 7.4 Hz, 1H), 
7.64-7.57 (m, 2H), 7.52 (ddd, J = 7.6, 7.6, 2.0 Hz, 1H), 7.41-7.36 (m, 2H), 7.33-7.25 (m, 6H), 6.64 
(d, J = 8.2 Hz, 2H); 13C NMR δ 141.0, 139.5, 133.6, 131.5, 130.2, 130.1, 129.8, 129.3, 128.3, 126.4, 
125.9, 125.0 (q, JC-F = 3.8 Hz, 1C), 123.5, 122.5, 120.4, 120.1, 110.6, 94.0, 88.4; HRMS (DART, 
positive): m/z calcd. for C27H17F3N [M + H]
+ 412.1308, found 412.1308. 
 
9-(2-((4-Methylphenyl)ethynyl)phenyl)-4-methoxy-9H-carbazole (2n) 
Isolated by flash silica gel column chromatography (hexane/DCM = 9/1). The title compound was 
obtained as a brown solid, 58% (2 steps); mp 40 °C; 1H NMR δ 8.41 (d, J = 7.7 Hz, 1H), 7.74 (d, J 
= 7.6 Hz, 1H), 7.56-7.43 (m, 3H), 7.36-7.21 (m, 4H), 6.90-6.84 (m, 3H), 6.72 (d, J = 7.9 Hz, 1H), 
6.53 (d, J = 7.8 Hz, 2H), 4.11 (s, 3H), 2.20 (s, 3H); 13C NMR δ 156.4, 142.5, 140.3 139.2, 138.5, 
133.3, 131.3, 129.2, 129.2, 128.8, 128.1, 126.5, 124.9, 123.4, 123.1, 122.8, 120.0, 119.6, 112.7, 
110.2, 103.6, 101.0, 95.7, 85.6, 55.7, 21.5; HRMS (DART, positive): m/z calcd. for C28H22NO [M + 
H]+ 388.1696, found 388.1696. 
 
Benzo[3,4]-9-(2-((4-methylphenyl)ethynyl)phenyl)-7H-carbazole (2o) 
Isolated by flash silica gel column chromatography (hexane/DCM = 9/1). The title compound was 
obtained as a white solid, 13% (2 steps); mp 74-75 °C; 1H NMR δ 8.88 (d, J = 8.4 Hz, 1H), 
8.68-8.63 (m, 1H), 7.99 (d, J = 8.0 Hz, 1H), 7.83-7.71 (m, 3H), 7.62-7.52 (m, 3H), 7.51-7.35 (m, 
5H), 6.75 (d, J = 8.1 Hz, 2H), 6.42 (d, J = 8.1 Hz, 2H), 2.15 (s, 3H); 13C NMR δ 140.3, 138.9, 138.8, 
138.6, 133.4, 131.2, 130.1, 129.6, 129.5, 129.3, 129.3, 128.8, 128.5, 127.2, 126.9, 124.4, 124.1, 
123.8, 123.5, 123.1, 122.1, 120.7, 119.3, 115.6, 112.5, 111.2, 95.7, 85.3, 21.5; HRMS (DART, posi-
tive): m/z calcd. for C31H22N [M + H]
+ 408.1748, found 408.1747. 
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Benzo[1,2]-9-(2-((4-methylphenyl)ethynyl)phenyl)-11H-carbazole (2p) 
Isolated by flash silica gel column chromatography (hexane/DCM = 9/1). The title compound was 
obtained as a white solid 12%; mp 125 °C; 1H NMR δ 8.24 (d, J = 8.5 Hz, 1H), 8.19 (d, J = 7.7 Hz, 
1H), 7.94 (d, J = 8.2 Hz, 1H), 7.80-7.75 (m, 1H), 7.71 (d, J = 8.4 Hz, 1H), 7.65-7.54 (m, 3H), 7.43 
(d, J = 8.5 Hz, 1H), 7.40-7.28 (m, 3H), 7.23-7.15 (m, 2H), 6.77 (d, J = 8.0 Hz, 2H), 6.36 (d, J = 8.0 
Hz, 2H), 2.13 (s, 3H); 13C NMR δ 141.7, 141.7, 138.5, 135.9, 133.5, 133.2, 131.3, 130.0, 129.5, 
129.2, 129.1, 128.8, 125.3, 125.1, 124.9, 124.8, 123.8, 122.6, 122.0, 121.3, 120.5, 119.7, 119.6, 
119.4, 119.3, 110.8, 95.3, 84.7, 21.5; HRMS (DART, positive): m/z calcd. for C31H22N [M + H]
+ 
408.1748, found 408.1747. 
 
9-(3-(4-Methoxyphenyl)ethynylnaphthalen-2-yl)-9H-carbazole (2q) 
Isolated by flash silica gel column chromatography (hexane/DCM = 9/1). The title compound was 
obtained as a white solid, 27% (2 steps); mp 164 °C; 1H NMR δ 8.25 (s, 1H), 8.19 (d, J = 7.6 Hz, 
2H), 8.06 (s, 1H), 7.95 (d, J = 7.8 Hz, 1H), 7.88 (d, J = 7.7 Hz, 1H), 7.63-7.56 (m, 2H), 7.40-7.38 
(m, 2H), 7.31-7.27 (m, 4H), 6.59 (d, J = 9.0 Hz, 2H), 6.51 (d, J = 9.0 Hz, 2H), 3.70 (s, 3H); 13C 
NMR δ 159.7, 141.7, 135.7, 133.2 133.1, 132.9, 132.8, 128.1, 128.0, 127.8, 127.4, 125.9, 123.4, 
121.4, 120.3, 119.9, 114.8, 114.3, 113.8, 110.7, 95.1, 85.3, 55.3; HRMS (DART, positive): m/z 
calcd. for C31H22NO [M + H]
+ 424.1695, found 424.1696. 
 
9-(2-(Pentylethynyl)phenyl)-9H-carbazole (2r) 
Isolated by flash silica gel column chromatography (hexane/DCM = 17/3). The title compound was 
obtained in 27% as a colorless oil; 1H-NMR δ 8.12 (dd, J = 0.6, 7.7 Hz, 2H), 7.64 (d, J = 7.3 Hz, 
1H), 7.52-7.32 (m, 5H), 7.30-7.15 (m, 4H, overlapped with CHCl3), 1.87 (t, J = 6.8 Hz, 2H), 
1.02-0.62 (m, 9H). 
 
Benzo[6,7]-8-(4-methylphenyl)azepino[3,2,1-jk]-9H-carbazole (3a) 
Isolated by PTLC (hexane/DCM = 15/1 x2). The title compound was obtained as a yellow solid, 
90%; mp 202-203 °C; 1H NMR δ 7.98 (d, J = 7.5 Hz, 1H), 7.80 (d, J = 8.3 Hz, 1H), 7.72 (dd, J = 
7.7, 1.1 Hz 1H), 7.46-7.41 (m, 1H), 7.31 (dd, J = 7.2, 7.2 Hz, 2H), 7.21-7.17 (m, 4H), 7.16-7.10 (m, 
2H), 7.06-7.02 (m, 2H), 6.75 (dd, J = 7.7, 0.8 Hz, 1H), 6.61 (s, 1H), 2.39 (s, 3H); 13C NMR δ 151.4, 
143.9, 142.5, 141.8, 140.8, 137.7, 132.1, 131.8, 131.5, 129.6, 129.2, 129.2, 128.3, 128.2, 127.6, 
126.8, 125.8, 125.1, 122.8, 122.2, 120.9, 120.7, 119.2, 116.5, 21.5; HRMS (DART, positive): m/z 
calcd. for C27H20N [M + H]
+ 358.1585, found 358.1590. Crystal data of 3a; C27H19N, M = 357.45, 
monoclinic, Space Group P21/n (#14), a = 9.10081(16)  Å, b = 11.9738(2) Å, c = 16.5272(3) Å, β 
= 96.3113(10)°, V = 1790.07(6) Å3, T = 123.2 K, Z = 4, μ(CuKα) = 5.841 cm-1, Number of Reflec-
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tions Measures: Total 19243, Unique: 3266 (Rint = 0.0402), R1 = 0.0418, wR2 = 0.1321. CCDC 
1495449. 
 
Benzo[6,7]-8-(2-methylphenyl)azepino[3,2,1-jk]-9H-carbazole (3b) 
Isolated by PTLC (hexane/DCM = 15/1). The title compound was obtained as a yellow solid, 75%; 
mp 172 °C; 1H NMR δ 7.97 (d, J = 7.8 Hz, 1H), 7.82 (d, J = 8.3 Hz, 1H), 7.67 (d, J = 7.6 Hz 1H), 
7.43 (dd, J = 7.8, 7.8 Hz, 1H), 7.36 (d, J = 8.3 Hz, 1H), 7.32-7.25 (m, 2H), 7.24-7.19 (m, 3H), 
7.18-7.13 (m, 1H), 7.08-7.01 (m, 2H), 6.95 (dd, J = 7.6. 7.6 Hz, 1H), 6.46-6.42 (m, 2H), 2.04 (s, 
3H); 13C NMR δ 150.3, 143.7, 142.9, 142.0, 141.5, 136.8, 132.1, 131.9, 131.8, 130.4, 130.0, 129.8, 
128.1, 127.9, 127.4, 127.2, 126.5, 126.1, 125.8, 125.2, 123.1, 122.1, 121.3, 120.7, 119.2, 116.2, 
19.8; HRMS (DART, positive): m/z calcd. for C27H19N [M]
+ 357.1512, found 357.1512. 
 
Benzo[6, 7]-8-(4-methoxylphenyl)azepino[3, 2, 1-jk]-9H-carbazole (3c) 
Isolated by PTLC (hexane/DCM = 15/1). The title compound was obtained as a yellow solid, 98%; 
mp 151 °C; 1H NMR δ 7.98 (d, J = 7.7 Hz, 1H), 7.80 (d, J = 8.2 Hz, 1H), 7.72 (dd, J = 7.7, 1.0 Hz 
1H), 7.45-7.41 (m, 1H), 7.33-7.29 (m, 2H), 7.20 (d, J = 8.7, 2H), 7.16-7.09 (m, 2H), 7.07-7.02 (m, 
2H), 6.90 (d, J = 8.7 Hz, 2H), 6.76 (d, J = 7.6 Hz, 1H), 6.60 (s, 1H), 3.84 (s, 3H) ; 13C NMR δ 
159.5, 151.3, 143.6, 142.6, 141.8, 136.1, 132.0, 131.8, 131.3, 130.5, 129.5, 128.3, 128.2, 127.6, 
126.8, 125.8, 125.1, 122.8, 122.3, 120.9, 120.7, 119.2, 116.5, 113.9, 55.6; HRMS (DART, positive): 
m/z calcd. for C27H20NO [M + H]
+ 374.1539, found 374.1539. 
 
Benzo[6,7]-8-(1-naphthyl)azepino[3,2,1-jk]-9H-carbazole (3d) 
Isolated by PTLC (hexane/DCM = 15/1). The title compound was obtained as a yellow solid, 92%); 
mp 204 °C; 1H NMR δ 7.99 (d, J = 7.7 Hz, 1H), 7.90-7.82 (m, 3H), 7.78 (d, J = 8.3 Hz, 1H), 7.64 
(d, J = 7.2 Hz, 1H), 7.51 (dd, J = 7.4, 7.4 Hz, 1H), 7.48-7.37 (m, 4H), 7.36-7.26 (m, 2H), 7.22-7.16 
(m, 1H), 7.09-7.01 (m, 1H), 6.82 (dd, J = 7.8, 7.8 Hz, 1H), 6.62 (s, 1H), 6.38 (s, 1H); 13C NMR δ 
150.1, 142.4, 142.1, 141.6, 141.0, 134.0, 133.3, 132.3 (a pair of peaks was overlapped), 131.8, 
130.0, 128.6, 128.4, 128.3, 127.9, 127.5, 127.2, 126.6, 126.4, 126.4, 126.1, 125.8, 125.8, 125.3, 
123.1, 122.2, 121.3, 120.8, 119.3, 116.3; HRMS (DART, positive): m/z calcd. for C30H20N [M + 
H]+ 394.1588, found 394.1590. 
 
Benzo[6,7]-8-(3-thienyl)azepino[3,2,1-jk]-9H-carbazole (3e) 
Isolated by PTLC (hexane/DCM = 15/1). The title compound was obtained as a yellow solid, 86%; 
mp 73-74 °C; 1H NMR δ 7.98 (d, J = 7.9 Hz, 1H), 7.80 (d, J = 8.2 Hz, 1H), 7.73 (dd, J = 7.9, 1.0 
Hz, 1H), 7.46-7.39 (m, 1H), 7.34-7.27 (m, 4H), 7.16-7.02 (m, 4H), 6.98 (dd, J = 5.0, 1.2 Hz, 1H), 
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6.90 (d, J = 7.3 Hz, 1H), 6.74 (s, 1H); 13C NMR δ 150.9, 143.9, 142.5, 141.5, 138.6, 131.8, 131.3, 
131.1, 129.4, 128.6, 127.5, 127.5, 127.3, 126.6, 125.7, 125.1, 124.9, 123.6, 122.6, 122.1, 120.7, 
120.5, 119.2, 116.3; HRMS (DART, positive): m/z calcd. C24H16NS [M + H]
+ 350.0999, found 
350.0998. 
 
Benzo[6,7]-8-(2-thienyl)azepino[3,2,1-jk]-9H-carbazole (3f) 
Isolated by PTLC (hexane/DCM = 15/1). The title compound was obtained as a yellow solid, 91%; 
mp 54-55 °C; 1H NMR δ 7.98 (d, J = 7.9 Hz, 1H), 7.79 (d, J = 8.2 Hz, 1H), 7.76 (dd, J = 6.5, 2.4 
Hz, 1H), 7.45-7.40 (m, 1H), 7.34-7.26 (m, 3H), 7.17-7.08 (m, 4H), 7.07-6.98 (m, 3H), 6.86 (s, 1H); 
13C NMR δ151.2, 145.3, 142.9, 141.8, 136.8, 132.3, 132.1, 131.1, 129.8, 127.9, 127.6, 127.3, 127.1, 
127.1, 127.0, 125.9, 125.2, 125.1, 122.8, 122.3, 120.7, 120.7, 119.6, 116.5; HRMS (DART, posi-
tive): m/z calcd. for C24H16NS [M + H]
+ 350.0997, found 350.0998. 
 
Benzo[6,7]azepino[3,2,1-jk]-9H-carbazole (3g) 
Isolated by PTLC (hexane/DCM = 15/1). The title compound was obtained as a yellow solid, 81%; 
mp 109 °C; 1H NMR δ 7.95-7.93 (m, 1H), 7.77 (dd, J = 8.3 Hz, 1H), 7.64 (dd, J = 7.8, 1.0 Hz, 1H), 
7.42-7.36 (m, 1H), 7.34 (d, J = 8.2 Hz, 1H), 7.26 (ddd, J = 7.4, 7.4, 1.3 Hz, 1H, overlapped with 
CHCl3), 7.17-7.12 (m, 1H), 7.05 (dd, J = 7.5, 7.5 Hz, 1H), 7.02-6.95 (m, 2H), 6.87 (d, J = 7.3 Hz, 
1H), 6.33-6.24 (m, 2H); 13C NMR δ 149.4, 141.5, 140.9, 132.4, 132.2, 132.0, 131.7, 130.0, 127.0, 
126.9, 126.7, 126.1, 125.6, 125.2, 122.9, 121.9, 121.6, 120.5, 119.0, 115.5; HRMS (DART, posi-
tive): m/z calcd. for C20H14N [M + H]
+ 268.1122, found 268.1121. 
 
Benzo[6,7]-8-phenylazepino[3,2,1-jk]-9H-carbazole (3h) 
Isolated by PTLC (hexane/DCM = 15/1). The title compound was obtained as a yellow solid, 99%; 
mp 102 °C; 1H NMR δ 7.98 (d, J = 7.6 Hz, 1H), 7.81 (d, J = 8.3 Hz, 1H), 7.72 (dd, J = 7.5, 1.0 Hz, 
1H), 7.47-7.40 (m, 1H), 7.40-7.33 (m, 3H), 7.33-7.26 (m, 4H), 7.18-7.11 (m, 2H), 7.08-7.01 (m, 
2H), 6.72 (dd, J = 7.6, 0.9 Hz, 1H), 6.61 (s, 1H); 13C NMR δ 151.1, 143.8, 143.4, 142.3, 141.5, 
131.9, 131.7, 131.5, 129.5, 129.1, 128.3, 128.0, 127.9, 127.7, 127.3, 126.6, 125.6, 124.9, 122.6, 
122.0, 120.8, 120.0, 119.1, 116.2; HRMS (DART, positive): m/z calcd. for C26H18N [M + H]
+ 
344.1433, found 344.1434. 
 
Benzo[6,7]-8-(3-methylphenyl)azepino[3,2,1-jk]-9H-carbazole (3i) 
Isolated by PTLC (hexane/DCM = 15/1). The title compound was obtained as a yellow solid, 86%; 
mp 106 °C; 1H NMR δ 7.98 (d, J = 7.9 Hz, 1H), 7.81 (d, J = 8.3 Hz, 1H), 7.72 (dd, J = 7.6, 1.0 Hz, 
1H), 7.45-7.40 (m, 1H), 7.31 (dd, J = 7.8, 7.8 Hz, 2H), 7.27-7.23 (m, 1H, overlapped with CHCl3), 
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7.18-7.09 (m, 4H), 7.08-7.01 (m, 3H), 6.73 (dd, J = 7.7, 1.0 Hz, 1H), 6.60 (s, 1H), 2.36 (s, 3H); 13C 
NMR δ 151.2, 140.0, 143.5, 142.4, 141.6, 138.0, 132.0, 131.7, 131.6, 129.9, 129.5, 128.5, 128.3, 
128.2, 128.1, 127.5, 126.7, 126.4, 125.7, 125.1, 122.7, 122.2, 120.9, 120.6, 119.1, 116.4, 21.6; 
HRMS (DART, positive): m/z calcd. for C27H19N [M + H]
+ 358.1590, found 358.1590. 
 
Benzo[6,7]-8-(3-methoxylphenyl)azepino[3,2,1-jk]-9H-carbazole (3j) 
Isolated by PTLC (hexane/DCM = 15/1). The title compound was obtained as a yellow solid, 93%; 
mp 146 °C; 1H NMR δ 7.98 (d, J = 7.7 Hz, 1H), 7.80 (d, J = 8.5 Hz, 1H), 7.71 (dd, J = 7.6, 1.0 Hz, 
1H), 7.45-7.40 (m, 1H), 7.33-7.26 (m, 3H), 7.17-7.10 (m, 2H), 7.07-7.01 (m, 2H), 6.88 (dd, J = 7.6, 
7.6 Hz, 2H), 6.83 (dd, J = 2.4, 2.3 Hz, 1H), 6.75 (dd, J = 7.4, 0.9 Hz, 1H), 6.62 (s, 1H), 3.79 (s, 
3H); 13C NMR δ 159.5, 151.1, 144.9, 143.6, 142.3, 141.5, 131.9, 131.6, 131.4, 129.5, 129.2, 128.0, 
127.7, 127.3, 126.6, 125.6, 124.9, 122.6, 122.0, 121.6, 120.8, 120.5, 119.1, 116.2, 114.7, 113.2, 
55.3; HRMS (DART, positive): m/z calcd. for C27H20NO [M + H]
+ 374.1540, found 374.1539. 
 
Benzo[6,7]-8-(4-biphenyl)azepino[3,2,1-jk]-9H-carbazole (3k) 
Isolated by PTLC (hexane/DCM = 15/1). The title compound was obtained as a yellow solid, 98%; 
mp 167-168 °C; 1H NMR δ 7.98 (d, J = 7.7 Hz, 1H), 7.81 (d, J = 8.3 Hz, 1H), 7.73 (d, J = 7.6 Hz, 
1H), 7.63 (d, J = 7.6 Hz, 2H), 7.59 (d, J = 8.4 Hz, 2H), 7.48-7.41 (m, 3H), 7.38-7.28 (m, 5H), 
7.17-7.12 (m, 2H), 7.08-7.02 (m, 2H), 6.81 (d, J = 7.6 Hz, 1H), 6.68 (s, 1H); 13C NMR δ 151.2, 
143.4, 142.4, 142.4, 141.5, 140.7, 140.6, 131.9, 131.7, 131.5, 129.6, 129.5, 128.8, 128.0, 127.8, 
127.4, 127.4, 127.1, 127.0, 126.7, 125.7, 125.0, 122.7, 122.1, 120.8, 120.6, 119.1, 116.3; HRMS 
(DART, positive): m/z calcd. for C32H22N [M + H]
+ 420.1746, found 420.1747. 
 
Benzo[6,7]-8-(4-chlorophenyl)azepino[3,2,1-jk]-9H-carbazole (3l) 
Isolated by PTLC (hexane/DCM = 15/1). The title compound was obtained as a yellow solid, 86%; 
mp 129 °C; 1H NMR δ 7.98 (d, J = 7.6 Hz, 1H), 7.79 (d, J = 8.3 Hz, 1H), 7.72 (d, J = 7.3 Hz, 1H), 
7.46-7.41 (m, 1H), 7.36-7.29 (m, 4H), 7.23-7.19 (m, 2H), 7.18-7.13 (m, 1H), 7.11 (dd, J = 7.7, 1.6 
Hz, 1H) 7.07-7.01 (m, 2H), 6.68 (d, J = 7.7 Hz, 1H), 6.59 (s, 1H); 13C NMR δ 151.1, 143.8, 143.4, 
142.3, 141.5, 131.9, 131.7, 131.5, 129.5, 129.1, 128.3, 128.0, 127.9, 127.7, 127.3, 126.6, 125.6, 
124.9, 122.6, 122.0, 120.8, 120.0, 119.1, 116.2; HRMS (DART, positive): m/z calcd. for C26H17ClN 
[M + H]+ 378.1045, found 378.1044. 
 
Benzo[6,7]-8-(4-trifluoromethylphenyl)azepino[3,2,1-jk]-9H-carbazole (3m) 
Isolated by PTLC (hexane/DCM = 15/1). The title compound was obtained as a yellow solid, 97%; 
mp 197 °C; 1H NMR δ 7.99 (d, J = 7.7 Hz, 1H), 7.80 (d, J = 8.4 Hz, 1H), 7.73 (d, J = 7.4 Hz, 1H), 
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7.62 (d, J = 8.2 Hz, 2H), 7.44 (ddd, J = 7.8, 1.0, 1.0 Hz, 1H), 7.39 (d, J = 8.0 Hz, 2H), 7.32 (dd, J = 
7.3, 7.3 Hz, 2H), 7.20-7.15 (m, 1H), 7.12 (dd, J = 7.7, 1.5 Hz, 1H), 7.05 (m, 2H), 6.63 (d, J = 7.8 
Hz, 1H), 6.01 (s, 1H); 13C NMR δ 151.3, 147.1, 142.5, 142.3, 141.5, 132.6, 132.1, 131.0, 129.9, 
129.7, 129.5, 127.7, 127.2, 127.2, 126.9, 125.8, 125.3 (q, JC-F = 3.6 Hz, 1C), 125.0, 123.1, 122.7, 
122.2, 120.9, 120.6, 119.4, 116.2; HRMS (DART, positive): m/z calcd. for C27H17F3N [M + H]
+ 
412.1309, found 412.1310. 
 
Benzo[6,7]-8-(4-methylphenyl)azepino-5-methoxy-[3,2,1-jk]-9H-carbazole (3n) 
Isolated by PTLC (hexane/DCM = 15/1). The title compound was obtained as a white solid, 77%; 
mp 183 °C; 1H NMR δ 8.27 (d, J = 7.8 Hz, 1H), 7.76 (d, J = 8.2 Hz, 1H), 7.40-7.25 (m, 3H), 
7.19-7.14 (m, 4H), 7.13-6.99 (m, 3H), 6.68 (d, J = 8.4 Hz, 1H), 6.49 (d, J = 8.4 Hz, 1H), 6.46 (s, 
1H), 4.00 (s, 3H), 2.38 (s, 3H); 13C NMR δ 155.8, 152.5, 143.8, 141.8, 141.1, 141.0, 137.5, 132.3, 
131.7, 129.2, 129.2, 129.2, 129.0, 129.0, 126.7, 125.1, 124.9, 123.5, 122.1, 121.2, 121.0, 116.1, 
115.6, 103.4, 55.7, 21.4; HRMS (DART, positive): m/z calcd. for C28H22NO [M + H]
+ 388.1694, 
found 388.1696. 
 
Benzo[g] benzo[4,5]-8-(4-methylphenyl)azepino[3, 2, 1-jk]-9H-carbazole (3o) and Benzo[c] 
benzo[6,7]-8-(4-methylphenyl)azepino[3, 2, 1-jk]-9H-carbazole (3o’) 
Isolated by PTLC (hexane/DCM = 15/1). The title compound was obtained as a white solid, 88% 
(3o/3o’ = 3/2); mp 60-61 °C; 1H NMR δ 8.70 (d, J = 8.2 Hz, 0.4H), 8.63 (d, J = 8.2 Hz, 0.6H), 8.52 
(dd, J = 6.5, 1.9 Hz, 0.6H), 8.25 (d, J = 7.9 Hz, 0.4H), 8.01 (d, J = 8.0 Hz, 0.4H), 7.97-7.92 (m, 1H), 
7.86 (d, J = 8.9 Hz, 0.4H), 7.73-7.68 (m, 0.4H), 7.65 (d, J = 8.2 Hz, 1H), 7.62-6.57 (m, 0.6H), 7.53 
(dd, J = 7.2, 7.2 Hz, 0.4H), 7.48-7.40 (m, 2H), 7.37-7.33 (m, 0.6H), 7.24-7.14 (m, 7.2H), 7.12-7.07 
(m, 1H), 6.81 (d, J = 7.6 Hz, 0.4H), 6.71 (s, 0.6H), 6.69 (s, 0.4H), 2.41 (s, 1.8H), 2.40 (s, 1.2H); 13C 
NMR δ 151.1, 148.5, 144.3, 143.7, 141.8, 141.1, 141.1, 140.9, 140.8, 140.0, 137.7, 137.6, 132.0, 
132.0, 131.7, 131.6, 131.5, 131.0, 131.0, 130.5, 129.8, 129.5, 129.4, 129.3, 129.2, 129.2, 129.2, 
129.1, 128.9, 128.1, 128.0, 127.8, 127.6, 127.4, 127.2, 127.0, 126.8, 125.4, 125.2, 124.4, 124.3, 
124.3, 123.4, 123.2, 123.1, 122.6 122.5, 121.9, 121.1, 120.6, 119.4, 116.7, 116.2, 21.4, 21.4 (three 
pairs of peaks at the aromatic region were overlapped); HRMS (DART, positive): m/z calcd. for 
C31H22N [M + H]
+ 408.1747, found 408.1747. 
 
Naphtho[2',3':6,7]-8-(4-methoxyphenyl)azepino-[3,2,1-jk]-9H-carbazole (3q) 
Isolated by PTLC (hexane/DCM = 7/1). The title compound was obtained as a yellow solid, 85%; 
mp 124-125 °C; 1H NMR δ 8.04 (d, J = 7.7 Hz, 1H), 7.93 (d, J = 8.2 Hz, 1H), 7.78 (d, J = 7.6 Hz, 
1H), 7.72 (s, 1H), 7.68 (d, J = 6.9 Hz, 1H), 7.58 (s, 1H), 7.53 (d, J = 6.2 Hz, 1H), 7.50-7.46 (m, 1H), 
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7.38-7.30 (m, 3H), 7.27-7.22 (m, 2H, overlapped with CHCl3), 7.08 (dd, J = 7.6, 7.6 Hz, 1H), 6.92 
(d, J = 8.6 Hz, 2H), 6.85 (d, J = 7.6 Hz, 1H), 6.82 (s, 1H), 3.86 (s, 3H); 13C NMR δ 159.4, 149.2, 
142.5, 142.0, 140.7, 136.1, 134.4, 131.6, 131.5, 131.1, 131.0, 130.6, 128.5, 127.7, 127.5, 127.5, 
127.1, 126.8, 126.7, 125.9, 125.9, 122.6, 122.3, 120.7, 119.2, 118.0, 116.6, 113.8, 55.5; HRMS 
(DART, positive): m/z calcd. for C31H22NO [M + H]
+ 424.1693, found 424.1696. 
 
Synthetic schemes of substrates in 2.1.2.: Compounds 429 and 8m30 are known.  
Preparation of 1-(2-(2-alkynyl)phenyl)-1H-indoline derivatives (6) 
Br
I
Br
R
R
PdCl2(PPh3)2, CuI
Et3N, 60 °C
indoline
Pd2dba3 + rac-BINAP
NaOt-Bu
toluene, reflux
6
N
R
 
Sonogashira coupling was performed under the literature conditions31: A dry Schlenk tube was 
charged with 1-bromo-2-iodobenzene (1.0 eq.), PdCl2(PPh3)2 (5 mol%), CuI (5 mol%), alkyne (1.5 
eq.) and triethylamine (0.25 M) was added to the reaction vessel. The reaction mixture was then 
stirred at room temperature for 8 h. The bromides produced in the first step were purified by a short 
column and subjected to the next Pd-catalyzed amination without isolation. 
The Pd-catalyzed amination was performed under the literature conditions32: A dry Schlenk tube 
was charged with crude product (1.0 eq.), Pd2dba3 (2 mol%), rac-BINAP (4 mol%), NaOt-Bu (1.3 
eq.) and toluene (0.25 M). The solution was stirred at 125 °C (oil bath temperature) for 24 h. After 
cooling, it was filtered by silica gel and the solvents were removed. The residue was then purified 
by flash silica gel column chromatography on silica gel to give desired indoline derivatives 6. 
 
Preparation of N-(2-ethynylphenyl)indoline (6m) 
Br
I
Br
TIPS
TIPS
PdCl2(PPh3)2, CuI
Et3N, 60 °C
TBAF
Et2O, r.t.
indoline
Pd2dba3 + rac-BINAP
NaOt-Bu
toluene, reflux
6m
N
TIPS
N
H
 
First, Sonogashira coupling of 1-bromo-2-iodobenzene with triisopropylsilylacetylene was con-
ducted under the reported literature.33 A dry Schlenk tube was charged with 
2-bromo-1-iodobenzene (0.5 mmol), PdCl2(PPh3)2 (0.01 mmol), CuI (0.02 mmol), triisopropylsi-
lylacetylene (0.75 mmol) and triethylamine (1.0 ml). The solution was stirred at 60 ℃ (oil bath 
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temperature) for 24 h. After cooling, the obtained bromide was purified by a short column and sub-
jected to the next Pd-catalyzed amination without complete isolation: Pd-catalyzed amination was 
conducted under the same condition as the latter step in the preparation of 6, and the crude product 
was subjected to the desilylation34: A dry Schlenk tube was charged with triisopropylsilylalkyne 
(0.29 mmol), tetrabutylammoniumfluoride (0.34 mmol), and diethyl ether (1.16 ml). The solution 
was stirred at room temperature for 5 minutes, and filtered by silica gel. The solvents were removed 
and the residue was purified by PTLC to give 6m (60.6 mg, 68% in three steps). 
 
Preparation of substituted indoline derivatives (6n, 6o) 
N
H
R
NaBH3CN
acetic acid, r.t. N
H
R
Pd2dba3 + rac-BINAP
NaOt-Bu
toluene, reflux
N
p-Tol
Br
p-Tol
S1
R = 4-OMe (6n)
    = 6-F (6o)
R
 
First, 6-fluoroindoline was produced via hydrogenation of the corresponding substituted in-
doles35: A dry Schlenk tube was charged with 6-fluoroindole (0.5 mmol), NaBH3CN (1.0 mmol) 
and acetic acid (0.2 ml). The solution was stirred at room temperature for 2 h, then quenched with 5 
ml of 2M NaOH, and the organic material was extracted by CH2Cl2. The organic layer was washed 
with brine, and dried over Na2SO4. After removal of solvent, the crude products were purified by 
PTLC (hexane/ethyl acetate = 5/1) to give 6-fluoroindoline (39.5 mg, 57%). 
 The Pd-catalyzed amination was conducted under the same condition as the latter step in the 
preparation of 6, to give 6n (23.4 mg, 18% in two steps). 
 4-Methoxyindoline derivative 6o was synthesized under the same conditions as above to give 3o 
(77.1 mg, 62% in two steps) 
 
Preparation of 1-(2-(2-(4-methylphenyl)ethynyl)phenyl)-1,2,3,4-tetrahydroquinoline (9) 
Br
p-Tol
tetrahydroquinoline
Pd(OAc)2 + rac-BINAP
KOt-Bu
toluene, reflux N
p-Tol
S4 9  
Pd-Catalyzed amination was conducted36: A dry Schlenk tube was charged with S4 (0.36 mmol), 
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tetrahydroquinoline (0.43 mmol), Pd(OAc)2 (0.018 mmol), rac-BINAP (0.020 mmol), KOt-Bu 
(0.50 mmol) and toluene (0.66 ml). The solution was stirrd at 100 °C for 24 h, and filtered by silica 
gel, then the solvents were removed. The residue was then purified by flash silica gel column 
chromatography (hexane/toluene = 5/1) to give desired product 9. 
 
Preparation of N-methyl-N-phenyl-2-(2-(4-methylphenyl)ethynyl)benzenamine (11) 
Br
p-Tol
N-Methylaniline
Pd(OAc)2 + rac-BINAP
KOt-Bu
tolulene, reflux N
Me
p-Tol
S4 11  
The preparation of 11 was the same as the preparation of 9 using N-methylaniline instead of tet-
rahydroquinoline, and desired 11 was produced (99.6 mg, 72%). 
 
Preparation of 1-(3-(2-(4-methylphenyl)ethynyl)pyridin-2-yl)indoline (6p)  
N Cl
p-Tolyl
Pd2dba3 + IPr•HCl
KOt-Bu
dioxane, reflux
N N
p-Tol
S5 6p  
In this scheme, S5 was synthesized under the reported conditions37. Next, Pd-catalyzed amination 
was conducted under modified conditions: A dry schlenk tube was charged with S2 (0.50 mmol), 
indoline (0.56 mmol), Pd2dba3 (0.005 mmol), IPr･HCl (0.02 mmol), KOt-Bu (0.75 mmol) and 1.5 
ml of dioxane. The solution was stirred at 110 ℃ (oil bath temperature) for 5 h, and then filtered by 
silica gel. After removal of solvent, desired 6p was obtained (75.1 mg, 48%). 
 
General procedures for the cycloisomerization in Table 5 and 6 
Ph3PAuCl (0.0050 mmol), AgOTf (0.0050 mmol), and N-(2-alkynylphenyl)indoline derivatives 6 
(0.050 mmol) were placed in a Schlenk tube under an argon atmosphere in globe box, which was 
then evacuated and backfilled with argon (×3). To the reaction vessel was added pyridine (0.0050 
mmol) and anhydrous DCE (0.50 mL), then the solution was stirred at 40 °C (oil bath temperature). 
The reaction mixture was cooled to room temperature, and the solution was filtered by silica gel. 
The crude product was subjected to the next oxidation reaction without purification under the re-
ported condition. The crude product and DDQ (0.05 mmol) were placed in another Schlenk tube 
under air, which was then evacuated and backfilled with argon (×3). To the reaction vessel was 
added benzene (1.0 ml), then the solution was stirred at room temperature. After 1 hour, the solu-
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tion was quenched by sat. aqueous NaHCO3, and organic material was extracted with ethyl acetate. 
The organic layer was dried over Na2SO4. After removal of solvent, the crude products were puri-
fied by PTLC to give 8. 
 
Characterization data for new compounds in 2.1.2. 
(Z)-10-(4-Methylbenzylidene)indolo[1,2-a]indole (5) 
Isolated by PTLC (hexane/DCM = 10/1). The title compound was obtained as a yellow solid (22.0 
mg, 71%). The stereochemistry was determined by the correlation between the vinylic and aromatic 
protons in the NOESY spectrum; mp 134-135 °C; 1H NMR δ 8.57 (d, J = 8.2 Hz, 1H), 8.48 (d, J = 
8.2 Hz, 1H), 7.80 (d, J = 7.4 Hz, 1H), 7.55-7.66 (m, 4H), 7.27-7.43 (m, 5H), 7.07 (s, 1H), 6.85 (s, 
1H), 2.44 (s, 3H); 13C NMR δ 138.2, 136.8, 136.2, 136.0, 133.5, 133.1, 130.3, 129.5, 129.0, 128.5, 
128.4, 124.8, 123.0, 122.7, 122.0, 122.0, 121.4, 115.4, 114.4, 97.9, 21.5; HRMS (ESI, positive): 
m/z calcd. for C23H18N ([M+H]
+) 308.1434, found 308.1431. 
 
1-(2-(2-(4-Methylphenyl)ethynyl)phenyl)indoline (6a) 
Isolated by flash silica gel column chromatography (hexane/ethyl acetate = 10/1). The title com-
pound was obtained as a white solid (305.8 mg, 92%); mp 66-68 °C; 1H NMR δ 7.56 (dd, J = 1.7, 
7.8 Hz, 1H), 7.40 (dd, J = 1.1, 8.0 Hz, 1H), 7.29 (ddd, J = 1.7, 7.4, 7.4 Hz, 1H), 7.14-7.20 (m, 3H), 
7.06-7.12 (m, 3H), 7.02 (dd, J = 7.6, 7.6 Hz, 1H), 6.74 (ddd, J = 1.0, 7.3, 7.3 Hz, 1H), 6.71 (d, J = 
8.0 Hz, 1H), 4.11 (t, J = 8.3 Hz, 2H), 3.16 (t, J = 8.3 Hz, 2H), 2.33 (s, 3H); 13C NMR δ 148.6, 146.9, 
138.4, 134.0, 131.3, 130.9, 129.2, 126.9, 124.8, 123.9, 122.2, 120.6, 118.9, 118.7, 110.0, 95.6, 87.6, 
54.2, 29.1, 21.6 (a pair of peaks at the aromatic region was overlapped); HRMS (ESI, positive): m/z 
calcd. for C23H20N ([M+H]
+) 310.1590, found 310.1588. 
 
1-(2-(2-(3-Methylphenyl)ethynyl)phenyl)indoline (6b) 
Isolated by PTLC (hexane/ethyl acetate = 10/1). The title compound was obtained as brown oil 
(77.4 mg, 74%); 1H NMR δ 7.56 (dd, J = 1.6, 7.8 Hz, 1H), 7.40 (dd, J = 1.1, 8.1 Hz, 1H), 7.29 (ddd, 
J = 1.7, 7.4, 7.4 Hz, 1H), 7.18 (dd, J = 6.4, 6.4 Hz, 1H), 7.15 (d, J = 7.6 Hz, 1H), 7.06-7.12 (m, 3H), 
7.00-7.05 (m, 2H), 6.75 (ddd, J = 1.1, 7.4, 7.4 Hz, 1H), 6.70 (d, J = 7.8 Hz, 1H), 4.11 (t, J = 8.5 Hz, 
2H), 3.16 (t, J = 8.5 Hz, 2H), 2.28 (s, 3H); 13C NMR δ 148.6, 146.9, 138.1, 134.0, 132.1, 130.9, 
129.3, 129.2, 128.5, 128.3, 126.9, 124.8, 123.9, 123.4, 122.2, 118.8, 118.7, 110.0, 95.6, 87.9, 54.2, 
29.1, 21.4; HRMS (ESI, positive): m/z calcd. for C23H20N ([M+H]
+) 310.1590, found 310.1590. 
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1-(2-(2-(2-Methylphenyl)ethynyl)phenyl)indoline (6c) 
Isolated by PTLC (hexane/ethyl acetate = 10/1). The title compound was obtained as brown oil 
(78.8 mg, 73%); 1H NMR δ 7.60 (dd, J = 1.7, 7.8 Hz, 1H), 7.40 (dd, J = 1.1, 8.0 Hz, 1H), 7.29-7.33 
(m, 1H), 7.25 (d, J = 7.7 Hz, 1H), 7.06-7.20 (m, 5H), 7.01 (dd, J = 7.5, 7.5 Hz, 1H), 6.72 (ddd, J = 
1.0, 7.4, 7.4 Hz, 1H), 6.67 (d, J = 7.8 Hz, 1H), 4.09 (t, J = 8.4 Hz, 2H), 3.15 (t, J = 8.4 Hz, 2H), 
2.30 (s, 3H); 13C NMR δ 148.7, 146.5, 140.0, 134.0, 131.8, 130.7, 129.4, 129.2, 128.2, 120.8, 125.5, 
124.7, 123.9, 123.3, 122.1, 119.4, 118.6, 109.7, 93.9, 91.7, 54.1, 29.0, 20.4; HRMS (ESI, positive): 
m/z calcd. for C23H20N ([M+H]
+) 310.1590, found 310.1590. 
 
1-(2-(2-(4-Methoxyphenyl)ethynyl)phenyl)indoline (6d) 
Isolated by PTLC (hexane/ethyl acetate = 10/1). The title compound was obtained as brown oil 
(79.9 mg, 56%); 1H NMR δ 7.57 (dd, J = 1.6, 7.9 Hz, 1H), 7.41 (d, J = 7.8 Hz, 1H), 7.30 (ddd, J = 
1.6, 7.7, 7.7 Hz, 1H), 7.17-7.23 (m, 3H), 7.10 (ddd, J = 1.1, 7.4, 7.4 Hz, 1H), 7.00-7.06 (m, 1H), 
6.79-6.83 (m, 2H), 6.69-6.77 (m, 2H), 4.12 (t, J = 8.5 Hz, 2H), 3.80 (s, 3H), 3.18 (t, J = 8.5 Hz, 
2H); 13C NMR δ 159.7, 148.6, 146.7, 133.6, 132.9, 130.8, 129.0, 126.9, 124.8, 123.9, 122.3, 119.1, 
118.7, 115.8, 114.1, 110.0, 95.4, 86.9, 55.4, 54.2, 29.1; HRMS (ESI, positive): m/z calcd. for 
C23H20NO ([M+H]
+) 326.1539, found 326.1539. 
 
1-(2-(2-(3-Methoxyphenyl)ethynyl)phenyl)indoline (6e) 
Isolated by PTLC (hexane/ethyl acetate = 10/1). The title compound was obtained as brown oil 
(123.4 mg, 71%); 1H NMR δ 7.57 (dd, J = 1.5, 7.7 Hz, 1H), 7.38 (d, J = 7.9 Hz, 1H), 7.27-7.32 (m, 
1H), 7.14-7.18 (m, 2H), 7.09 (ddd, J = 1.2, 7.5, 7.5 Hz, 1H), 7.02 (dd, J = 7.9, 7.9 Hz, 1H), 6.88 (d, 
J = 7.4 Hz, 1H), 6.80-6.84 (m, 1H), 6.68-6.75 (m, 3H), 4.09 (t, J = 8.5 Hz, 2H), 3.73 (s, 3H), 3.15 (t, 
J = 8.5 Hz, 2H); 13C NMR δ 159.5, 148.5, 146.9, 134.1, 130.9, 129.5, 129.5, 126.9, 124.9, 124.7, 
124.0, 123.9, 122.2, 118.8, 118.6, 115.9, 115.2, 110.1, 95.5, 88.1, 55.5, 54.2, 29.3; HRMS (ESI, 
positive): m/z calcd. for C23H19NNaO ([M+Na]
+) 348.1359, found 348.1359. 
 
1-(2-(2-(2-Methoxyphenyl)ethynyl)phenyl)indoline (6f) 
Isolated by PTLC (hexane/ethyl acetate = 10/1). The title compound was obtained as brown oil 
(121.3 mg, 80%); 1H NMR δ 7.60 (dd, J = 1.5, 7.7 Hz, 1H), 7.43 (dd, J = 0.7, 7.9 Hz, 1H), 
7.19-7.28 (m, 3H), 7.15 (d, J = 7.1 Hz, 1H), 7.06 (ddd, J = 0.9, 7.6, 7.6 Hz, 1H), 7.01 (dd, J = 7.6, 
7.6 Hz, 1H), 6.80-6.87 (m, 2H), 6.69-6.76 (m, 2H), 4.18 (t, J = 8.5 Hz, 2H), 3.80 (s, 3H), 3.15 (t, J 
= 8.5 Hz, 2H); 13C NMR δ 159.8, 148.5, 146.8, 134.1, 133.2, 130.8, 129.6, 129.0, 126.7, 124.7, 
123.6, 121.7, 120.4, 118.9, 118.5, 112.8, 110.6, 109.8, 92.0, 91.4, 55.7, 53.9, 29.0; HRMS (ESI, 
positive): m/z calcd. for C23H19NNaO ([M+Na]
+) 348.1359, found 348.1359. 
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1-(2-(2-Phenylethynyl)phenyl)indoline (6g) 
Isolated by PTLC (hexane/ethyl acetate = 20/1). The title compound was obtained as brown oil 
(68.0 mg, 40%); 1H NMR δ 7.57 (dd, J = 1.8, 7.7 Hz, 1H), 7.40 (dd, J = 1.0, 8.0 Hz, 1H), 7.29 (ddd, 
J = 1.7, 7.3, 7.3 Hz, 1H), 7.26 (m, 5H), 7.18 (d, J = 7.2 Hz, 1H), 7.09 (ddd, J = 0.9, 7.8, 7.8 Hz, 
1H), 7.02 (dd, J = 7.8, 7.8 Hz, 1H), 6.74 (dd, J = 7.4, 7.4 Hz, 1H), 6.71 (d, J = 8.0 Hz, 1H), 4.10 (t, 
J = 8.3 Hz, 2H), 3.16 (t, J = 8.4 Hz, 2H); 13C NMR δ 148.5, 146.9, 134.1, 131.4, 130.9, 129.4, 
128.4, 128.2, 126.9, 124.9, 123.9, 123.6, 122.2, 118.8, 118.7, 110.0, 95.4, 88.2, 54.2, 29.1; HRMS 
(ESI, positive): m/z calcd. for C22H18N ([M+H]
+) 296.1434, found 296.1430. 
 
1-(2-(2-(4-Chlorophenyl)ethynyl)phenyl)indoline (6h) 
Isolated by PTLC (hexane/DCM = 10/1). The title compound was obtained as brown oil (62.8 mg, 
63%); 1H NMR δ 7.56 (dd, J = 1.6, 7.7 Hz, 1H), 7.39 (d, J = 7.6 Hz, 1H), 7.29-7.35 (m, 1H), 
7.07-7.16 (m, 3H), 7.17-7.26 (m, 3H), 7.02 (dd, J = 7.5, 7.5 Hz, 1H), 6.75 (dd, J = 7.3, 7.3 Hz, 1H), 
6.69 (d, J = 8.0 Hz, 1H), 4.08 (t, J = 8.5 Hz, 2H), 3.16 (t, J = 8.5 Hz, 2H); 13C NMR δ 148.3, 146.9, 
134.2, 133.9, 132.6, 130.8, 129.6, 128.7, 126.8, 124.8, 123.8, 122.2, 122.0, 118.8, 118.2, 109.9, 
94.4, 89.1, 54.2, 29.0 ; HRMS (ESI, positive): m/z calcd. for C22H17
35ClN ([M+H]+) 330.1044, 
found 330.1044. 
 
1-(2-(2-(3-Chlorophenyl)lethynyl)phenyl)indoline (6i) 
Isolated by flash silica gel column chromatography (hexane/ethyl acetate = 40/1). The title com-
pound was obtained as brown oil (108.9 mg, 79%); 1H NMR δ 7.55 (dd, J = 1.4, 7.9 Hz, 1H), 7.39 
(dd, J = 1.0, 8.2 Hz, 1H), 7.31 (ddd, J = 1.7, 7.3, 7.3 Hz, 1H), 7.15-7.24 (m, 4H), 7.07-7.12 (m, 2H), 
7.02 (dd, J = 7.7, 7.7 Hz, 1H), 6.76 (dd, J = 7.3, 7.3 Hz, 1H), 6.68 (d, J = 7.9 Hz, 1H), 4.08 (t, J = 
8.4 Hz, 2H), 3.16 (t, J = 8.4 Hz, 2H); 13C NMR δ 148.3, 147.1, 134.2, 134.1, 131.3, 130.9, 129.8, 
129.6, 129.5, 128.5, 126.9, 125.4, 125.0, 123.9, 122.3, 119.0, 118.1, 110.0, 94.2, 89.5, 54.3, 29.2; 
HRMS (ESI, positive): m/z calcd. for C22H17
35ClN ([M+H]+) 330.1044, found 330.1044. 
 
1-(2-(2-(4-Trifluoromethylphenyl)ethynyl)phenyl)indoline (6j) 
Isolated by flash silica gel column chromatography (hexane/ethyl acetate = 10/1). The title com-
pound was obtained as a yellow solid (59.6 mg, 59%); mp 86-87 °C; 7.58 (dd, J = 1.5, 7.7 Hz, 1H), 
7.51 (d, J = 8.3 Hz, 2H), 7.39 (dd, J = 1.1, 8.4 Hz, 1H), 7.34 (ddd, J = 1.7, 7.4, 7.4 Hz, 1H), 7.28 (d, 
J = 8.1 Hz, 2H), 7.19 (d, J = 6.3 Hz, 1H), 7.08-7.14 (m, 1H), 7.02 (dd, J = 7.8, 7.8 Hz, 1H), 6.76 
(dd, J = 7.4, 7.4 Hz, 1H), 6.69 (d, J = 7.9 Hz, 1H), 4.09 (t, J = 8.5 Hz, 2H), 3.17 (t, J = 8.5 Hz, 2H); 
13C NMR δ 148.2, 147.1, 134.1, 131.6, 130.9, 130.0, 129.9, 129.7, 127.4 (q, J = 1.68 Hz), 126.8, 
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125.2 (q, J = 3.83 Hz), 124.9, 123.9, 122.2, 119.0, 117.8, 110.0, 94.2, 90.6, 54.3, 29.1; HRMS (ESI, 
positive): m/z calcd. for C23H17F3N ([M+H]
+) 364.1308, found 364.1305. 
 
1-(2-(2-(1-Naphthyl)ethynyl)phenyl)indoline (6k) 
Isolated by flash silica gel column chromatography (hexane/ethyl acetate = 40/1). The title com-
pound was obtained as brown oil (72.4 mg, 33%); 1H NMR δ 8.10 (d, J = 7.9 Hz, 1H), 7.16 (dd, J = 
8.8, 8.8 Hz, 2H), 7.70 (dd, J = 1.5, 7.7 Hz, 1H), 7.52 (dd, J = 1.0, 7.2 Hz, 1H), 7.30-7.46 (m, 5H), 
7.22 (dd, J = 1,1.1, 7.5 Hz, 1H), 7.14 (ddd, J = 1.3, 7.4, 7.4 Hz, 1H), 7.02 (dd, J = 7.3, 7.3 Hz, 1H), 
6.71-6.77 (m, 2H), 4.11 (t, J = 8.4 Hz, 2H), 3.17 (t, J = 8.4 Hz, 2H); 13C NMR δ 149.0, 146.8, 134.1, 
133.3, 133.3, 130.8, 130.3, 129.6, 128.7, 128.2, 127.0, 126.8, 126.4, 125.3, 124.9, 124.3, 122.5, 
121.3, 119.6, 118.9, 109.7, 93.4, 92.9, 54.3, 29.2 (a pair of peaks at the aromatic region was over-
lapped); HRMS (ESI, positive): m/z calcd. for C26H20N ([M+H]
+) 346.1590, found 346.1587. 
 
1-(2-(2-(4-Phenylphenyl)ethynyl)phenyl)indoline (6l) 
Isolated by flash silica gel column chromatography (hexane/ethyl acetate = 40/1). The title com-
pound was obtained as a white solid (30.5 mg, 12%); mp 160-161 °C; 1H NMR δ 7.55-7.61 (m, 
3H), 7.49-7.53 (m, 2H), 7.40-7.45 (m, 3H), 7.28-7.36 (m, 4H), 7.19 (d, J = 7.3 Hz, 1H), 7.11 (ddd, 
J = 1.2, 7.4, 7.4 Hz, 1H), 7.04 (dd, J = 7.6, 7.6 Hz, 1H), 6.76 (ddd, J = 0.9, 7.4, 7.4 Hz, 1H), 6.72 
(d, J = 7.9 Hz, 1H), 4.12 (t, J = 8.4 Hz, 2H), 3.18 (t, J = 8.4 Hz, 2H); 13C NMR δ 148.5, 146.9, 
140.9, 140.5, 134.1, 131.8, 130.9, 129.4, 129.0, 127.7, 127.1, 127.1, 126.9, 124.9, 123.9, 122.5, 
122.2, 118.8, 118.7, 110.0, 95.4, 89.0, 54.3, 29.1 ; HRMS (ESI, positive): m/z calcd. for C28H22N 
([M+H]+) 372.1747, found 372,1747. 
 
1-(2-Ethynylphenyl)indoline (6m) 
Isolated by flash silica gel column chromatography (hexane/ethyl acetate = 30/1). The title com-
pound was obtained as a brown solid (60.6 mg, 68%); mp 43-44 °C; 1H NMR δ 7.55 (dd, J = 1.6, 
7.9 Hz, 1H), 7.42 (dd, J = 1.0, 8.5 Hz, 1H), 7.28-7.31 (m, 1H), 7.16 (d, J = 7.3 Hz, 1H), 7.07 (ddd, 
J = 1.1, 7.4, 7.4 Hz, 1H), 7.02 (dd, J = 7.3, 7.3 Hz, 1H), 6.74 (ddd, J = 1.0, 7.3, 7.3 Hz, 1H), 6.68 (d, 
J = 7.9 Hz, 1H), 4.05 (t, J = 8.6 Hz, 2H), 3.27 (s, 1H), 3.15 (t, J = 8.6 Hz, 2H); 13C NMR δ 148.7, 
148.0, 135.0, 130.9, 129.9, 126.9, 125.0, 124.0, 122.0, 119.0, 118.0, 110.0, 82.6, 82.2, 54.2, 29.1; 
HRMS (ESI, positive): m/z calcd. for C16H14N ([M+H]
+) 220.1121, found 220.1119. 
 
6-Fluoro-1-(2-(2-(4-methylphenyl)ethynyl)phenyl)indoline (6n) 
Isolated by flash silica gel column chromatography (hexane/ethyl acetate = 5/1). The title com-
pound was obtained as brown oil (23.4 mg, 18%); 1H NMR δ 7.57 (dd, J = 1.5, 7.7 Hz, 1H), 7.38 
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(dd, J = 1.0, 8.1 Hz, 1H), 7.32 (ddd, J = 1.6, 7.3, 8.1 Hz, 1H), 7.19 (d, J = 8.2 Hz, 2H), 7.14 (ddd, J 
= 1.3, 7.6, 7.6 Hz, 1H), 7.09 (d, J = 7.9 Hz, 2H), 7.00-7.06 (m, 1H), 6.39 (ddd, J = 2.3, 8.0, 9.3 Hz, 
1H), 6.34 (dd, J = 2.3, 10.5 Hz, 1H), 4.12 (t, J = 8.4 Hz, 2H), 3.11 (t, J = 8.4, 2H), 2.33 (s, 3H); 13C 
NMR δ 163.1 (d, J = 240.2 Hz), 150.5 (d, J = 11.9 Hz), 145.8, 138.6, 134.1, 131.4, 129.3, 129.2, 
125.9 (d, J = 2.4 Hz), 124.9 (d, J = 10.4 Hz), 124.7, 122.9, 120.4, 119.5, 104.4 (d, J = 22.7 Hz), 
97.7 (d, J = 27.7 Hz), 95.8, 87.1, 55.0, 28.3, 21.6; HRMS (ESI, positive): m/z calcd. for C23H19FN 
([M+H]+) 328.1496, found 328.1494. 
 
4-Methoxy-1-(2-(2-(4-methylphenyl)ethynyl)phenyl)indoline (6o) 
Isolated by flash silica gel column chromatography (hexane). The title compound was obtained as 
brown oil (77.1 mg, 54%); 1H NMR δ 7.55 (dd, J = 1.4, 7.7 Hz, 1H), 7.41 (dd, J = 0.4, 8.2 Hz, 1H), 
7.26 (ddd, J = 1.5, 7.2, 8.0 Hz, 1H), 7.19-7.24 (m, 2H), 7.05-7.10 (m, 3H), 7.00 (dd, J = 8.0, 8.0 Hz, 
1H), 6.39 (d, J = 7.9 Hz, 1H), 6.33 (d, J = 8.2 Hz, 1H), 4.13 (t, J = 8.6 Hz, 2H), 3.84 (s, 3H), 3.11 (t, 
J = 8.6 Hz, 2H), 2.32 (s, 3H); 13C NMR δ 156.6, 150.4, 147.1, 138.4, 134.0, 131.3, 129.2, 129.1, 
128.3, 123.9, 122.6, 120.6, 119.1, 117.3, 103.9, 101.8, 95.3, 87.5, 55.4, 54.6, 26.1, 21.6; HRMS 
(ESI, positive): m/z calcd. for C24H22NO ([M+H]
+) 340.1696, found 340.1696. 
 
1-(3-(2-(4-Methylphenyl)ethynyl)pyridin-2-yl)indoline (6p)  
Isolated by PTLC (hexane/ethyl acetate = 10/1). The title compound was obtained as a white solid 
(75.1 mg, 48%); mp 93-94 °C; 1H NMR δ 8.26 (dd, J = 1.9, 4.8 Hz, 1H), 7.79 (dd, J = 2.0, 7.7 Hz, 
1H), 7.30 (d, J = 7.9 Hz, 1H), 7.15-7.22 (m, 3H), 7.07-7.11 (m, 3H), 6.90 (dd, J = 4.8, 7.6 Hz, 1H), 
6.85 (ddd, J = 0.9, 7.4, 7.4 Hz, 1H), 4.38 (t, J = 8.3 Hz, 2H), 3.16 (t, J = 8.3 Hz, 2H), 2.34 (s, 3H); 
13C NMR δ 156.7, 147.4, 145.5, 142.5, 138.8, 131.8, 131.2, 129.3, 126.5, 124.6, 120.6, 120.2, 
116.7, 113.7, 109.3, 97.3, 86.4, 52.8, 29.1, 21.7; HRMS (ESI, positive): m/z calcd. for C22H19N2 
([M+H]+) 311.1543, found 311.1543. 
 
6-(4-Methylphenyl)indolo[1,7-ab][1]benzazepine (8a) 
Isolated by PTLC (hexane/toluene = 10/1). The title compound was obtained as a yellow solid 
(14.1 mg, 93); mp 108-111 °C; 1H NMR δ 7.39 (d, J = 3.7 Hz, 1H), 7.15 (m, 5H), 7.06 (dd, J = 7.2 
Hz, 1H), 6.86 (m, 3H), 6.70 (dd, J = 7.7, 7.7 Hz, 1H), 6.50 (d, J = 3.5 Hz, 1H), 6.34 (dd, J = 1.1, 
7.6 Hz, 1H) 6.02 (s, 1H), 2.37 (s, 3H); 13C NMR δ 143.7, 143.2, 141.6, 140.6, 137.3, 133.6, 131.8, 
131.7, 130.2, 129.7, 129.1, 129.0, 127.7, 125.6, 125.1, 124.8, 122.0, 120.9, 120.8, 106.5, 21.4; 
HRMS (ESI, positive): m/z calcd. for C23H17N ([M]
+) 307.1356, found 307.1356. 
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6-(3-Methylphenyl)indolo[1,7-ab][1]benzazepine (8b) 
Isolated by PTLC (hexane/ethyl acetate = 10/1). The title compound was obtained as yellow oil 
(15.8 mg, 98%);1H NMR δ 7.41 (d, J = 3.6 Hz, 1H), 7.26 (dd, J = 7.6, 7.6 Hz, 1H), 7.12-7.18 (m, 
2H), 7.06-7.12 (m, 3H), 6.82-6.92 (m, 3H), 6.72 (dd, J = 7.6, 7.6 Hz, 1H), 6.51 (d, J = 3.5 Hz, 1H), 
6.32 (dd, J = 0.9, 7.5 Hz, 1H), 6.02 (s, 1H), 2.37 (s, 3H); 13C NMR δ 143.5, 143.3, 143.2, 141.4, 
138.0, 133.5, 131.7, 131.5, 130.2, 129.6, 129.5, 128.2, 128.1, 127.6, 126.0, 125.5, 125.0, 124.7, 
121.9, 120.7, 120.7, 106.3, 21.5; HRMS (ESI, positive): m/z calcd. for C23H17N ([M]
+) 307.1356, 
found 307.1356. 
 
6-(2-Methylphenyl)indolo[1,7-ab][1]benzazepine (8c) 
Isolated by PTLC (hexane/ethyl acetate = 10/1). The title compound was obtained as yellow oil 
(13.8 mg, 87%);1H NMR δ 7.41 (d, J = 3.5 Hz, 1H), 7.23-7.30 (m, 3H), 7.16-7.19 (m, 1H), 
7.06-7.13 (m, 2H), 6.91 (d, J = 8.0 Hz, 1H), 6.87 (dd, J = 1.0, 7.4 Hz, 1H), 6.78 (dd, J = 1.4, 7.7 Hz, 
1H), 6.63 (dd, J = 7.6, 7.6 Hz, 1H), 6.50 (d, J = 3.5 Hz, 1H), 6.02 (dd, J = 0.7, 7.4 Hz, 1H), 5.89 (s, 
1H), 2.30 (s, 3H); 13C NMR δ 142.6, 142.6, 141.4, 136.6, 133.8, 131.7, 131.5, 130.5, 130.2, 129.6, 
129.5, 127.6, 127.3, 126.2, 125.2, 125.2, 123.8, 122.2, 120.9, 120.6, 106.3, 19.6 (a pair of peaks at 
the aromatic reagion was overlapped.); HRMS (ESI, positive): m/z calcd. for C23H17N ([M]
+) 
307.1356, found 307.1356. 
 
6-(4-Methoxylphenyl)indolo[1,7-ab][1]benzazepine (8d) 
Isolated by PTLC (hexane/ethyl acetate = 10/1). The title compound was obtained as yellow oil 
(13.8 mg, 86%);1H NMR δ 7.41 (d, J = 3.6 Hz, 1H), 7.18-7.23 (m, 2H), 7.17 (dd, J = 1.0, 8.0 Hz, 
1H), 7.08 (ddd, J = 1.9, 7.1, 8.1 Hz, 1H), 6.83-6.93 (m, 5H), 6.73 (dd, J = 7.6, 7.6 Hz, 1H), 6.52 (d, 
J = 3.6 Hz, 1H), 6.37 (dd, J = 0.7, 7.6 Hz, 1H), 6.04 (s, 1H), 3.84 (s, 3H); 13C NMR δ 159.0, 143.6, 
142.7, 141.4, 135.7, 133.3 ,131.6, 131.5, 130.1, 130.0, 129.6, 127.7, 125.6, 125.0, 124.7, 121.8, 
120.8, 120.7, 113.7, 106.4, 55.3; HRMS (ESI, positive): m/z calcd. for C23H17NO ([M]
+) 323.1305, 
found 323.1305. 
 
6-(3-Methoxylphenyl)indolo[1,7-ab][1]benzazepine (8e) 
Isolated by PTLC (hexane/toluene = 10/1). The title compound was obtained as yellow oil (15.6 
mg, 96%); 1H NMR δ 7.42 (d J = 3.4 Hz, 1H), 7.29 (dd, J = 8.2, 8.2 Hz, 1H), 7.16 (d, J = 7.9 Hz, 
1H), 7.08-7.13 (m, 1H), 6.84-6.92 (m, 6H), 6.72 (dd, J = 7.8, 7.8 Hz, 1H), 6.52, (d, J = 3.6 Hz, 1H), 
6.35 (d, J = 7.3 Hz, 1H), 6.05 (s, 1H), 3.81 (s, 3H); 13C NMR δ 159.8, 144.9, 143.6, 143.1, 141.6, 
133.7, 131.9, 131.7, 130.4, 129.6, 129.5, 127.5, 125.6, 125.1, 124.8, 122.1, 121.5, 120.9, 120.9, 
114.6, 113.2, 106.5, 55.4; HRMS (ESI, positive): m/z calcd. for C23H17NO ([M]
+) 323.1305, found 
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323.1306. 
 
6-(2-Methoxylphenyl)indolo[1,7-ab][1]benzazepine (8f) 
Isolated by PTLC (hexane/toluene = 3/1). The title compound was obtained as a yellow solid (14.3 
mg, 88%); mp 127-128 °C; 1H NMR δ 7.39 (d, J = 3.6 Hz, 1H), 7.33 (ddd, J = 1.8, 7.8, 7.8 Hz, 1H), 
7.20 (dd, J = 1.8, 7.4 Hz, 1H), 7.04-7.12 (m, 2H), 7.00 (dd, J = 7.3, 7.3 Hz, 1H), 6.94 (d, J = 8.1 Hz, 
1H), 6.89 (d, J = 8.1 Hz, 1H), 6.85 (dd, J = 7.3, 7.3 Hz, 1H), 6.78 (dd, J = 1.6, 7.7 Hz, 1H), 6.64 
(dd, J = 7.8, 7.8 Hz, 1H), 6.48 (d, J = 3.5 Hz, 1H), 6.11 (d, J = 7.4 Hz, 1H), 5.94 (s, 1H), 3.73 (s, 
3H); 13C NMR δ 157.4, 142.4, 141.5, 140.1, 133.9, 132.3, 132.2, 131.5, 130.9, 130.4, 129.5, 129.0, 
127.3, 125.1, 125.0, 123.7, 122.0, 121.0, 120.7, 120.4, 111.3, 106.2, 55.9; HRMS (ESI, positive): 
m/z calcd. for C23H17NNaO ([M+Na]
+) 346.1202, found 346.1203. 
 
6-Phenylindolo[1,7-ab][1]benzazepine (8g) 
Isolated by PTLC (hexane/DCM = 5/1). The title compound was obtained as a yellow solid (14.6 
mg, >99%); mp 136-137 °C; 1H NMR δ 7.42 (d, J = 3.5 Hz, 1H), 7.32-7.40 (m, 3H), 7.28-7-31 (m, 
2H), 7.17 (dd, J = 1.1, 8.0 Hz, 1H), 7.08-7.12 (m, 1H), 6.85-6.93 (m, 3H), 6.72 (dd, J = 7.8, 7.8 Hz, 
1H), 6.53 (d, J = 3.5 Hz, 1H), 6.32 (dd, J = 0.9, 7.1 Hz, 1H), 6.04 (s, 1H); 13C HMR δ 143.6, 143.4, 
143.2, 141.5, 133.6, 132.0, 131.6, 130.3, 129.6, 129.1, 128.4, 127.6, 127.5, 125.6, 125.1, 124.8, 
122.0, 120.8, 106.5 (a pair of peaks at the aromatic region was overlapped); HRMS (ESI, positive): 
m/z calcd. for C22H15N ([M]
+) 293.1199, found 293.1198. 
 
6-(4-Chlorophenyl)indolo[1,7-ab][1]benzazepine (8h) 
Isolated by PTLC (hexane/DCM = 5/1). The title compound was obtained as a yellow solid (14.2 
mg, 88%); mp 126-127 °C; 1H NMR δ 7.42 (d, J = 3.5 Hz, 1H), 7.33-7.37 (m, 2H), 7.20-7.24 (m, 
2H), 7.17 (dd, J = 1.0, 8.0 Hz, 1H), 7.11 (ddd, J = 1.7, 7.6, 8.1 Hz, 1H), 6.91 (ddd, J = 1.0, 7.4, 7.4 
Hz, 1H), 6.84-6.89 (m, 2H), 6.72 (dd, J = 7.8, 7.8 Hz, 1H), 6.53 (d, J = 3.7 Hz, 1H), 6.27 (dd, J = 
0.6, 7.3 Hz, 1H), 6.01 (s, 1H); 13C NMR δ 143.7, 142.1, 141.9, 141.6, 133.7, 133.4, 132.3, 131.8, 
130.6, 130.5, 129.4, 128.7, 127.3, 125.7, 125.2, 124.6, 122.1, 121.1, 121.0, 106.6; HRMS (ESI, 
positive): m/z calcd. for C22H14
35ClN ([M]+) 327.0809, found 327.0810. 
 
6-(3-Chlorophenyl)indolo[1,7-ab][1]benzazepine (8i) 
Isolated by PTLC (hexane/DCM = 5/1). The title compound was obtained as yellow oil (16.6 mg, 
>99%); 1H NMR δ 7.40 (d, J = 3.7 Hz, 1H), 7.26-7.34 (m, 3H), 7.13-7.20 (m, 2H), 7.10 (dd, J = 
1.7, 7.4 Hz, 1H), 6.82-6.92 (m, 3H), 6.73 (dd, J = 7.5, 7.5 Hz, 1H), 6.52 (d, J = 3.8 Hz, 1H), 6.26 (d, 
J = 7.4 Hz, 1H), 6.01 (s, 1H); 13C NMR δ 145.2, 143.6, 141.9, 141.6, 134.4, 133.8, 132.5, 131.8, 
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130.7, 129.8, 129.3, 129.2, 127.7, 127.4, 127.2, 125.7, 125.2, 124.6, 122.1, 121.1, 121.0, 106.6; 
HRMS (ESI, positive): m/z calcd. for C22H14
35ClN ([M]+) 327.0809, found 327.0810. 
 
6-(4-Trifluoromethylphenyl)indolo[1,7-ab][1]benzazepine (8j) 
Isolated by PTLC (hexane/DCM = 10/1). The title compound was obtained as a yellow solid (9.1 
mg, 51%); mp 119-120 °C; 1H NMR δ 7.64 (d, J = 8.2 Hz, 2H), 7.38-7.44 (m, 3H), 7.18 (d, J = 7.8 
Hz, 1H), 7.13 (ddd, J = 1.7, 7.7, 7.7 Hz, 1H), 6.84-6.95 (m, 3H), 6.73 (ddd, J = 2.0, 7.6, 7.6 Hz, 
1H), 6.52-6.55 (m, 1H), 6.22 (d, J = 7.4 Hz, 1H), 6.01 (s, 1H); 13C NMR δ 147.1 (q, J = 1.44 Hz), 
143.7, 142.0, 141.6, 133.8, 132.7, 131.9, 130.8, 129.8, 129.5, 129.2, 127.1, 125.8, 125.7, 125.5 (q, 
J = 3.83 Hz), 125.2, 124.5, 122.1, 121.2, 121.0, 106.6; HRMS (ESI, positive): m/z calcd. for 
C23H14F3N ([M]
+) 361.1073, found 361.1073. 
 
6-(1-Naphthyl)indolo[1,7-ab][1]benzazepine (8k) 
Isolated by PTLC (hexane/DCM = 5/1). The title compound was obtained as a yellow solid (17.0 
mg, 98%); mp 138-140 °C; 1H NMR δ 8.05 (d, J = 8.5 Hz, 1H), 7.86 (dd, J = 8.5, 8.5 Hz, 2H), 
7.35-7.54 (m, 5H), 7.06-7.15 (m, 2H), 6.96 (d, J = 8.2 Hz, 1H), 6.88 (ddd, J = 1.9, 7.4, 7.4 Hz, 1H), 
6.78 (dd, J = 1.5, 7.6 Hz, 1H), 6.49-.6.54 (m, 2H), 6.06 (s, 1H), 5.96 (d, J = 7.3, 1H); 13C NMR δ 
142.2, 141.4, 141.3, 140.6, 133.8, 133.7, 132.9, 132.1, 131.4, 130.5, 129.3, 128.2, 127.8, 126.5, 
126.2, 126.2, 125.9, 125.8, 125.1, 125.1, 124.6, 122.1, 120.8, 120.5, 106.2 (a pair of peaks at the 
aromatic region was overlapped): m/z calcd. for C26H17N ([M]
+) 343.1356, found 343.1356. 
 
6-(4-Phenylphenyl)indolo[1,7-ab][1]benzazepine (8l) 
Isolated by PTLC (hexane/ethyl acetate = 10/1). The title compound was obtained as a yellow solid 
(14.0 mg, 76%); mp 163-164 °C; 1H NMR δ 7.59-7.67 (m, 4H), 7.42-7.49 (m, 3H), 7.34-7.40 (m, 
3H), 7.19 (dd, J = 0.9, 7.8 Hz, 1H), 7.12 (ddd, J = 2.1, 7.3, 7.9 Hz, 1H), 6.86-6.95 (m, 3H), 6.76 
(dd, J = 7.6, 7.6 Hz, 1H), 6.54 (d, J = 3.4 Hz, 1H), 6.42 (dd, J = 0.8, 7.4 Hz, 1H), 6.11 (s, 1H); 13C 
NMR δ 143.7, 142.9, 142.5, 141.6, 140.9, 140.4, 133.6, 132.0, 132.0, 131.7, 130.4, 129.6, 129.5, 
128.9, 127.5, 127.4, 127.2, 125.7, 125.1, 124.8, 122.0, 120.9, 120.9, 106.5; HRMS (ESI, positive): 
m/z calcd. for C28H19N ([M]
+) 369.1512, found 369.1514. 
 
5-Fluoro-6-(4-methylphenyl)indolo[1,7-ab][1]benzazepine (8n) 
Isolated by PTLC (hexane/toluene = 10/1). The title compound was obtained as a yellow solid 
(12.3 mg, 71%); mp 119-121 °C; 1H NMR δ 7.40 (d, J = 3.5 Hz, 1H), 7.20-7.25 (m, 1H), 7.11-7.17 
(m, 5H), 7.03 (dd, J = 1.9, 7.6 Hz, 1H), 7.00 (dd, J = 7.2, 7.2 Hz, 1H), 6.78 (d, J = 8.2 Hz, 1H), 
6.66 (dd, J = 8.4, 11.6 Hz, 1H), 6.56 (d, J = 3.5 Hz, 1H), 6.36 (s, 1H), 2.36 (s, 3H); 13C NMR 157.6 
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(d, J = 247.46 Hz), 147.7 (d, J = 7.75 Hz), 142.5, 141.4 (d, J = 3.28 Hz), 139.9, 137.0, 133,3, 132.6, 
130.0, 129.5, 128.9, 127.9, 127.5 (d, J = 3.28 Hz), 126.7 (d, J = 2.68 Hz), 125.1, 121.9, 121.2 (d, J 
= 11.03 Hz), 124.9 (d, J = 13.41 Hz), 112.4 (d, J = 25.63 Hz), 107.0, 21.3; HRMS (ESI, positive): 
m/z calcd. for C23H16FN ([M]
+) 325.1261, found 325.1262. 
 
3-Methoxy-6-(4-methylphenyl)indolo[1,7-ab][1]benzazepine (8o) 
Isolated by PTLC (hexane/toluene = 10/1). The title compound was obtained as yellow oil (8.0 mg, 
62%); 1H NMR δ 7.32 (d, J = 3.5 Hz, 1H), 7.17-7.19 (m, 4H), 7.05 (dd, J = 1.7, 7.5 Hz, 1H), 
6.86-6.91 (m, 2H), 6.81 (dd, J = 1.6, 7.6 Hz, 1H), 6.61 (d, 3.5 Hz, 1H), 6.27 (d, 8.3 Hz, 1H), 6.12 
(d, 8.4 Hz, 1H), 5.86 (s, 1H), 3.85 (s, 3H), 2.38 (s, 3H); 13C NMR δ 153.2, 144.3, 143.1, 140.9, 
140.9, 137.2, 133.4, 130.1, 129.7, 129.3, 129.1, 129.0, 125.9, 125.3, 124.3, 122.5, 121.3, 120.7, 
103.3, 101.0, 55.4, 21.4; HRMS (ESI, positive): m/z calcd. for C24H19NO ([M]
+) 337.1461, found 
337.1462. 
 
6-(4-Methylphenyl)pyrido[3’,2’:6,7]azepino[3,2,1-hi]indoline (8p) 
Isolated by PTLC (hexane/ethyl acetate = 10/1). The title compound was obtained as a yellow solid 
(30.5 mg, 97%); mp 130 °C (decomp.); 1H NMR δ 7.84 (dd, J = 1.7, 4.9 Hz, 1H), 7.13-7.20 (m, 
4H), 6.92 (dd, J = 1.3, 7.3 Hz, 2H), 6.50-6.60 (m, 2H), 6.36 (d, J = 7.8, 1H), 5.94 (s, 1H), 4.19 (dd, 
J = 8.4 Hz, 2H), 2.91 (t, J = 8.4 Hz, 2H), 2.37 (s, 3H); 13C NMR δ 160.0, 151.3, 146.7, 143.4, 
139.9, 138.9, 137.5, 133.8, 130.2, 129.4, 129.1, 128.8, 127.7, 125.9, 124.3, 122.5, 117.1, 47.3, 27.6, 
21.3; HRMS (ESI, positive): m/z calcd. for C22H19N2 ([M+H]
+) 310.1541, found 310.1543. 
 
1-(2-(2-(4-Methylphenyl)ethynyl)phenyl)-1,2,3,4-tetrahydroquinoline (9) 
Isolated by flash silica gel column chromatography (hexane/toluene = 5/1). The title compound was 
obtained as a white solid (66.6 mg, 57%); mp 81-83 °C; 1H NMR δ 7.58 (dd, J = 1.6, 7.8 Hz, 1H), 
7.27-7.35 (m, 2H), 7.18 (ddd, J = 1.7, 7.7, 7.7 Hz, 1H), 7.12-7.15 (m, 2H), 7.07 (d, J = 7.9 Hz, 2H), 
7.03 (dd, J = 1.2, 7.5 Hz, 1H), 6.89 (ddd, J = 1.6, 7.0, 7.0 Hz, 1H), 6.65 (ddd, J = 1.1, 7.3, 7.3 Hz, 
1H), 6.40 (dd, 0.9, 8.0 Hz, 1H) 3.69 (m, 2H), 2.88 (t, J = 6.4 Hz, 2H), 2.32 (s, 3H), 2.04-2.11 (m, 
2H); 13C NMR δ 149.8, 145.0, 138.4, 133.9, 131.3, 123.0, 129.4, 129.1, 128.4, 126.9, 125.4, 123.0, 
122.4, 120.5, 117.9, 115.1, 94.7, 85.9, 51.2, 28.1, 22.6, 21.8; HRMS (ESI, positive): m/z calcd. for 
C24H22N ([M+H]
+) 324.1747, found 324.1745. 
 
7-(4-Methylphenyl)-2,3-dihydrobenzo[6,7]azepino[3,2,1-ij]quinoline (10) 
Isolated by PTLC (hexane/ethyl acetate = 10/1). The title compound was obtained as a yellow solid 
(15.3 mg, 94%); mp 68-70 °C; 1H NMR δ 7.28 (d, J = 8.0 Hz, 2H), 7.12-7.22 (m, 4H), 7.09 (d, J = 
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7.6 Hz, 1H), 6.92-7.02 (m, 2H), 6.84 (s, 1H), 6.79 (dd, J = 7.6, 7.6 Hz, 1H), 6.64 (d, J = 7.6 Hz, 
1H), 4.00-4.08 (m, 1H), 3.53-3.63 (m, 1H), 2.90-3.00 (m, 2H), 2.39-2.50 (m, 1H), 2.37 (s, 3H), 
1.96-2.05 (m, 1H); 13C NMR δ 153.5, 150.7, 144.8, 141.4, 137.1, 134.6, 133.1, 131.0, 130.1, 130.1, 
129.0, 129.0, 128.9, 128.9, 128.4, 122.8, 122.6, 117.7, 48.8, 27.1, 21.2, 20.6; HRMS (ESI, posi-
tive): m/z calcd. for C24H22N ([M+H]
+) 324.1747, found 324.1742. 
 
N-Methyl-N-phenyl-2-(2-(4-methylphenyl)ethynyl)benzenamine (11) 
Isolated by flash silica gel column chromatography (hexane/toluene = 3/1). The title compound was 
obtained as brown oil (99.6 mg, 72%); 1H NMR δ 7.56 (dd, J = 1.4, 7.7 Hz, 1H), 7.31 (ddd, J = 1.6, 
7.5, 8.1 Hz, 1H), 7.13-7.26 (m, 4H), 7.10 (d, J = 8.1 Hz, 2H), 7.04 (d, J = 8.0 Hz, 2H), 6.72-6.80 
(m, 3H), 3.36 (s, 3H), 2.30 (s, 3H); 13C NMR δ 150.2, 149.2, 138.4, 133.9, 131.5, 129.5, 129.0, 
128.9, 127.7, 125.2, 122.0, 120.3, 118.1, 114.9, 95.0, 86.7, 39.9, 21.6; HRMS (ESI, positive): m/z 
calcd. for C22H20N ([M+H]
+) 298.1590, found 298.1588. 
 
5-Methyl-10-(4-methylphenyl)dibenzo[b,f]azepine (12) 
Isolated by PTLC (hexane/toluene = 3/1). The title compound was obtained as a yellow solid (12.2 
mg, 82%); mp 128-129 °C; 1H NMR δ 7.33 (d, J = 8.1 Hz, 2H), 7.21-7.30 (m, 2H), 7.18 (dd, J = 
0.5, 8.4 Hz, 2H), 7.15 (dd, J = 8.1, 8.1 Hz, 2H), 7.05 (d, J = 8.1 Hz, 1H), 7.00 (ddd, J = 1.1, 7.4, 
7.4 Hz, 1H), 6.97 (s, 1H), 6.90 (ddd, J = 1.1, 7.9, 7.9 Hz, 1H), 6.87 (dd, J = 2.1, 7.7 Hz, 1H), 3.39 
(s, 3H), 2.39 (s, 3H); 13C NMR δ 153.9, 153.0, 144.3, 140.9, 137.3, 134.7, 132.9, 130.7, 130.3, 
129.6, 129.2, 129.1, 129.0, 128.5, 123.2, 118.8, 117.9, 38.8, 21.3 (a pair of peaks at the aromatic  
region was overlapped); HRMS (ESI, positive): m/z calcd. for C22H20N ([M+H]
+) 298.1590, found 
298.1590. 
  
Synthetic schemes of substrates in 2.2. 
Preparation of 13a 
F
O2N
N
H
N
Ph
O2N
+
NaH
DMF, 150 °C
10 h
N
Ph
H2N
EtOAc, 40 °C
overnight
S6 S7
SnCl2•2H2O
N
Ph
HN
Ts
TsCl, pyridine
DCM, r.t., overnight
N
Ph
TsNK2CO3
Br
DMF, 80 °C, 2 h
13aS8  
Diphenylamine (3.0 mmol, 1.0 eq.) and 2-fluoronitrobenzene (3.3 mmol, 1.1 eq.) were placed in a 
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round-bottom flask, which was then evacuated and backfilled with argon (×3). Anhydrous DMF 
(10.5 ml) was added to the reaction vessel, then the solution was stirred at room temperature. NaH 
(4.5 mmol, 1.5 eq.) was added and the reaction solution was stirred at 150 °C for 10 h. After cool-
ing, the solution was quenched with 1N HCl, and extracted by ethyl acetate. The organic layer was 
dried over Na2SO4 and filtrated. After removal of solvent from the filtrate, the obtained S6 was 
subjected to the next reduction reaction without isolation. 
S6 (2.1 mmol, 1.0 eq.), and SnCl2・2H2O (7.875 mmol, 3.75 eq.) were placed in a round-bottom 
flask, which was then evacuated and backfilled with argon (×3). Ethyl acetate (10.5 ml) was added 
to the reaction vessel and the resulting solution was stirred at 40 °C overnight. After cooling, 1N 
NaOH (10.5 ml) was added and stirred at room temperature for 10 min. The reaction mixture was 
filtered by celite to remove precipitate. The organic material was extracted by ethyl acetate, and the 
organic layer was dried over Na2SO4 and filtrated. After removal of solvent from the filtrate, the 
obtained S7 was subjected to the next sulfonylation reaction of amino group without further purifi-
cation. 
S7 (0.84 mmol, 1.0 eq.) was placed in a Schlenk tube and then evacuated and backfilled with ar-
gon (×3). Pyridine (1.68 mmol, 2.0 eq.) was added to the reaction vessel, and p-toluenesulfonyl 
chloride (1.01 mmol, 1.2 eq.) in 1.0 ml of dichloromethane was added dropwise. The reaction 
mixture was stirred at room temperature overnight, and then quenched with 1N HCl. The organic 
material was extracted by ethyl acetate, and the organic layer dried over Na2SO4, then filtrated. Af-
ter removal of solvent from the filtrate, the obtained S3 was subjected to the next propargylation of 
amino group without isolation. 
S8 (0.5 mmol, 1.0 eq.), and K2CO3 (1.0 mmol, 2.0 eq.) were placed in a Schlenk tube and then 
evacuated and backfilled with argon (×3). To the reaction vessel was added propargyl bromide (0.6 
mmol, 1.2 eq.) and anhydrous DMF (4.0 ml), then the solution was heated at 80 °C for 2 h. After 
cooling, the solution was quenched using sat. NH4Cl. The organic material was extracted by ethyl 
acetate. After washing by H2O, the organic layer was dried over Na2SO4, and then the solvent was 
removed. The crude products were purified by flash silica gel column chromatography (hex-
ane/ethyl acetate = 3:1) to give desired 13a (16% in total yield of four steps). 
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Preparation of 13b and 13c 
N
H
NH2
R
Br
+
R
Pd2(dba)3
rac-BINAP
NaOtBu
toluene, 100 °C, overinght
2-Bromonitrobenzene
Pd2(dba)3
rac-BINAP
Cs2CO3
toluene, 100 °C, overnight N
Ph
O2NR
N
Ph
TsN
R = 3,5-OMe (13b)
       4-F (13c)
R
 
 Pd2(dba)3 (0.003 mmol, 0.3 mol%), rac-BINAP (0.008 mmol, 0.8 mol%) and NaO
tBu (1.4 mmol, 
1.4 eq.) were added in a round-bottom flask, and then evacuated and backfilled with argon (×3). To 
the reaction vessel was added bromobenzene (1.0 mmol, 1.0 eq.), 4-fluoroaniline (1.2 mmol, 1.2 
eq.), and toluene (1.57 ml, 0.63 M). The reaction mixture was stirred at 100 °C overnight. After 
cooling, the solution was filtered by short column, then purified by flash silica gel column chro-
matography (hexane/ethyl acetate = 4:1) to give desired 4-fluoro-N-phenylaniline. 
 Subsequent Buchwald-Hartwig cross coupling was conducted under the reported conditions38: 
Pd2(dba)3 (0.03 mmol), rac-BINAP (0.1 mmol), Cs2CO3 (0.6 mmol) were added in a round bottom 
flask, then evacuated and backfilled with argon (×3). To the reaction vessel was added 
4-fluoro-N-phenylaniline (0.5 mmol, 1.0 eq.), 2-bromonitrobenzene (0.6 mmol, 1.2 eq.) and tolu-
ene (0.9 ml, 0.6 M). The reaction mixture was stirred at 100 °C overnight. After cooling, the solu-
tion was filtered by short column. The solvent was removed, and the crude product was subjected 
to the next reaction without further purification. 
 Following reactions were the same conditions as synthesis of 13 to give 13c (126.1 mg, 27% in 
total yield of five steps). 
 3,5-Methoxydiphenylamine derivative 13b was synthesized under the same conditions as above 
(89.1 mg, 17% in total yield of five steps). 
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Preparation of 13d and 13e 
F
O2N
N
H
N
Ph
O2N
+
NaH
DMF, 150 °C
10 h
N
Ph
H2N
EtOAc, 40 °C
overnight
R
R R
SnCl2•2H2O
N
Ph
HN
Ts
TsCl, pyridine
DCM, r.t., overnight
N
Ph
TsNK2CO3
Br
DMF, 80 °C, 2 h
R = Me (13d)
       CF3 (13e)
R R
 
The preparation of 13d and 13e was the same as the preparation of 13a using 
4-fluoro-3-nitrotoluene and 2-fluoro-5-trifluoronitrobenzene, respectively, in place of 
2-fluoronitrobenzene, and desired 13d (105.3 mg, 8% in total yield) and 13e (141.6 mg, 9% in total 
yield) was obtained. 
 
Preparation of 13g-13l 
N
Ph
TsN
N
Ph
TsN
R
PdCl2(PPh3)2
CuI
Et3N
I R
+
DMF, r.t.
13g-13l  
Sonogashira coupling was conducted under the literature conditions.39 A dry Schlenk tube was 
charged with 13a (1.0 eq.), PdCl2(PPh3)2 (3 mol%), CuI (3 mol%), iodobenzene derivatives (1.2 
eq.), triethylamine (1.2 ml) and DMF (5.0 ml). Reaction mixture was then stirred at room tempera-
ture overnight. The reaction mixture was poured into water, and extracted with dichloromethane. 
The organic layer was successively washed with water, dried over anhydrous Na2SO4
 and then fil-
tered. The solvent from the filtrate was removed under reduced pressure to give a crude product, 
which was purified by PTLC to give pure compounds 13g-13l. 
 
Preparation of 13m 
N
Ph
TsN
N
Ph
TsN
CO2Et
nBuLi
ClCO2Et
THF, -78 °C
13m  
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Synthesis of 13m was conducted under the literature conditions40: To a solution of 13a (0.30 
mmol) in THF (0.9 ml) at -78 °C under argon, n-BuLi (2.0 mmol) was added dropwise. After stir-
ring for 5 min, ethyl chloroformate (0.36 mmol) was added slowly to the above solution. After stir-
ring at -78 °C for 2 h, the reaction was gradually warmed to room temperature. The mixture was 
washed with sat. NH4Cl solution. The aqueous phase was extracted with ethyl acetate (10 ml × 3). 
The combined organic phase was dried over anhydrous Na2SO4 and then filtered. The solvent from 
the filtrate was removed under reduced pressure to give crude products, which were purified by 
PTLC (dichloromethane only) to give pure compound 13m. 
 
Preparation of 15 
H2N
HO
N
Ph
HO
N
Ph
O
Iodobenzene
CuI
Cs2CO3
DMF, 110 °C
K2CO3
Br
DMF, 80 °C, 2 h
15  
Synthesis of 2-diphenylaminophenol was conducted under the reported conditions41: 
2-aminophenol (1.0 mmol), CuI (20 mol%) and Cs2CO3 (3.0 eq.) were added in a Schlenk tube, 
then evacuated and backfilled with argon (×3). To the solution iodobenzene (3.0 eq.) and DMF (2 
ml) were added and stirred overnight at 110 °C. The solution was quenched with 1N HCl, and ex-
tracted by ethyl acetate, then the organic layer was dried over Na2SO4. After Na2SO4 was filtrated, 
the solvent was removed from the filtrate and the crude product was purified by flash silica gel 
column chromatography (hexane/ethyl acetate = 9/1) to give 2-diphenylaminophenol (66%). 
Subsequent propargylation was conducted under the same conditions as the synthesis of 1 to give 
15 (160.4 mg, 81%). 
 
Preparation of 17 
F
O2N O2N
O
Phenol
K2CO3
DMSO, 100 °C O
H2N
EtOAc, 40 °C, overnight
SnCl2•2H2O
O
HN
Ts
TsCl, pyridine
DCM, r.t., overnight
O
TsNK2CO3
Br
DMF, 80 °C, 2 h
17
R R
 
Synthesis of 1-nitro-2-phenoxybenzene was conducted under the reported conditions42: Phenol 
(2.0 mmol) and K2CO3 (2.0 eq.) were added to a Schlenk tube, then evacuated and backfilled with 
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argon (×3). To the solution 2-fluoronitrobenzene (1.0 eq.) and DMSO (3 ml) were added and stirred 
overnight at 100 °C. The reaction mixture was quenched with H2O, then extracted by ethyl acetate. 
The combined organic layer was dried over Na2SO4 and then filtered. The solvent from the filtrate 
was removed under reduced pressure to give a nitro compound, which was subjected to the next 
step without isolation. 
Subsequent reduction of nitro group, tosylation and propargylation was done under same condi-
tions as synthesis of 1 to give 17 (22% in total yield of four steps). 
 
Characterization data for new compounds in 2.2. 
N-(2-(Diphenylamino)phenyl)-4-methyl-N-(prop-2-yn-1-yl)benzenesulfonamide (13a) 
Isolated by silica gel column chromatography (hexane/ethyl acetate = 3/1). The title compound was 
obtained as a brown solid, 16% in total yield; mp 193-195 °C; 1H NMR δ 7.62 (d, J = 8.4 Hz, 2H), 
7.35-7.27 (m, 2H), 7.25-7.18 (m, 7H), 7.08-7.02 (m, 5H), 6.99 (dd, J = 7.4, 7.4 Hz, 2H), 3.98 (brs, 
1H), 3.03 (brs, 1H), 2.40 (s, 3H), 1.99 (dd, J = 2.3, 2.5 Hz, 1H); 13C NMR δ 148.0, 147.8, 143.6, 
137.0, 135.4, 131.7, 129.9, 129.6, 129.2, 129.2, 128.6, 124.9, 123.7, 122.7, 78.5, 73.8, 38.3, 21.7; 
HRMS (ESI, positive): m/z calcd. For C28H24N2NaO2S ([M+Na]
+) 475.1451, found 475.1451. 
 
N-(2-((3,5-Dimethoxyphenyl)(phenyl)amino)phenyl)-4-methyl-N-(prop-2-yn-1-yl)benzenesulf
onamide (13b) 
Isolated by PTLC (hexane/dichloromethane = 1/2). The title compound was obtained as red oil, 
27% in total yield; 1H NMR δ 7.66-7.61 (m, 2H), 7.35-7.28 (m, 2H), 7.25-7.19 (m, 5H), 7.10-7.04 
(m, 3H), 7.02-6.96 (m, 1H), 6.23 (d, J = 2.1 Hz, 2H), 6.15 (t, J = 2.2 Hz, 1H), 4.01 (brs, 1H), 3.69 
(s, 6H), 3.14 (brs, 1H), 2.41 (s, 3H), 1.99 (t, J = 2.5 Hz, 1H); 13C NMR δ 161.3, 149.9, 147.7, 
147.5, 143.6, 137.0, 135.6, 131.6, 129.9, 129.8, 129.2, 129.1, 128.7, 125.2, 124.0, 122.9, 102.3, 
95.2, 78.6, 73.8, 55.5, 38.4, 21.7; HRMS (ESI, positive): m/z calcd for 
C30H28N2NaO4S([M+Na]
+)535.1661, found 535.1662. 
 
N-(2-((4-Fluorophenyl)(phenyl)amino)phenyl)-4-methyl-N-(prop-2-yn-1-yl)benzenesulfonami
de (13c) 
Isolated by PTLC (hexane/dichloromethane = 1/2). The title compound was obtained as a light 
yellow solid, 17% in total yield; mp 180 °C; 1H NMR δ 7.63 (d, J = 8.4 Hz, 2H), 7.36-7.14 (m, 7H), 
7.10-6.86 (m, 8H), 4.01 (brs, 1H), 3.01 (brs, 1H), 2.42 (s, 3H), 1.99 (t, J = 2.5 Hz, 1H); 13C NMR δ 
158.9 (d, J = 241.8 Hz), 148.3, 147.9, 144.2 (d, J = 2.6 Hz), 143.7, 136.9, 135.2, 131.6, 130.0, 
129.3, 129.2, 128.6, 125.7 (d, J = 8.2 Hz), 124.9, 123.3, 122.7, 115.9 (d, J = 22.5 Hz), 78.4, 73.9, 
53.6, 38.4, 21.7; HRMS (ESI, positive): m/z calcd for C28H23FN2NaO2S ([M+Na]
+) 493.1357, 
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found 493.1356. 
 
N-(2-(Diphenylamino)-5-methylphenyl)-4-methyl-N-(prop-2-yn-1-yl)benzenesulfonamide 
(13d) 
Isolated by recrystallization (hexane/dichloromethane). The title compound was obtained as a white 
solid, 8% in total yield; mp 150-152 °C; 1H NMR δ 7.62 (d, J = 8.2 Hz, 2H), 7.24-7.17 (m, 7H), 
7.12 (dd, J = 1.6, 8.2 Hz, 1H), 7.06-7.00 (m, 5H), 6.96 (dd, J = 7.4, 7.4 Hz, 2H), 3.91 (brs, 1H), 
3.08 (brs, 1H), 2.40 (s, 3H), 2.25 (s, 3H), 2.01 (dd, J = 2.4, 2.4 Hz, 1H); 13C NMR δ 148.0, 144.7, 
143.6, 137.0, 135.3, 135.2, 132.2, 130.7, 129.6, 129.1, 129.1, 128.6, 123.3, 122.4, 78.5, 73.7, 38.3, 
21.7, 20.9; HRMS (ESI, positive): m/z calcd. For C29H26N2NaO2S ([M+Na]
+) 489.1607, found 
489.1608 
 
N-(2-(Diphenylamino)-5-(trifluoromethyl)phenyl)-4-methyl-N-(prop-2-yn-1-yl)benzenesulfon
amide (13e) 
Isolated by silica gel column chromatography (hexane/ethyl acetate = 10/1). The title compound 
was obtained as a white solid, 9% in total yield; mp 121-122 °C; 1H NMR δ 7.59 (d, J = 8.3 Hz, 
2H), 7.50 (dd, J = 2.1, 8.5 Hz, 1H), 7.38 (d, J = 8.5 Hz, 1H), 7.35-7.22 (m, 7H), 7.14-7.04 (m, 6H), 
3.97 (brs, 1H), 2.92 (brs, 1H), 2.42 (s, 3H), 2.01 (dd, J = 2.4, 2.4 Hz, 1H); 13C NMR δ 151.7, 147.7, 
144.2, 136.2, 134.4, 129.5, 129.4 (q, J = 3.9 Hz), 129.3, 128.6, 128.6, 126.6 (q, J = 3.3 Hz,), 125.6 
(q, J = 33.4 Hz), 124.6, 123.9, 123.7 (q, J = 272.4 Hz), 77.9, 74.5, 38.0, 21.7; HRMS (ESI, posi-
tive): m/z calcd. For C29H23F3N2NaO2S ([M+Na]
+) 543.1325, found 543.1326 
 
N-(2-(Diphenylamino)phenyl)-4-methyl-N-(3-phenylprop-2-yn-1-yl)benzenesulfonamide (13f) 
Isolated by PTLC (hexane/dichloromethane = 1/2). The title compound was obtained as a white 
solid, 58%; mp 159 °C; 1H NMR δ 7.68 (d, J = 7.1 Hz, 2H), 7.39-7.29 (m, 2H), 7.29-7.20 (m, 8H), 
7.18 (d, J = 7.9 Hz, 2H), 7.11 (d, J = 8.1 Hz, 4H), 7.08-7.03 (m, 3H), 7.01 (dd, J = 6.9, 6.9 Hz, 
2H), 4.18 (brs, 1H), 3.15 (brs, 1H), 2.34 (s, 3H); 13C NMR δ 148.2 148.2, 143.4, 137.4, 135.8, 
131.5, 131.4, 129.9, 129.5, 129.3, 129.2, 128.7, 128.4, 128.3, 124.9, 123.9, 122.7, 122.6, 85.4, 84.1, 
39.3, 21.6; HRMS (ESI, positive): m/z calcd for C34H28N2NaO2S ([M+Na]
+) 551.1765, found 
551.1764. 
 
N-(2-(Diphenylamino)phenyl)-N-(3-(4-methoxyphenyl)prop-2-yn-1-yl)-4-methylbenzenesulfo
namide (13g) 
Isolated by PTLC (hexane/dichloromethane = 1/2). The title compound was obtained as a light 
yellow solid, 56%; mp 114 °C; 1H NMR δ 7.68 (d, J = 8.2 Hz, 2H), 7.39-7.27 (m, 2H), 7.27-7.21 
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(m, 5H), 7.20-7.14 (m, 2H), 7.11 (dd, J = 0.7, 7.7 Hz, 3H), 7.07-6.96 (m, 6H), 6.76 (d, J = 8.4 Hz, 
2H), 4.16 (brs, 1H), 3.79 (s, 3H), 3.13 (br, 1H), 2.35 (s, 3H); 13C NMR δ 159.7, 148.2, 148.2, 143.3, 
137.4, 135.8, 132.9, 131.5, 129.9, 129.5, 129.3, 129.2, 128.7, 124.9, 123.9, 122.7, 114.7, 113.9, 
85.3, 82.6, 55.4, 39.4, 21.6; HRMS (ESI, positive): m/z calcd for C35H30N2NaO3S ([M+Na]
+) 
581.1869, found 581.1869. 
 
N-(2-(Diphenylamino)phenyl)-N-(3-(3-methoxyphenyl)prop-2-yn-1-yl)-4-methylbenzenesulfo
namide (13h) 
Isolated by PTLC (hexane/dichloromethane = 1/2). The title compound was obtained as a yellow 
solid, 50%; mp 114 °C; 1H NMR δ 7.68 (d, J = 8.2 Hz, 2H), 7.38-7.34 (m, 1H), 7.33-7.28 (m, 1H), 
7.28-7.17 (m, 7H), 7.16-7.08 (m, 5H), 7.07-6.98 (m, 3H), 6.83 (dd, J = 2.4, 8.3 Hz, 1H), 6.65 (d, J 
= 7.6 Hz, 1H), 6.59 (s, 1H), 4.17 (brs, 1H), 3.77 (s, 3H), 3.13 (brs, 1H), 2.35 (s, 3H); 13C NMR δ 
159.3, 148.2, 148.2, 143.5, 137.3, 135.8, 131.4, 129.9, 129.5, 129.3, 129.3, 129.2, 128.7, 124.9, 
124.0, 123.9, 123.6, 122.7, 117.0, 114.4, 85.3, 84.0, 55.4, 39.2, 21.6; HRMS (ESI, positive): m/z 
calcd for C35H30N2NaO3S ([M+Na]
+) 581.1869, found 581.1869. 
 
N-(2-(Diphenylamino)phenyl)-N-(3-(2-methoxyphenyl)prop-2-yn-1-yl)-4-methylbenzenesulfo
namide (13i) 
Isolated by PTLC (hexane/dichloromethane = 1/2). The title compound was obtained as a light red 
solid, 51%; mp 189 °C; 1H NMR δ 7.67 (d, J = 8.3 Hz, 2H), 7.40-7.33 (m, 2H), 7.32-7.27 (m, 1H), 
7.27-7.21 (m, 5H), 7.15-7.07 (m, 6H), 7.06-6.97 (m, 3H), 6.95 (dd, J = 1.8, 7.7 Hz, 1H), 6.86-6.77 
(m, 2H), 4.23 (brs, 1H), 3.77 (s, 3H), 3.14 (brs, 1H), 2.27 (s, 3H); 13C NMR δ 160.1, 148.3, 148.2, 
143.2, 137.2, 135.8, 133.3, 131.8, 129.8, 129.8, 129.3, 129.2, 129.1, 128.8, 124.7, 123.9, 122.7, 
120.3, 111.9, 110.5, 88.1, 82.1, 55.6, 39.6, 21.6; HRMS (ESI, positive): m/z calcd for 
C35H30N2NaO3S ([M+Na]
+) 581.1868, found 581.1869. 
 
N-(2-(Diphenylamino)phenyl)-4-methyl-N-(3-(4-(trifluoromethyl)phenyl)prop-2-yn-1-yl)benz
enesulfonamide (13j) 
Isolated by PTLC (hexane/dichloromethane = 1/2). The title compound was obtained as a white 
solid, 62%; mp 154 °C; 1H NMR δ 7.67 (d, J = 6.7 Hz, 2H), 7.50 (d, J = 7.8 Hz, 2H), 7.39-7.30 (m, 
2H), 7.22-7.29 (m, 5H), 7.17 (dd, J = 7.4, 7.7 Hz, 4H), 7.13-7.04 (m, 5H), 7.01 (t, J = 7.4 Hz, 2H), 
4.18 (brs, 1H), 3.19 (brs, 1H), 2.35 (s, 3H); 13C NMR δ 148.2, 148.1, 143.5, 137.3, 135.7, 131.7, 
131.3, 130.2 (q, J = 33.1 Hz), 130.1, 129.7, 129.3, 129.2, 128.7, 126.4 (q, J = 1.5 Hz), 125.2 (q, J = 
3.9 Hz), 124.9, 123.9, 123.9 (q, J = 271.8 Hz), 122.8, 86.8, 84.1, 39.1, 21.6 HRMS (ESI, positive): 
m/z calcd for C35H27F3N2NaO2S ([M+Na]
+) 619.1634, found 619.1638. 
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N-(2-(Diphenylamino)phenyl)-N-(3-(4-fluorophenyl)prop-2-yn-1-yl)-4-methylbenzenesulfona
mide (13k) 
Isolated by PTLC (hexane/dichloromethane = 1/2). The title compound was obtained as a white 
solid, 28%; mp 147 °C; 1H NMR δ 7.67 (d, J = 8.2 Hz, 2H), 7.38-7.29 (m, 2H), 7.28-7.20 (m, 5H), 
7.18 (d, J = 7.9 Hz, 2H), 7.10 (d, J = 8.0 Hz, 4H), 7.07-6.98 (m, 5H), 6.93 (dd, J = 8.7, 8.7 Hz, 
2H), 4.13 (brs, 1H), 3.14(brs, 1H), 2.34 (s, 3H); 13C NMR δ 162.6 (d, J = 250.0 Hz), 148.2, 148.2, 
143.4, 137.4, 135.8, 133.4 (d, J = 8.3 Hz), 131.4, 129.9, 129.6, 129.3, 129.2, 128.7, 124.9, 123.9, 
122.8, 118.7 (d, J = 3.6 Hz), 115.6 (d, J = 22.1 Hz), 84.4, 83.8 (d, J = 1.5 Hz), 39.2, 21.6; HRMS 
(ESI, positive): m/z calcd for C34H27FN2NaO2S ([M+Na]
+) 569.1669, found 569.1669. 
 
N-(3-(4-Chlorophenyl)prop-2-yn-1-yl)-N-(2-(diphenylamino)phenyl)-4-methylbenzenesulfona
mide (13l) 
Isolated by PTLC (hexane/dichloromethane = 1/2). The title compound was obtained as a light 
yellow solid, 79%; mp 165 °C; 1H NMR δ 7.70-7.62 (m, 2H), 7.39-7.29 (m, 2H), 7.27-7.14 (m, 9H), 
7.13-7.08 (m, 4H), 7.07-7.03 (m, 1H), 7.03-6.93 (m, 4H), 4.13 (brs, 1H), 3.14 (brs, 1H), 2.35 (s, 
3H); 13C NMR δ 148.2, 148.2, 143.5, 137.3, 135.7, 134.5, 132.7, 131.3, 130.0, 129.6, 129.3, 129.2, 
128.7, 128.6, 124.9, 123.9, 122.8, 121.1, 85.2, 84.3, 39.2, 21.6; HRMS (ESI, positive): m/z calcd 
for C34H27ClN2NaO2S ([M+Na]
+) 585.1374, found 585.1374. 
 
Ethyl 4-((N-(2-(diphenylamino)phenyl)-4-methylphenyl)sulfonamido)but-2-ynoate (13m) 
Isolated by PTLC (dichloromethane). The title compound was obtained as a white solid, 34%; mp 
128 °C; 1H NMR δ 7.63 (d, J = 8.2 Hz, 2H), 7.36-7.29 (m, 2H), 7.27-7.20 (m, 7H), 7.10-7.02 (m, 
6H), 7.00 (dd, J = 7.4, 7.4 Hz, 2H), 4.15 (q, J = 7.2 Hz, 2H), 4.07 (brs, 1H), 3.03 (brs, 1H), 2.41 (s, 
3H), 1.27(t, J = 7.2 Hz, 3H); 13C NMR δ 152.9, 148.2, 148.1, 143.9, 136.4, 135.0, 131.5, 130.3, 
129.6, 129.5, 129.3, 128.6, 125.2, 123.8, 122.9, 82.2, 77.3, 62.1, 38.3, 21.7, 14.1, ; HRMS (ESI, 
positive): m/z calcd for C31H28N2NaO4S ([M+Na]
+)547.1663, found 547.1662. 
 
N-(2-(Diphenylamino)phenyl)-4-methyl-N-(3-(p-tolyl)prop-2-yn-1-yl)benzenesulfonamide 
(13o) 
Isolated by PTLC (hexane/dichloromethane = 1/2) The title compound was obtained as a white 
solid, 53%; mp 159 °C; 1H NMR δ 7.68 (d, J = 8.1 Hz, 2H), 7.37-7.33 (m, 1H), 7.33-7.28 (ddd, J = 
1.6, 7.3, 7.3 Hz, 1H), 7.28-7.21 (m, 5H), 7.18 (d, J = 8.1 Hz, 2H), 7.11 (dd, J = 0.7, 8.1 Hz, 4H), 
7.03-6.97 (m, 5H), 6.95 (d, J = 7.9 Hz, 2H), 4.18 (brs, 1H), 3.12 (brs, 1H), 2.35 (s, 3H), 2.32 (s, 
3H); 13C NMR δ 148.2, 148.2, 143.4, 138.6, 137.4, 135.8, 131.5, 131.4, 129.9, 129.5, 129.3, 129.2, 
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129.0, 128.7, 124.9, 123.9, 122.7, 119.5, 85.5, 83.4, 39.3, 21.6, 21.6; HRMS (ESI, positive):m/z 
calcd for C35H30N2NaO2S ([M+Na]
+) 565.1924, found 565.1920. 
 
General procedure for the cycloisomerization in Table 7, and 8 
2-Propargyltosylaminodiphenylaniline derivative 13 (0.050 mmol) was placed in a Schlenk tube 
in air. This reaction vessel was evacuated and backfilled with argon (×3), then gold(I) complex (10 
mol%) and silver salt (10 mol%) were placed to the reaction vessel in globe box. After solvent (0.5 
ml) was added, the solution was stirred at room temperature for 1 h. The solution was filtered by 
silica gel. After removal of solvent, the crude products were filtered by short column, and purified 
by PTLC to give desired cyclized product 14. 
 
7-Methylene-12-phenyl-5-tosyl-5,6,7,12-tetrahydrodibenzo[b,e][1,4]diazocine (14a) 
Isolated by PTLC (dichloromethane). The title compound was obtained as a brown solid 99%; mp 
146-148 °C; 1H NMR δ 7.80-7.74 (m, 1H), 7.48 (d, J = 7.5 Hz, 1H), 7.34 (dd, J = 7.8, 7.8 Hz, 1H), 
7.28-7.22 (m, 3H), 7.20-7.16 (m, 2H), 7.12 (d, J = 8.2 Hz, 2H), 7.04 (dd, J = 8.1, 8.1 Hz, 2H), 6.90 
(d, J = 8.1 Hz, 2H), 6.78 (dd, J = 7.2, 7.2 Hz, 1H) 6.42 (d, J = 8.6 Hz, 2H), 5.38 (s, 1H), 5.20 (s, 
1H), 4.54 (s, 2H), 2.29 (s, 3H); 13C NMR δ 147.8, 143.6, 143.3, 131.8, 139.7, 139.6, 137.0, 136.0, 
131.2, 130.4, 129.5, 129.4, 129.0, 128.5, 127.7, 127.4, 126.8, 126.7, 126.6, 119.2, 117.8, 115.4, 
54.7, 21.6; HRMS (ESI, positive): m/z calcd. For C28H24N2NaO2S ([M+Na]
+) 475.1451, found 
475.1452. 
 
8,10-Dimethoxy-7-methylene-12-phenyl-5-tosyl-5,6,7,12-tetrahydrodibenzo[b,e][1,4]diazocine 
(14b) 
Isolated by PTLC (hexane/ethyl acetate = 5/1). The title compound was obtained as a light yellow 
solid, >99%; mp 146 °C; 1H NMR δ 7.71 (d, J = 7.6 Hz, 1H), 7.28-7.22 (m, 2H), 7.20-7.12 (m, 3H), 
7.04 (dd, J = 8.0, 8.0 Hz, 2H), 6.94 (d, J = 7.9 Hz, 2H), 6.79 (dd, J = 6.9 Hz, 1H), 6.48 (d, J = 8.2 
Hz, 2H), 6.37 (d, J = 2.3 Hz, 1H), 6.33 (d, J = 2.3 Hz, 1H), 5.40 (s, 1H), 5.34 (s, 1H), 4.36 (s, 2H), 
3.78 (s, 3H), 3.70 (s, 3H), 2.30 (s, 3H); 13C NMR δ 160.4, 159.2, 147.6, 144.4, 143.0, 139.9, 137.3, 
136.8, 135.5, 130.7, 129.4, 129.0, 127.7, 127.4, 126.8, 126.7, 121.4, 120.4, 119.5, 116.2, 104.0, 
97.1, 56.3, 55.9, 55.5, 21.6; HRMS (ESI, positive):m/z calcd for C30H28N2NaO4S ([M+Na]
+) 
535.1662, found 535.1662. 
 
12-(4-Fluorophenyl)-7-methylene-5-tosyl-5,6,7,12-tetrahydrodibenzo[b,e][1,4]diazocine (14c) 
Isolated by PTLC (hexane/ethyl acetate = 5/1). The title compound was obtained as yellow oil, 
99%; 1H NMR δ 7.79-7.74 (m, 1H), 7.41 (dd, J = 1.4, 7.6 Hz, 1H), 7.30-7.26 (m, 1H), 7.23-7.11 
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(m, 7H), 6.90 (d, J = 8.1 Hz, 2H), 6.72-6.64 (m, 2H), 6.39-6.28 (m, 2H), 5.37 (s, 1H), 5.21 (s, 1H), 
4.55 (s, 2H), 2.29 (s, 3H); 13C NMR δ 156.9 (d, J = 237.9 Hz), 144.2 (d, J = 1.9 Hz), 143.5, 142.9, 
142.6, 139.7, 139.0, 137.5, 136.0, 131.4, 130.3, 129.5, 129.4, 128.5, 127.5, 127.0 (d, J = 5.0 Hz), 
126.2, 118.9, 116.9, 116.9, 115.6, 115.4, 54.5, 21.5; HRMS (ESI, positive):m/z calcd for 
C28H23FN2NaO2S ([M+Na]
+) 493.1357, found 493.1356. 
 
3-Methyl-7-methylene-12-phenyl-5-tosyl-5,6,7,12-tetrahydrodibenzo[b,e][1,4]diazocine (14d) 
Isolated by PTLC (hexane/diethyl ether = 1/1). The title compound was obtained as brown oil, 
82%; 1H NMR δ 8.00 (d, J = 1.8 Hz, 1H), 7.55 (dd, J = 1.6, 7.3 Hz, 1H), 7.42-7.33 (m, 4H), 7.18 
(dd, J = 1.4, 7.7 Hz, 1H), 7.10-7.02 (m, 4H), 6.92 (d, J = 8.0 Hz, 2H), 6.81 (dd, J = 7.3, 7.3 Hz, 1H), 
6.40 (d, J = 7.9 Hz, 2H), 5.37 (s, 1H), 5.19 (s, 1H), 4.56 (s, 2H), 2.28 (s, 3H), 1.55 (s, 3H); 13C 
NMR δ 147.9, 143.3, 143.3, 142.3, 139.2, 139.2, 136.9, 135.9, 134.4, 131.0, 130.3, 129.4, 129.4, 
129.0, 128.2, 128.1, 127.7, 126.2, 119.0, 118.3, 115.5, 54.5, 21.6, 21.4 (a pair of aromatic peaks 
was overlapped) ; HRMS (ESI, positive): m/z calcd. For C29H26N2NaO2S ([M+Na]
+) 489.1607, 
found 489.1606. 
 
7-Methylene-12-phenyl-5-tosyl-3-trifluoromethyl-5,6,7,12-tetrahydrodibenzo[b,e][1,4] 
diazocine (14e) 
Isolated by PTLC (hexane/diethyl ether = 1/1). The title compound was obtained as a brown solid, 
95%; mp 149-151 °C; 1H NMR δ 8.00 (d, J = 1.8 Hz, 1H), 7.55 (dd, J = 1.7, 7.4 Hz, 1H), 7.42-7.33 
(m, 4H), 7.81 (dd, J = 1.4, 7.7 Hz, 1H), 7.09-7.02 (m, 4H), 6.91 (d, J = 8.2 Hz, 2H), 6.80 (dd, J = 
7.4 Hz, 1H), 6.39 (d, J = 7.8 Hz, 2H), 5.36 (s, 1H), 5.19 (s, 1H), 4.56 (s, 2H), 2.28 (s, 3H); 13C 
NMR δ 147.3, 144.1, 144.0, 140.3, 140.2, 140.0, 139.2, 135.3, 130.9, 130.8, 129.8, 129.7, 129.5, 
129.2, 128.0, 127.7, 124.7 (q, J = 21.5 Hz), 123.7 (q, J = 272.7 Hz), 123.5 (q, J = 4.5 Hz), 123.0 (q, 
J = 3.9 Hz), 119.9, 116.5, 115.4, 54.7, 21.6; HRMS (ESI, positive): m/z calcd. For 
C29H23F3N2NaO2S ([M+Na]
+) 543.1325, found 543.1326. 
 
(E)-7-Benzylidene-12-phenyl-5-tosyl-5,6,7,12-tetrahydrodibenzo[b,e][1,4]diazocine (14f) 
Isolated by PTLC (hexane/dichloromethane = 1/2). The title compound was obtained as a yellow 
solid, 94%. The stereochemistry was determined by the correlation between the vinylic and meth-
ylene protons in the NOESY spectrum; mp 196 °C; 1H NMR δ 7,71-7.62 (m, 1H), 7.32-7.24 (m, 
2H), 7.23-7.13 (m, 4H), 7.13-7.03 (m, 7H), 6.97-6.86 (m, 3H), 6.85-6.74 (m, 3H), 6.60 (d, J = 8.6 
Hz, 2H), 6.53 (s, 1H), 4.54 (brs, 1H), 4.43 (brs, 1H), 2.28 (s, 3H); 13C NMR 147.8, 143.5, 143.3, 
139.7, 137.7, 136.7, 136.1, 135.1, 135.1, 133.0, 132.3, 130.8, 129.5, 129.2, 129.0, 128.9, 128.0, 
128.0, 127.7, 127.6, 127.2, 126.9, 126.8, 124.9, 119.9, 116.8, 57.0, 21.6; HRMS (ESI, positive):m/z 
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calcd for C34H28N2NaO2S ([M+Na]
+) 551.1764, found 551.1764. 
 
(E)-7-(4-Methoxybenzylidene)-12-phenyl-5-tosyl-5,6,7,12-tetrahydrodibenzo[b,e][1,4] 
diazocine (14g) 
Isolated by PTLC (hexane/dichloromethane = 1/2). The title compound was obtained as colorless 
oil, 41%; 1H NMR δ 8.24 (s, 1H), 7.78 (dd, J = 1.4, 7.9 Hz, 1H), 7.65 (dd, J = 1.5, 8.2 Hz, 1H), 
7.40 (dd, J = 1.5, 7.9 Hz, 1H), 7.36 (d, J = 8.6 Hz, 2H), 7.22-7.18 (m, 2H), 7.18-7.12 (m, 4H), 
7.12-7.00 (m, 5H), 6.91-6.88 (m, 2H), 6.82 (s, 1H), 6.79 (d, J = 8.2 Hz, 2H), 4.08 (s, 2H), 3.81 (s, 
3H), 2.20 (s, 3H); 13C NMR δ 158.3, 148.7, 148.1, 143.2, 142.8, 136.6, 136.0, 135.8, 134.6, 132.6, 
132.2, 130.5, 129.9, 129.3, 129.2, 128.6, 128.0, 127.4, 126.9, 125.3, 125.0, 124.8, 123.6, 123.4, 
120.1, 114.2, 55.4, 42.8, 21.5; HRMS (ESI, positive): m/z calcd for C35H30N2NaO3S ([M+Na]+) 
581.1870, found 581.1869. 
 
(E)-7-(3-Methoxybenzylidene)-12-phenyl-5-tosyl-5,6,7,12-tetrahydrodibenzo[b,e][1,4] 
diazocine (14h) 
Isolated by PTLC (hexane/dichloromethane = 1/2). The title compound was obtained as a yellow 
solid, 53%; mp 91 °C; 1H NMR δ 7.66 (dd, J = 1.6, 8.8 Hz, 1H), 7.30-7.26 (m, 1H), 7.25-7.04 (m, 
9H), 7.00 (dd, J = 7.9, 7.9 Hz, 1H), 6.96-6.89 (m, 3H), 6.82 (dd, J = 7.3, 7.3 Hz, 1H), 6.63 (dd, J = 
2.4, 8.4 Hz, 1H), 6.59 (d, J = 4.0 Hz, 2H), 6.51 (s, 1H), 6.43 (d, J = 4.0 Hz, 1H), 6.27 (s, 1H), 4.54 
(brs, 1H), 4.42 (brs, 1H), 3.54 (s, 3H), 2.29 (s, 3H); 13C NMR δ 159.2, 147.9, 143.5, 143.3, 139.8, 
138.1, 137.8, 136.7, 136.2, 135.4, 133.1, 132.4, 130.8, 129.5, 129.2, 129.1, 129.0, 128.1, 127.8, 
127.6, 126.9, 126.9, 124.9, 121.7, 120.0, 116.9, 113.8, 113.6, 57.0, 55.1, 21.6; HRMS (ESI, posi-
tive): m/z calcd for C35H30N2NaO3S ([M+Na]+) 581.1869, found 581.1869. 
 
(E)-7-(2-Methoxybenzylidene)-12-phenyl-5-tosyl-5,6,7,12-tetrahydrodibenzo[b,e][1,4] 
diazocine (14i) 
Isolated by PTLC (hexane/dichloromethane = 1/2). The title compound was obtained as brown oil, 
50%; 1H NMR δ 7.70 (d, J = 8.2 Hz, 1H), 7.32 (d, J = 8.2 Hz, 1H), 7.25-7.11 (m, 6H), 7.06 (dd, J 
= 8.0, 8.0 Hz, 3H), 7.00 (d, J = 7.8 Hz, 1H), 6.91 (d, J = 8.1 Hz, 2H), 6.81 (q, J = 8.2 Hz, 2H), 
6.77 (d, J = 4.3 Hz, 1H), 6.68 (s, 1H), 6.58 (d, J = 8.1 Hz, 2H), 6.45 (dd, J = 7.6, 7.6 Hz, 1H), 6.04 
(d, J = 7.7 Hz, 1H), 4.69 (brs, 1H), 4.26 (brs, 1H), 3.81 (s, 3H), 2.29 (s, 3H); 13C NMR δ 157.6, 
147.8, 144.0, 143.1, 140.2, 137.8, 136.6, 136.2, 133.9, 132.7, 131.6, 130.2, 129.8, 129.5, 129.2, 
128.8, 128.5, 127.7, 127.4, 127.1, 126.6, 125.9, 124.4, 120.0, 119.8, 116.9, 110.4, 56.8, 55.5, 21.6 
(a pair of peaks at the aromatic region was overlapped); HRMS (ESI, positive): m/z calcd for 
C35H30N2NaO3S ([M+Na]+) 581.1868, found 581.1869. 
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(E)-12-Phenyl-5-tosyl-7-(4-(trifluoromethyl)benzylidene)-5,6,7,12-tetrahydrodibenzo[b,e][1,4]
diazocine (14j) 
Isolated by PTLC (hexane/dichloromethane = 1/2). The title compound was obtained as a white 
solid, 85%; mp 172 °C; 1H NMR δ 7.64 (dd, J = 1.5, 8.2 Hz, 1H), 7.31 (d, J = 8.2 Hz, 2H), 
7.31-7.23 (m, 4H), 7.20-7.01 (m, 6H), 6.86-6.98 (m, 5H), 6.83 (dd, J = 7.3, 7.3 Hz, 1H), 6.58 (d, J 
= 8.1 Hz, 2H), 6.52 (s, 1H), 4.54 (brs, 1H), 4.51 (brs, 1H), 2.30 (s, 3H); 13C NMR δ 147.8, 143.7, 
143.5, 140.4, 139.7, 138.2, 137.7, 136.2, 136.1, 133.0, 130.7, 130.1, 129.5, 129.5, 129.2, 129.2, 
129.0 (q, J = 32.2 Hz), 128.1, 127.8, 127.7, 127.0, 126.9, 125.3, 125.1 (q, J = 3.9 Hz), 124.6 (q, J 
= 237.5 Hz), 120.2, 116.9, 56.9, 21.6 HRMS (ESI, positive): m/z calcd for C35H27F3N2NaO2S 
([M+Na]+) 619.1635, found 619.1638. 
 
(E)-7-(4-Fluorobenzylidene)-12-phenyl-5-tosyl-5,6,7,12-tetrahydrodibenzo[b,e][1,4]diazocine 
(14k) 
Isolated by PTLC (hexane/dichloromethane = 1/2). The title compound was obtained as a yellow 
solid, 87%; mp 193 °C; 1H NMR δ 7.65 (dd, J = 1.4, 8.0 H, 1H), 7.30-7.20 (m, 4H), 7.20-7.11 (m, 
3H), 7.08 (dd, J = 7.7, 7.7 Hz, 3H), 6.97-6.88 (m, 3H), 6.82 (dd, J = 7.4, 7.4 Hz, 1H), 6.76 (d, J = 
7.2 Hz, 4H), 6.58 (d, J = 8.0 Hz, 2H), 6.47 (s, 1H), 4.52 (brs, 1H), 4.42 (brs, 1H), 2.29 (s, 3H); 13C 
NMR δ 162.0 (d, J = 217.8 Hz), 147.8, 143.7, 143.4, 139.8, 137.7, 136.1, 136.5, 135.3 (d, J = 1.2 
Hz), 132.9, 132.8, 132.8, 131.0, 130.8, 130.6 (d, J = 8.1 Hz), 129.5, 129.2, 129.1, 128.0, 127.8, 
126.9 (d, J = 4.2 Hz), 125.0, 120.0, 116.9, 115.1 (d, J = 21.5 Hz), 57.0, 21.6 (a pair of peaks at the 
aromatic region was overlapped.); HRMS (ESI, positive): m/z calcd for C34H27FN2NaO2S 
([M+Na]+) 569.1669, found 569.1669. 
 
(E)-7-(4-Chlorobenzylidene)-12-phenyl-5-tosyl-5,6,7,12-tetrahydrodibenzo[b,e][1,4]diazocine 
(14l) 
Isolated by PTLC (hexane/dichloromethane = 1/2). The title compound was obtained as a yellow 
solid, 89%; mp 210 °C; 1H NMR δ 7.64 (d, J = 8.0 Hz, 1H), 7.32-7.21 (m, 4H), 7.20-7.10 (m, 3H), 
7.08 (t, J = 7.3 Hz, 3H), 7.04 (d, J = 8.4 Hz, 2H), 6.96-6.89 (m, 3H), 6.82 (dd, J = 7.2, 7.2 Hz, 1H), 
6.72 (d, J = 8.3 Hz, 2H), 6.57 (d, J = 8.2 Hz, 2H), 6.45 (s, 1H), 4.52 (brs, 1H), .4.44 (brs, 1H), 2.29 
(s, 3H); 13C NMR δ 147.8, 143.6, 143.4, 139.7, 137.7, 136.4, 136.2, 136.1, 135.2, 133.0, 132.9, 
130.8, 130.7, 130.3, 129.5, 129.5, 129.2, 128.3, 127.9, 127.9, 127.7, 126.9, 126.9, 125.1, 120.1, 
116.9, 57.0, 21.6; HRMS (ESI, positive): m/z calcd for C34H27O2ClNaO2S ([M+Na]
+) 585.1373, 
found 585.1374. 
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Ethyl (E)-2-(12-phenyl-5-tosyl-5,12-dihydrodibenzo[b,e][1,4]diazocin-7(6H)-ylidene)acetate 
(14m) 
Isolated by PTLC (dichloromethane). The title compound was obtained as yellow oil, 98%; 1H 
NMR δ 7.62 (dd, J = 1.5, 7.7 Hz, 1H),7.31-7.51 (m, 4H), 7.17 (dd, J = 1.1, 8.0 Hz, 1H), 6.99-7.14 
(m, 8H), 6.76 (dd, J = 7.3, 7.3 Hz, 1H), 6.51 (d, J = 7.8 Hz, 2H), 5.73 (s, 1H), 4.88 (brs, 1H), 4.20 
(brs, 1H), 4.02 (q, J = 7.1 Hz, 2H), 2.31 (s, 3H), 1.13 (t, J = 7.1 Hz, 3H); 13C NMR δ 165.1, 154.6, 
147.4, 143.9, 140.8, 139.2, 137.4, 137.1, 136.3, 134.0, 130.8, 129.6, 129.6, 129.6, 128.9, 127.9, 
126.5, 126.4, 125.9, 125.1, 119.6, 116.9, 115.1, 60.1, 56.4, 21.6, 14.2; HRMS (ESI, positive):  m/z 
calcd for C31H28N2NaO4S ([M+Na]
+) 547.1661, found 547.1662. 
 
4-(4-methoxyphenyl)-N,N-diphenyl-1-tosyl-1,2-dihydroquinolin-8-amine (14g’) 
Isolated by PTLC (hexane/dichloromethane = 1/2) The title compound was obtained as a white 
solid, 70%; mp 237 °C; 1H NMR δ 7.42 (d, J = 8.2 Hz, 2H), 7.30-7.14 (m, 9H), 7.09-6.99 (m, 5H), 
6.79-6.73 (m, 2H), 6.70-6.60 (m, 3H), 5.36 (dd, J = 2.6, 6.0 Hz, 1H), 4.26 (dd, J = 6.0, 18.2 Hz, 
1H), 3.80 (s, 3H), 3.26 (dd, J = 2.6, 18.6 Hz, 1H), 2.27 (s, 3H); 13C NMR δ 159.2, 146.5, 143.2, 
138.5, 137.3, 134.9, 130.5, 129.9, 129.2, 129.2, 129.1, 128.9, 128.6, 128.2, 127.7, 127.5, 122.7, 
121.5, 113.3, 55.4, 53.6, 44.1, 21.5; HRMS (ESI, positive): m/z calcd for C35H30N2NaO3S 
([M+Na]+) 581.1870, found 581.1869. 
 
N,N-diphenyl-4-(p-tolyl)-1-tosyl-1,2-dihydroquinolin-8-amine (14o’) 
Isolated by PTLC (hexane/dichloromethane = 1/2) The title compound was obtained as light yellow 
oil, 43%; 1H NMR δ 7.44-7.40 (m, 2H), 7.30-7.15 (m, 9H), 7.08-6.99 (m, 7H), 6.66-6.59 (m, 3H), 
5.39 (dd, J = 2.5, 6.0 Hz, 1H), 4.27 (dd, J = 6.0, 18.3 Hz, 1H), 3.27 (dd, J = 2.3, 18.4 Hz, 1H), 2.33 
(s, 3H), 2.27 (s, 3H); 13C NMR δ146.5, 143.2, 138.9, 137.4, 137.2, 135.2, 134.8, 129.7, 129.5, 
129.3, 129.0, 128.9, 128.7, 128.6, 128.5, 128.1, 127.6, 127.5, 123.0, 121.6, 44.1, 21.5, 21.3; HRMS 
(ESI, positive): m/z calcd for C35H30N2NaO2S ([M+Na]
+) 565.1920, found 565.1920.  
 
N,N-Diphenyl-2-(prop-2-yn-1-yloxy)aniline (15) 
Isolated by flash silica gel column chromatography (hexane/ethyl acetate = 9/1). The title com-
pound was obtained as brown oil, 81%; 1H NMR δ 7.24-7.16 (m, 6H), 7.12 (dd, J = 0.9, 7.9 Hz, 
1H), 7.05-6.97 (m, 5H), 6.93 (dd, J = 7.3, 7.3 Hz, 2H), 4.48 (d, J = 2.4 Hz, 2H), 2.40 (dd, J = 2.4 
Hz, 1H); 13C NMR δ 154.0, 147.7, 136.8, 130.2, 129.0, 126.5, 123.2, 122.0, 121.8, 116.6, 78.8, 
75.4, 56.8; HRMS (ESI, positive): m/z calcd. For C21H17NNaO ([M+Na]
+) 322.1202, found 
322.1202. 
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N,N-Diphenyl-2H-chromen-8-amine (16’) 
Isolated by PTLC (hexane/ethyl acetate = 15/1). The title compound was obtained as orange oil, 
59%; 1H NMR δ 7.23-7.15 (m, 4H), 7.07-7.00 (m, 4H),7.00-6.98 (m, 3H), 6.83 (d, J = 4.9 Hz, 2H), 
6.41 (dt, Jt = 1.8 Hz, Jd = 9.9 Hz, 1H), 5.72 (dt, Jt = 3.5, Jd = 9.9 Hz, 1H), 4.52 (dd, J = 1.8, 3.5 Hz, 
2H); 13C NMR 150.0, 147.7, 134.3, 129.7, 129.0, 124.7, 124.5, 124.0, 122.8, 121.9, 121.8, 121.7, 
65.2; HRMS (ESI, positive): m/z calcd. For C21H18NO ([M+H]
+) 300.1383, found 300.1383. 
 
4-Methyl-N-(2-oxopropyl)-N-(2-phenoxyphenyl)benzenesulfonamide (17) 
Isolated by PTLC (hexane/ethyl acetate = 4/1). The title compound was obtained as a white solid, 
22% in total yield; mp 100-102 °C; 1H NMR δ 7.63 (d, J = 8.3 Hz, 2H), 7.45 (dd, J = 1.7, 7.9 Hz, 
1H), 7.29-7.16 (m, 5H), 7.12-7.07 (m, 1H), 7.05 (ddd, J = 1.4, 7.7, 7.7 Hz, 1H), 6.77-6.71 (m, 3H), 
4.51 (d, J = 1.8 Hz, 2H), 2.38 (s, 3H), 2.18 (t, J = 2.5 Hz, 1H); 13C NMR δ 155.7, 155.1, 143.5, 
137.1, 133.5, 130.0, 129.8, 129.5, 128.2, 127.9, 124.1, 123.0, 119.6, 118.1, 78.5, 73.5, 40.2, 21.6; 
HRMS (ESI, positive): m/z calcd. For C22H19NNaO3S ([M+Na]
+) 400.0978, found 400.0979. 
 
4-Methyl-N-(2-oxopropyl)-N-(2-phenoxyphenyl)benzenesulfonamide (18’) 
Isolated by PTLC (hexane/ethyl acetate = 3/1). The title compound was obtained as a brown solid, 
72%; mp 88-89 °C; 1H NMR δ 7.62 (d, J = 8.0 Hz, 1H), 7.56 (d, 8.1 Hz, 2H), 7.25 (dd, J = 7.7, 7.7 
Hz, 2H), 7.22-7.15 (m, 3H), 7.12-7.03 (m, 2H), 6.66 (d, J = 8.3 Hz, 1H), 6.61 (d, J = 8.6 Hz, 2H), 
4.41 (s, 2H), 2.37 (s, 3H), 2.30 (s, 3H); 13C NMR δ 204.9, 155.1, 154.3, 143.7, 136.5, 133.5, 129.9, 
129.5, 128.8, 127.9, 124.3, 123.1, 119.5, 117.6, 60.3, 27.3, 21.7 (a pair of aromatic region was 
overlapped); HRMS (ESI, positive): m/z calcd. For C22H21NNaO4S ([M+Na]
+) 418.1084, found 
418.1080. 
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Backgrounds  
The spirocyclic skeleton is a unique structure found in various natural products and biologically 
active compounds.1 Azaspirocyclic skeleton is also important, because it is a substructure of bio-
logically active gabapentin lactam and a key synthetic intermediate of a natural product, crinine.2,3 
Therefore, many synthetic chemists developed the synthetic strategies for spirocyclic skeletons. 
One of the most common strategies is the dearomative spirocyclization of phenols to give spirocy-
clohexadienones, and there are mainly three strategies.4 The first one is oxidative spirocyclization 
of phenols. In 1987, Kita and co-workers reported the first example of dearomative spirocyclization 
of phenols by using hypervalent iodine, where phenols act as an electrophile (Scheme 1a).5a The 
reaction is considered to proceed via phenoxy-λ3-iodane species, which was intramolecularly at-
tacked by nucleophiles. After their intensive works, they developed an enantioselective spirocy-
clization of phenols using chiral hypervalent iodine in 2008 (Scheme 1b).5b This reaction was the 
first example of highly enantioselective reaction mediated by chiral hypervalent iodine. The rigid 
structure of 1,1’-spirobiindane skeleton of chiral hypervalent iodine was the key to high enantiose-
lectivity, and the use of mCPBA as a co-oxidant could lower the loading of hypervalent iodine to a 
catalytic amount. 
 
Scheme 1. Oxidative spirocyclization of phenols by hypervalent iodine 
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The second one is radical spirocyclization. In 2016, Zhang and co-workers reported the radical 
spirocyclization of phenols under mild conditions using photocatalyst (fac-Ir(ppy)3) and blue LED 
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(Scheme 2).6 The visible light excited the Ir(III) catalyst to generate Ir(III)* species. Ir(III)* species 
gave a single electron to bromo compound along with the homolytic cleavage of C-Br bond to pro-
vide a radical intermediate and Ir(IV) complex. The resulting radical intermediate underwent C-C 
bond formation at the ipso-position and a single electron transferred to Ir(IV) complex to complete 
the catalytic cycle along with the formation of an oxonium intermediate. It was converted to the 
product by aid of base. 
 
Scheme 2. Radical spirocyclization of phenols 
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The third one is ipso-Friedel-Crafts-type spirocyclization. In 2014, Aparece and Vadola devel-
oped gold(I)-catalyzed 5-endo-dig spirocyclization of alkyne-containing phenol derivatives, where 
anisyl moiety acts as a nucleophile to alkyne (Scheme 3).7 They found that the use of H2O as an ad-
ditive promoted the dearomative spirocyclization and the anhydrous condition induced 6-endo-dig 
hydroarylation to give coumarin selectively. The presence of water was considered important for 
the demethylation from an oxonium intermediate. 
 
Scheme 3. ipso-Friedel-Crafts type spirocyclization of phenol derivatives 
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Metal carbenoid species were used for the ipso-Fridel-Crafts-type spirocyclization.8,9 For a pio-
neering work, Iwata and co-workers reported transition metal-catalyzed dearomative spirocycliza-
tion of phenols using metal carbenoid species prepared from diazoketones in 1985 (Scheme 4).8b,8c 
They used rhodium, palladium, and copper catalysts for the generation of metal carbenoid species. 
However, the scope of substrates was limited. 
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Scheme 4. Dearomative spirocyclization via metal carbenoid species 
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Recently, Nemoto and co-workers developed an enantioselective dearomative spirocyclization of 
phenols using a chiral silver catalyst and diazoketones (Scheme 5).9 The high enantioselectivity was 
achieved by a chiral counteranion and the addition of benzoic acid. Compared to rhodium carbe-
noid, which promoted Büchner type reaction and C-H insertion, the lower bond order of silver car-
benoid resulted in a more carbocationic character, which facilitates spirocyclization. However, 
these reactions used poisonous diazo compounds for the generation of metal carbenoid species. 
 
Scheme 5. Enantioselective dearomative spirocyclization via Ag-carbenoid species 
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 Against this background, the author envisioned gold(I)-catalyzed dearomative spirocyclization of 
phenol derivatives via gold carbenoid species derived from ynamide (Scheme 6). This strategy did 
not use hazardous diazo compounds to generate metal carbenoid species and could introduce sub-
stituents (R) easily. To achieve the transformation, suppression of possible side reactions, such as 
overoxidation, C-H insertion, and Büchner type reaction, was a difficult problem to be solved.  
 
Scheme 6. Concept of this work 
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Results and Discussion  
 First, the author conducted screening of solvents by using terminal ynamide 1a (Table 1). When 
the reaction was examined by using DCE as a sole solvent, the desired spirocyclic compound 2a 
was obtained in low yield (Entry 1). According to previous work,7 the author considered that the 
addition of water would be effective for this reaction (see, Scheme 3). Various ratio of mixed sol-
vent of DCE and water were examined (Entries 2-4). As a result, the addition of water improved the 
yield and the 1/4 mixed solvent of DCE and water gave the highest yield of 2a (Entry 4). In contrast, 
the reaction using water as a sole solvent gave only trace amount of 2a without the consumption of 
1a. 
 
Table 1. Screening of solvent 
NTs
O
O
2a
MeO
N
Ts
Ph3PAuCl (10 mol%)
AgSbF6 (10 mol%)
4-Ph-pyridine-N-oxide (2.0 eq.)
solvent, r.t.
1a  
Entry Solvent Time /h Yield /%[a] 
1 DCE 1 ca. 27 
2 DCE/H2O = 4/1 5 55 
3 DCE/H2O = 1/1 5 54 
4 DCE/H2O = 1/4 5 60 
5 H2O 5 trace 
[a] NMR yields was measured using 1,1,2,2-tetrachloroethane as an internal standard. 
 
 Next, the author subjected internal ynamide 1b to gold(I)-catalyzed spirocyclization. Preliminary 
experiments showed the 1/4 mixed solvent of DCE and water was suitable for spirocyclization. The 
author then started the screening of N-oxides oxidants (Table 2). The use of pyridine N-oxide gave 
the desired spirocyclic compound 2b in moderate yield along with the complete consumption of 1b 
(Entry 1). The major by-product was an overoxidized product, diketone 2b’. The reaction of 
4-phenylpyridine N-oxide was complete within 30 min, but the yield was not improved (Entry 2). 
To inhibit the generation of diketone, sterically hindered pyridine N-oxides were used (Entries 3-5). 
However, the yield was not improved. Next, quinoline N-oxides were examined (Entries 6 and 7). 
The use of quinoline N-oxide improved the yield slightly (Entry 6). The use of sterically more hin-
dered quinoline N-oxide was not effective (Entry 7). The author determined quinoline N-oxide as 
the best oxidant, but the formation of diketone by-product could not be fully prevented. 
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Table 2. Screening of oxidants 
NTs
O
O Ph
2b
MeO
N
Ts
Ph3PAuCl (10 mol%)
AgSbF6 (10 mol%)
N-oxide (2.0 eq.)
DCE/H2O = 1/4, 80 °C, 1 h
Ph
1b
MeO
N
Ts
Ph
O
O
2b'  
Entry N-oxide Yield of 2b /%[a] Yield of 2b’ /%[a] 
1 Pyridine 51 19 
 i2[b] 4-Ph-pyridine (46) - 
 i3[c] 2,6-Br2-pyridine 18 Trace 
4 2,6-Me2-pyridine 40 24 
5 2-Me-pyridine 51 48 
6 quinoline 54 46 
7 8-Me-quinoline 26 31 
[a] NMR yields was measured using 1,1,2,2-tetrachloroethane as an internal standard. When the 
total yield of 2b and 2b’ exceeded 100%, the yields were calculated by the ratio of 2b and 2b’, de-
termined by 1H-NMR. Isolated yield was shown in parentheses. [b] The reaction was conducted for 
30 min. [c] The reaction was conducted at room temperature. 
 
To accelerate the ipso-Friedel-Crafts reaction and inhibit the over-oxidation, phosphine ligands 
and silver salts were examined (Table 3). Electron-deficient ligands were ineffective: the yield of 
2b was lower and the yield of the diketone increased (Entries 2 and 3). Almost no effect was ob-
served by silver salts (Entries 1, 4 and 5). While the reaction did not proceed in the absence of gold 
catalysts, only a slight loss of yield was observed in the absence of silver salts (Entries 6 and 7). 
The author considered that silver salts are not significant for this transformation and further 
screened the ligands under silver salt-free conditions.  
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Table 3. Screening of phosphine ligands and silver salts 
NTs
O
O Ph
2b
MeO
N
Ts
LAuCl (10 mol%)
silver salt (10 mol%)
quinoline N-oxide (2.0 eq.)
DCE/H2O = 1/4, 80 °C, 1 h
Ph
1b
MeO
N
Ts
Ph
O
O
2b'  
Entry L Silver salt Yield of 2b /%[a] Yield of 2b’ /%[a] 
1 PPh3 AgSbF6 54 46 
2 P(C6F5)3 AgSbF6 17 83 
3 P(4-CF3C6H4)3 AgSbF6 33 67 
4 PPh3 AgOTf 53 47 
5 PPh3 AgBF4 51 49 
6[b] None AgSbF6 Trace Trace 
7 PPh3 None 48 52 
[a] NMR yields was measured by using 1,1,2,2-tetrachloroethane as an internal standard. When the 
total yield of 2b and 2b’ exceeded 100%, the yields were calculated by the ratio of 2b and 2b’, de-
termined by 1H-NMR. [b] The reaction was conducted without gold complexes. 
 
 Next, NHC ligands and additives were examined (Table 4). When the reaction was conducted for 
3 h using the IPr ligand, the yield was low due to the low conversion along with formation of the 
diketone as a by-product (Entry 1). When the reaction time was prolonged to 24 h, the yield was 
improved. More important still, the amount of diketone did not increase (Entry 2). The catalytic 
activity was drastically decreased in DCE as a single solvent and the yield of 2b was low because 
of low conversion (Entry 3). Other NHC ligands were examined and IPr gave the best results (En-
tries 2, 4-7). These results indicated that the bulkiness around the gold catalyst inhibited the gener-
ation of diketone, and high yield of spirocyclic product 2b was achieved.10 Judging from entries 1 
and 2, the author speculated that quinoline generated from quinoline N-oxide suppressed the for-
mation of diketone and added quinolone as an additive (Entry 8). Gratifyingly, the isolated yield 
was improved to 85%. The reaction could also be conducted by the larger reaction scale (Entry 9). 
It is noteworthy that the present reaction smoothly proceeded under air and the comparable yield 
was achieved (Entry 10). 
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Table 4. Screening of NHC ligand and additive 
NTs
O
O Ph
2b
MeO
N
Ts
LAuCl (10 mol%)
additive (10 mol%)
quinoline N-oxide (2.0 eq.)
DCE/H2O = 1/4, 80 °C
Ph
1b
MeO
N
Ts
Ph
O
O
2b'  
Entry L Additive Time /h Yield of 2b /%[a] Yield of 2b’ /%[a] 
1 IPr None 3 35 20 
2 IPr None 24 78 (75) 22 
 i3[b] IPr None 24 14 - 
4 SIPr None 24 (72) - 
5 ICy None 24 29 71 
6 IMes None 24 59 (57) 41 
7 SIMes None 24 (63) - 
8 IPr Quinoline 24 (85) - 
 i9[c] IPr Quinoline 24 (79) - 
10[d] IPr Quinoline 24 77 23 
[a] NMR yields were measured using 1,1,2,2-tetrachloroethane as an internal standard. When the 
total yield of 2b and 2b’ exceeded 100%, the yields were calculated by the ratio of 2b and 2b’, de-
termined by 1H-NMR. Isolated yields were shown in parentheses. [b] DCE (0.5 mL) was used as a 
sole solvent. [c] The reaction was conducted four times as much scale as other entries: 1b (0.20 
mmol), Au cat. (10 mol%), quinoline (10 mol%), quinoline N-oxide (0.2 mmol), DCE (0.4 mL), 
H2O (7.6 mL), 80 °C, 24 h. [d] The reaction was conducted under air. 
 
 Under the optimized conditions (Entry 8 in Table 4), various ynamides were examined for the 
spirocyclization (Table 4). The reactions of haloaryl-substituted ynamides 1c-1g gave the desired 
compounds 2c-2g in good to excellent yields (Entries 1-5). In the reactions of 1d, 1g and 
p-methoxycarbonyl-substituted ynamide 1h, DCE content in the mixed solvent was increased be-
cause of low solubility of the ynamides (Entries 2, 5 and 6). The best substrate for this transfor-
mation was p-trifluoromethylphenyl-substituted ynamide 1i that gave spirocyclic product 2i in 98% 
(Entry 7). Sterically hindered substrate 1j showed low reactivity (Entry 8). Electron-donating group 
substituted-ynamides 1k-1n were not suitable for this reaction and the yield was low to moderate 
because of the formation of a significant amount of diketones (Entries 9-12). Heteroaryl-substituted 
ynamide 1o could also be used for this reaction and pyridyl-substituted product 2o was obtained in 
moderate yield (Entry 13). When terminal alkyne 1a was subjected to the reaction under the opti-
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mized conditions, 2a was obtained in low yield (Entry 14). After screening of conditions, the reac-
tion of terminal alkyne 1a proceeded in the presence of chloro(triphenylphosphine)gold(I) and 
4-phenylpyridine N-oxide at room temperature to give 2a in moderate yield. 
 
Table 4. Scope of alkyne terminus 
NTs
O
O R
2
MeO
N
Ts
IPrAuCl (10 mol%)
quinoline (10 mol%)
quinoline N-oxide (2.0 eq.)
DCE/H2O = 1/4, 80 °C, 24 h
R
1  
Entry R Yield /%[a] Entry R Yield /%[a] 
1 4-FC6H4 (1c) 68 (2c) 8 2-CF3C6H4 (1j) 27, 35
[b] (2j) 
2 4-ClC6H4 (1d) 30, 79
[b] (2d) 9 4-MeC6H4 (1k) 37, 51
[c] (2k) 
3 4-BrC6H4 (1e) 85 (2e) 10 3-MeC6H4 (1l) 52 (2l) 
4 3-ClC6H4 (1f) 82 (2f) 11 2-MeC6H4 (1m) 49 (2m) 
5 4-Br-2-FC6H3 (1g) 31, 69
[b] (2g) 12 4-MeOC6H4 (1n) trace, 14
[c] (2n) 
6 4-(CO2Me)C6H4 (1h) 55, 86
[b] (2h) 13 3-Pyridyl (1o) 67 (2o) 
7 4-CF3C6H4 (1i) 98 (2i) 14 H (1a) 22, 53
[d] (2a) 
[a] Isolated yield. [b] Quinoline (20 mol%), DCE (0.2 mL) and H2O (0.4 mL) were used. [c] 
Ph3PAuCl (10 mol%), quinoline (20 mol%) and quinoline N-oxide (0.1 mmol) were used in a 
mixed solvent of PhCl (0.2 mL) and H2O (0.8 mL) at 100 °C for 24 h. [d] 1o (0.05 mmol), 
Ph3PAuCl (10 mol%), 4-phenylpyridine N-oxide (0.1 mmol) were used in a mixed solvent of DCE 
(0.1 mL) and H2O (0.4 mL) at r.t. for 5 h. 
 
Next, the author examined the reaction of substrates possessing other alkoxy-substituted aryl 
groups (Scheme 7). The reaction of 2,4-dimethoxybenzylamine derived substrate 1p gave spirocy-
clic product 2p in good yield with moderate diastereoselectivity [Equation (1)]. The author sub-
jected naphthol derivatives 1q and 1r in the present spirocyclization [Equation (2) and (3)]. 
1-Naphthol derivative 1q was a good substrate and tricyclic compound 2q was obtained in high 
yield. When 2-naphthol derivative 1r was subjected to the reaction, the desired product 2r was ob-
tained in moderate yield. This reaction required an electron-donating group on the arene moiety. 
Actually, 3-bromo-4-methoxybenzylamine derivative 1s gave only a trace amount of spirocyclic 
compound 2s [Equation (4)]. This result indicated that the nucleophilicity of ipso position was im-
portant. The reaction of tert-butoxy-substituted substrate 1t also gave spirocyclic product 2a in 
moderate yield [Equation (5)]. 
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Scheme 7. Scope of substrates possessing other alkoxy-substituted aryl groups 
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Some synthetic transformations of 2b were demonstrated (Scheme 8). The deprotection of the 
tosyl group was conducted using magnesium in methanol, but diarylacetate 3 was obtained by re-
aromatization of the cyclohexadienone moiety along with C-C bond cleavage [Equation (6)].11 To 
prevent the rearomatization, Pd-catalyzed hydrogenation of the cyclohexadienone moiety was car-
ried out prior to deprotection of the tosyl group [Equation (7)]. The reaction proceeded smoothly to 
give gabapentin lactam derivative 4 quantitatively in two steps.3 Lewis acid-mediated rearrange-
ment of 2b gave dihydroisoquinolone derivative 5 in high yield [Equation (8)].12 Methylation ad-
jacent to carbonyl group proceeded under basic conditions to provide 6 in high yield [Equation 
(9)]. 
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Scheme 8. Synthetic applications of 2b 
NTs
O
O Ph
Mg (20 eq.)
MeOH, reflux, 2 h
Pd/C (10 mol%)
EtOAc, r.t., ovn
under H2
NH
O
HO Ph
BF3·OEt2 (5.0 eq.)
MeNO2, reflux, 1 h
NTs
Ph
O
5
87%
NTs
O
O Ph
Mg (2.0 eq.)
MeOH, reflux, 1 h
NH
O
O Ph
N.D.
HO
Ph
3
91%
2a
2a
(6)
(7)
2a
4
quant. in two steps
(d.r. = 2.3:1)
(8)
CO2Me
2a
NaH (1.5 eq.)
MeI (1.5 eq.)
DMF, r.t., 1 h
NTs
O
O
Ph
6
96%
(9)
HO
 
The possible reaction mechanism was depicted in Scheme 9. The initial step is the formation of 
gold carbenoid species A from ynamide and N-oxide. The carbenoid species react at a highly nu-
cleophilic ipso position to provide spirocycle B. The spirocycle B react to give C by aid of water.7 
In this transformation, the water acts as a reactant to promote the formal demethylation step where 
nucleophilic addition of water along with elimination of methanol, and quinoline may also promote 
this step by increasing the basicity.13 Finally, protodemetallation of C yields spirocyclic product 2 
and the gold catalyst is regenerated. 
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Scheme 9. Plausible reaction mechanism 
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Conclusion  
 The author developed catalytic dearomative spirocyclization of phenol derivatives via gold car-
benoid species derived from ynamides. This reaction demonstrated new reactivity of gold carbenoid 
species. The use of IPr as a relatively bulky NHC ligand was important to suppress the generation 
of diketone by-product. The author speculated that the bulkiness shielded the gold carbenoid spe-
cies from the second attack of N-oxide, which is derived into the formation of diketone as a major 
by-product. In addition, the strong electron-donating ability of NHC ligand would improve the re-
activity toward spirocyclization. The presence of water as a co-solvent was crucial for the high re-
activity. In the plausible reaction mechanism, water acted as a nucleophile in formal demethylation 
step to convert intermediate B to C. The reactivity drastically decreased by using DCE as a sole 
solvent (Table 4, Entry 3). From these results, the author speculated that the counter anion of gold 
catalyst, chloride, exchanged to hydroxide in the presence of excess water and the gold-hydroxide 
complexes were the active species. The obtained spirocyclohexadienones were readily transformed 
into various compounds. 
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Experimental Section  
General information: 1H NMR spectra were recorded on JEOL ECX-500 (500 MHz) spectrome-
ters. The chemical shifts were reported in parts per million (δ) relative to internal standard TMS (0 
ppm) for CDCl3. The peak patterns are indicated as follows: s, singlet; d, doublet; t, triplet; dd, 
doublet of doublets; dt, triplet of doublet; m, multiplet; q, quartet. The coupling constants, J, are 
reported in Hertz (Hz). 13C NMR spectra were obtained by JEOL ECX-500 (125 MHz) spectrome-
ters and referenced to the internal solvent signals (central peak is 77.16 ppm in CDCl3). CDCl3 was 
used as a NMR solvent. High-resolution mass spectra (HRMS) were measured on a JMS-T100CS 
with ESI (Electro Spray Ionization) method. Preparative thin-layer chromatography (PTLC) was 
performed with silica gel-precoated glass plates (Wakogel B-5F) prepared in our laboratory, Flash 
column chromatography was performed over silica gel 200-300. All reagents were weighed and 
handled in air and backfilled under argon at room temperature. Unless otherwise noted, all reac-
tions were performed under an argon atmosphere. All reagents were purchased from Wako, Kanto, 
Aldrich, TCI and Strem and used without further purification.  
 
Preparation of N-(4-methoxybenzyl)-4-methyl-N-(arylethynyl)benzenesulfonamide (1): 
 
MeO
R
MeO
R
NHTs
TsCl (1.2 eq.)
pyridine (2.0 eq.)
NH2
S1
S3
MeO
CHO
R
1) Ti(Oi-Pr)4 (2.0 eq.)
    TsNH2 (1.5 eq.)
2) NaBH4 (4.0 eq.)
S2
CuSO4•5H2O (10 mol%)
1,10-phenanthroline (20 mol%)
K2CO3 (3.0 eq.)
Toluene, 80 °C, 16 h
Ar Br (1.2 eq.)
MeO
R
N
Ts
1
Ar
R = H, yield 89%
 
Method A:  
Preparation of Ts-protected p-methoxybenzylamine derivatives: A dry Schlenk tube equipped 
with a rubber septum was charged with S1 (1.0 mmol). Pyridine (2.0 mmol) and DCM (2.0 mL) 
were added to the reaction vessel under argon atmosphere. TsCl (1.2 mmol) was added slowly. The 
Method A 
Method B 
Chapter 3 
 94 
reaction mixture was stirred overnight at room temperature and quenched with 1N HCl solution. 
The solution was extracted with EtOAc, the organic extract was dried over Na2SO4. The dry or-
ganic extract was filtered, and evaporated under reduced pressure. The crude products were 
semi-purified by crystallization from hexane and DCM to give S3.14 
N-(4-methoxybenzyl)-4-methylbenzenesulfonamide was obtained in 89%. Other S3 products were 
used for the next reaction without further purification. 
 
Preparation of bromo-alkyne: To a solution of the terminal alkyne (1 equiv) in anhydrous acetone 
(conc = 0.30 M) were added N-bromosuccinimide (1.2 equiv) and AgNO3 (10 mol %). After 3 h at 
room temperature, the resulting mixture was then filtrated and the filtrate was extracted with hex-
ane (3 × 30 mL). The combined organic layers were dried (Na2SO4) and concentrated under vacu-
um (25°C, 200 mbar) to afford the title compounds.15a  
 
Preparation of ynamide: To a dry flask were added Ts-protected p-methoxybenzylamine deriva-
tives (0.5 mmol), CuSO4•5H2O (10 mol%), 1,10-phenanthroline (20 mmol) and K2CO3 (1.0 mmol). 
Then toluene (2.0 mL) and bromoalkyne (1.2 mmol) were added, and the resulting mixture was 
stirred at 80 oC for 12 h under an atmosphere of argon. When the reaction was complete, the crude 
mixture was cooled down to room temperature, filtered through celite and washed with ethyl ace-
tate. After solvent evaporation, the residue was purified by flash column chromatography on silica 
gel (eluent: hexane: ethyl acetate = 5:1) to afford compound 1.15b 
 
Method B: 
Preparation of Ts-protected p-methoxybenzylamine derivatives: A 30 mL dry two-necked 
pear-shaped flask equipped with a glass stopper and argon balloon was charged with S2 (1.0 mmol), 
TsNH2 (1.5 mmol), Ti(Oi-Pr)4 (2.0 mmol), and toluene (4.2 mL). The solution was refluxed for 3 h. 
After removal of the solvent under reduced pressure, MeOH (4.2 mL) and THF (4.2 mL) were 
added, and the reaction vessel equipped with argon balloon was cooled to 0 °C. To the cooled solu-
tion, NaBH4 (4.0 mmol) was slowly added. The reaction mixture was warmed to room temperature 
and stirred for 1 h. The solution was poured into ice cold water and extracted with EtOAc (×3). The 
organic extracts were combined, washed with brine, and dried over Na2SO4. The dry organic ex-
tract was filtered, and evaporated under reduced pressure. The crude products were semi-purified 
by crystallization from hexane and DCM to give S3. S3 were used for the next reaction without 
further purification.16 
 
Next steps are the same as Method A. 
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Preparation N-(4-methoxybenzyl)-N-ethynyl-p-toluenesulfonamide (1a): 
To a stirred solution of N-(4-methoxybenzyl)-4-methylbenzenesulfonamide (1 mmol) in dry DMF 
(20 mL) was added Cs2CO3 (1.3 eq.) at room temperature. After 30 min, a solution of (trimethylsi-
lyl)ethynyl iodonium trifluoromethanesulfonate salt (1.3 mmol) in dry CH2Cl2 (8 mL) was added 
dropwise. Stirring was continued until starting materials disappeared (TLC monitoring, typically 5 
h). Then, ether was added (10 mL) and the combined organic layers were extracted with water and 
brine, dried over anhydrous Na2SO4 and concentrated to dryness. Purification of the residue by 
flash chromatography on silica gel using a gradient mixture of EtOAc/hexanes as eluent afforded 
ynamides 1a in good yields.17 
 
Preparation of [(NHC)AuCl]: 
The protocol is the complete same as the reference.18 ICyAuCl was synthesized in the same way as 
IPrAuCl, and its 1H-NMR matched the data of the reference.19 
 
General procedure for reaction in Table 4: 
Condition A: IPrAuCl (3.1 mg, 0.0050 mmol), quinoline N-oxide･nH2O (18.1 mg, 0.10 mmol; 
calculated as n = 2), and N-(4-methoxybenzyl)-4-methyl-N-(phenylethynyl)benzenesulfonamide 1 
(0.050 mmol), were placed in a Schlenk tube, which was then evacuated and backfilled with argon 
(×3). To the reaction vessel, H2O (0.40 mL) and a solution of 50 mM quinoline in DCE (0.10 mL) 
were added. The solution was then stirred at 80 °C (oil bath temperature). The reaction mixture was 
cooled to room temperature and the solvent was evaporated. The obtained crude product was puri-
fied by PTLC to give products 2. 
Condition B: Ph3PAuCl (2.4 mg, 0.0050 mmol), quinoline N-oxide･nH2O (18.1 mg, 0.010 mmol; 
calculated as n = 2), and N-(4-methoxybenzyl)-4-methyl-N-(phenylethynyl)benzenesulfonamide 1 
(0.050 mmol), were placed in a Schlenk tube, which was then evacuated and backfilled with argon 
(×3). To the reaction vessel, H2O (0.80 mL) and a solution of 50 mM quinoline in PhCl (0.20 mL) 
were added. The solution was then stirred at room temperature. After removal of solvent, the crude 
product was purified by PTLC to give products 2. 
 
1-(4-Hydroxyphenyl)-1-methoxycarbonyl-1-phenylmethane (3) 
A dry Schlenk tube equipped with a rubber septum was charged with 2b (19.7 mg, 0.05 mmol), and 
activated Mg (2.5 mg, 0.1 mmol). MeOH (0.50 mL) was added to the reaction vessel, and it was 
capped with a glass stopper under argon atmosphere. The resulting solution was refluxed for 1 h, 
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then filtered through a short pad of celite. The filtrate was evaporated under reduced pressure. The 
crude products were purified by preparative TLC (elution: hexane/EtOAc = 1/1) to give the title 
compound 3 (11.1 mg, 91%) as a colorless oil. 
 
8-Hydroxy-4-phenyl-2-azaspiro[4.5]decan-3-one (4) 
A dry Schlenk tube equipped with a rubber septum was charged with 2b (23.0 mg, 0.058 mmol), 
dry 10% Pd/C (5.0 mg, 0.005 mmol), and EtOAc (1.0 mL). The reaction vessel was evacuated and 
backfilled with argon (×3), then backfilled with H2 (×3). The reaction mixture was stirred at room 
temperature overnight. After the consumption of starting material, the reaction vessel was evacuat-
ed and backfilled with argon (×3). The resulting solution was filtered through a short pad of celite 
and washed with EtOAc. The filtrate was evaporated under reduced pressure. The crude product 
was used directly in the next step. A dry Schlenk tube equipped with a rubber septum was charged 
with crude product, activated Mg (25.0 mg, 1.0 mmol). MeOH (0.50 mL) was added to the reaction 
vessel, and it was capped with a glass stopper under argon atmosphere. The resulting solution was 
refluxed for 2 h. The resulting solution was filtered through a short pad of celite. The filtrate was 
evaporated under reduced pressure to give pure 4 quantitatively without further purification. 
 
2-Tosyl-6-hydroxy-4-phenyl-1,2-dihydroisoquinolin-3(4H)-one (5) 
A dry Schlenk tube equipped with a rubber septum was charged with 2b (19.5 mg, 0.05 mmol), and 
BF3·Et2O (31 μL, 0.25 mmol). MeNO2 (1.5 mL) was added to the reaction vessel, and it was 
capped with a glass stopper under argon atmosphere. The resulting solution was refluxed for 1 h 
and quenched with sat. NaHCO3 solution. The solution was extracted with EtOAc, the organic ex-
tract was dried over Na2SO4. The dry organic extract was filtered, and evaporated under reduced 
pressure. The crude products were purified by preparative TLC (elution: hexane/EtOAc = 3/2) to 
give 5 (17.0 mg, 87%) as an off-white solid. 
 
2-Tosyl-4-methyl-4-phenyl-2-azaspiro[4.5]deca-6,9-diene-3,8-dione (6) 
A dry Schlenk tube equipped with a rubber septum was charged with 2b (18.9 mg, 0.048 mmol), ca. 
50% NaH in oil (4.0 mg, ca. 0.087 mmol), and DMF (0.5 mL). The solution was stirred for 30 min 
at room temperature. MeI (4.7 μL, 0.075 mmol) in DMF (0.5 mL) was added to the solution and 
the reaction mixture was stirred for 1 h. After consumption of starting material, water was added 
and the solution was extracted with EtOAc (×3). The combined organic layer was dried over 
Na2SO4. The dry organic extract was filtered and evaporated under reduced pressure. The crude 
products were purified by preparative TLC (elution: hexane/EtOAc = 1/1) to give 6 (18.9 mg, 96%) 
as a white solid. 
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2) Characterization data for new compounds 
N-(4-Methoxybenzyl)-N-ethynyl-p-toluenesulfonamide (1a) 
Isolated by flash silica gel column chromatography (hexane/EtOAc = 7/3). The title compound was 
obtained as an off-white solid, 70%; mp 121 °C; 1H NMR δ 7.75 (d, J = 8.5 Hz, 2H), 7.31 (d, J = 
8.4 Hz, 2H), 7.21 (d, J = 8.4 Hz, 2H), 6.82 (d, J = 8.5 Hz, 2H), 4.43 (s, 2H), 3.79 (s, 3H), 2.67 (s, 
1H), 2.44 (s, 3H); 13C NMR δ 159.8, 144.8, 134.9, 130.4, 129.9, 127.8, 126.4, 114.0, 76.4, 59.9, 
55.4, 54.9, 21.8; HRMS (ESI, positive): m/z calcd. for C17H17NNaO3S
 [M + Na]+ 338.0821, found 
338.0821. 
 
N-(4-Methoxybenzyl)-4-methyl-N-(phenylethynyl)benzenesulfonamide (1b) 
Synthesized by Method A. Isolated by flash silica gel column chromatography (hexane/EtOAc = 
7/3). The title compound was obtained as a white solid, 89%; mp 81 °C; 1H NMR δ 7.79 (d, J = 8.4 
Hz, 2H), 7.31 (d, J = 8.1 Hz, 2H), 7.27-7.22 (m, 7H, overlapped with CHCl3), 6.83 (d, J = 8.4 Hz, 
2H), 4.51 (s, 2H), 3.79 (s, 3H), 2.44 (s, 3H); 13C NMR δ 159.9, 144.7, 134.9, 131.3, 130.6, 129.8, 
128.3, 127.9, 127.8, 126.6, 123.0, 114.0, 82.9, 71.6, 55.4, 55.4, 21.8; HRMS (ESI, positive): m/z 
calcd. for C23H21NNaO3S [M + Na]
+ 414.1133, found 414.1134. 
 
N-((4-Fluorophenyl)ethynyl)-N-(4-methoxybenzyl)-4-methylbenzenesulfonamide (1c) 
Synthesized by Method A. Isolated by flash silica gel column chromatography (hexane/EtOAc = 
7/3). The title compound was obtained as a white solid, 90%; mp 59-60 °C; 1H NMR δ 7.78 (d, J = 
8.4 Hz, 2H), 7.31 (d, J = 8.1 Hz, 2H), 7.25-7.19 (m, 4H), 6.94 (dd, J = 8.6, 8.6 Hz, 2H), 6.83 (d, J = 
8.6 Hz, 2H), 4.50 (s, 2H), 3.79 (s, 3H), 2.44 (s, 3H); 13C NMR δ 162.3 (d, JC-F = 249.4 Hz, 1C), 
159.9, 144.7, 134.9, 133.3 (d, JC-F = 8.4 Hz, 1C), 130.5, 129.9, 127.9, 126.6, 119.0 (d, JC-F = 3.6 Hz, 
1C), 115.6 (d, JC-F = 22.1 Hz, 1C), 114.0, 82.4, 70.5, 55.4, 55.4, 21.8; HRMS (ESI, positive): m/z 
calcd. for C23H20FNNaO3S [M + Na]
+ 432.1040, found 432.1040. 
 
N-((4-Chlorophenyl)ethynyl)-N-(4-methoxybenzyl)-4-methylbenzenesulfonamide (1d) 
Synthesized by Method A. Isolated by flash silica gel column chromatography (hexane/EtOAc = 
7/3). The title compound was obtained as a white solid, 61%; mp 87-89 °C; 1H NMR δ 7.78 (d, J = 
8.2 Hz, 2H), 7.33 (d, J = 8.1 Hz, 2H), 7.28-7.19 (m, 4H), 7.15 (d, J = 8.3 Hz, 2H), 6.84 (d, J = 8.4 
Hz, 2H), 4.51 (s, 2H), 3.79 (s, 3H), 2.45 (s, 3H); 13C NMR δ 159.8, 144.8, 134.8, 133.6, 132.4, 
130.5, 129.8, 128.6, 127.8, 126.4, 121.5, 114.0, 83.6, 70.7, 55.4, 55.3, 21.7; HRMS (ESI, positive): 
m/z calcd. for C23H20
35ClNNaO3S [M + Na]
+ 448.0745, found 448.0745. 
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N-((4-Bromophenyl)ethynyl)-N-(4-methoxybenzyl)-4-methylbenzenesulfonamide (1e) 
Synthesized by Method A. Isolated by flash silica gel column chromatography (hexane/EtOAc = 
7/3). The title compound was obtained as a white solid, 74%; mp 75 °C; 1H NMR δ 7.78 (d, J = 8.4 
Hz, 2H), 7.37 (d, J = 8.8 Hz, 2H), 7.32 (d, J = 8.4 Hz, 2H), 7.23 (d, J = 8.6 Hz, 2H), 7.08 (d, J = 8.6 
Hz, 2H), 6.83 (d, J = 8.8 Hz, 2H), 4.50 (s, 2H), 3.79 (s, 3H), 2.45 (s, 3H); 13C NMR δ 159.9, 144.8, 
134.9, 132.6, 131.6, 130.6, 129.9, 127.9, 126.5, 122.0, 121.8, 114.0, 82.4, 70.8, 55.4, 55.3, 21.8; 
HRMS (ESI, positive): m/z calcd. for C23H20
79BrNNaO3S [M + Na]
+ 492.0241, found 492.0239 
 
N-((3-Chlorophenyl)ethynyl)-N-(4-methoxybenzyl)-4-methylbenzenesulfonamide (1f) 
Synthesized by Method A. Isolated by flash silica gel column chromatography (hexane/EtOAc = 
7/3). The title compound was obtained as a white solid, 84%; mp 113 °C; 1H NMR δ 7.78 (d, J = 
8.2 Hz, 2H), 7.33 (d, J = 7.9 Hz, 2H), 7.25-7.14 (m, 5H), 7.10 (dt, J = 7.4, 1.5 Hz, 1H), 6.84 (d, J = 
8.8 Hz, 2H), 4.51 (s, 2H), 3.80 (s, 3H), 2.45 (s, 3H); 13C NMR δ 159.9, 144.8, 134.8, 134.1, 130.8, 
130.5, 129.9, 129.5, 129.1, 127.8, 127.8, 126.3, 124.8, 114.0, 84.0, 70.6, 55.4, 55.3, 21.7; HRMS 
(ESI, positive): m/z calcd. for C23H20
35ClNNaO3S [M + Na]
+ 448.0747, found 448.0745. 
 
N-((4-Bromo-2-fluorophenyl)ethynyl)-N-(4-methoxybenzyl)-4-methylbenzenesulfonamide (1g) 
Synthesized by Method A. Isolated by flash silica gel column chromatography (hexane/EtOAc = 
7/3). The title compound was obtained as a white solid, 87%; mp 73-74 °C; 1H NMR δ 7.79 (d, J = 
8.4 Hz, 2H), 7.32 (d, J = 8.2 Hz, 2H), 7.24 (d, J = 8.6 Hz, 2H, overlapped with CDCl3), 7.20 (dd, J 
= 8.7, 1.8 Hz, 1H), 7.17 (dd, J = 8.3, 2.0 Hz, 1H), 7.09 (t, J = 7.9 Hz, 1H), 6.82 (d, J = 8.7 Hz, 2H), 
4.52 (s, 2H), 3.79 (s, 3H), 2.44 (s, 3H); 13C NMR δ 162.0 (d, JC-F = 255.1 Hz, 1C), 159.9, 144.8, 
134.8, 133.6 (d, JC-F = 1.8 Hz, 1C), 130.6, 129.8, 127.8, 127.4 (d, JC-F = 3.6 Hz, 1C), 126.2, 121.6 
(d, JC-F = 8.9 Hz, 1C), 119.2 (d, JC-F = 24.1 Hz, 1C), 114.0, 111.0 (d, JC-F = 15.8 Hz, 1C), 88.7 (d, 
JC-F = 3.0 Hz, 1C), 64.7, 55.4, 55.3, 21.7; HRMS (ESI, positive): m/z calcd. for 
C23H19
79BrFNNaO3S [M + Na]
+ 510.0148, found 510.0145. 
 
Methyl 4-(((N-(4-methoxybenzyl)-4-methylphenyl)sulfonamido)ethynyl)benzoate (1h) 
Synthesized by Method A. Isolated by flash silica gel column chromatography (hexane/EtOAc = 
7/3). The title compound was obtained as a white solid, 91%; mp 80 °C; 1H NMR δ 7.91 (d, J = 8.5 
Hz, 2H), 7.79 (d, J = 8.3 Hz, 2H), 7.33 (d, J = 8.0 Hz, 2H), 7.28-7.22 (m, 4H), 6.84 (d, J = 8.6 Hz, 
2H), 4.53 (s, 2H), 3.90 (s, 3H), 3.80 (s, 3H), 2.45 (s, 3H); 13C NMR δ 166.7, 159.9, 144.9, 134.8, 
130.5, 130.4, 129.9, 129.5, 128.7, 128.0, 127.8, 126.3, 114.0, 86.1, 71.8, 55.4, 55.3, 52.2, 21.7; 
HRMS (ESI, positive): m/z calcd. for C25H23NNaO5S [M + Na]
+ 472.1191, found 472.1189. 
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N-(4-Methoxybenzyl)-4-methyl-N-((4-(trifluoromethyl)phenyl)ethynyl)benzenesulfonamide 
(1i) 
Synthesized by Method A. Isolated by flash silica gel column chromatography (hexane/EtOAc = 
7/3). The title compound was obtained as pale yellow oil, 84%; 1H NMR δ 7.79 (d, J = 8.3 Hz, 2H), 
7.49 (d, J = 8.2 Hz, 2H), 7.33 (d, J = 8.2 Hz, 2H), 7.29 (d, J = 8.3 Hz, 2H), 7.24 (d, J = 8.8 Hz, 2H, 
overlapped with CHCl3), 6.84 (d, J = 8.8 Hz, 2H), 4.53 (s, 2H), 3.80 (s, 3H), 2.45 (s, 3H); 
13C NMR 
δ 159.9, 144.9, 134.8, 130.8, 130.5, 129.9, 129.2 (q, JC-F = 32.5 Hz, 1C), 127.8, 127.0 (q, JC-F = 1.5 
Hz, 1C), 126.2, 125.2 (q, JC-F = 3.9 Hz, 1C), 124.0 (q, JC-F = 272.4 Hz, 1C), 114.0, 85.4, 71.1, 55.4, 
55.2, 21.7; HRMS (ESI, positive): m/z calcd. for C24H20F3NNaO3S [M + Na]
+ 482.1008, found 
482.1009. 
 
N-(4-Methoxybenzyl)-4-methyl-N-((2-(trifluoromethyl)phenyl)ethynyl)benzenesulfonamide 
(1j) 
Synthesized by Method A. Isolated by flash silica gel column chromatography (hexane/EtOAc = 
7/3). The title compound was obtained as a white solid, 83%; mp 76-78 °C; 1H NMR δ 7.78 (d, J = 
8.3 Hz, 2H), 7.57 (d, J = 7.8 Hz, 1H), 7.40 (t, J = 7.2 Hz, 1H), 7.35-7.24 (m, 6H, overlapped with 
CHCl3), 6.83 (d, J = 8.6 Hz, 2H), 4.54 (s, 2H), 3.78 (s, 3H), 2.43 (s, 3H); 
13C NMR δ 159.8, 144.8, 
135.0, 133.2, 131.4, 130.5, 130.1 (q, JC-F = 30.4 Hz, 1C), 129.8, 127.8, 127.0, 126.4, 125.8 (q, JC-F 
= 5.1 Hz, 1C), 123.6 (d, JC-F = 272.1 Hz, 1C), 121.5 (d, JC-F = 2.1 Hz, 1C), 114.0, 88.5, 68.3, 55.5, 
55.4, 21.7; HRMS (ESI, positive): m/z calcd. for C24H20F3NNaO3S [M + Na]
+ 482.1008, found 
482.1008. 
 
N-(4-Methoxybenzyl)-4-methyl-N-(p-tolylethynyl)benzenesulfonamide (1k) 
Synthesized by Method A. Isolated by flash silica gel column chromatography (hexane/EtOAc = 
7/3). The title compound was obtained as pale yellow oil, 93%; 1H NMR δ 7.88 (d, J = 8.2 Hz, 2H), 
7.30 (d, J = 8.2 Hz, 2H), 7.26-7.23 (m, 2H, overlapped with CHCl3), 7.14 (d, J = 8.2 Hz, 2H), 7.05 
(d, J = 7.7 Hz, 2H), 6.82 (d, J = 8.8 Hz, 2H), 4.50 (s, 2H), 3.78 (s, 3H), 2.43 (s, 3H), 2.31 (s, 3H); 
13C NMR δ 159.8, 144.6, 138.0, 135.0, 131.4, 130.6, 129.8, 129.1, 127.9, 126.7, 119.9, 114.0, 82.1, 
71.5, 55.4, 55.4, 21.8, 21.5; HRMS (ESI, positive): m/z calcd. for C24H23NNaO3S [M + Na]
+ 
428.1291, found 428.1291. 
 
N-(4-Methoxybenzyl)-4-methyl-N-(m-tolylethynyl)benzenesulfonamide (1l) 
Synthesized by Method A. Isolated by flash silica gel column chromatography (hexane/EtOAc = 
7/3). The title compound was obtained as pale yellow oil, 93%; 1H NMR δ 7.78 (d, J = 8.4 Hz, 2H), 
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7.31 (d, J = 8.1 Hz, 2H), 7.27-7.23 (m, 2H, overlapped with CHCl3), 7.13 (dd, J = 7.5, 7.5 Hz, 1H), 
7.05 (dd, J = 7.5, 5.8 Hz, 3H), 6.83 (d, J = 8.6 Hz, 2H), 4.50 (s, 2H), 3.79 (s, 3H), 2.43 (s, 3H), 2.28 
(s, 3H); 13C NMR δ 159.8, 144.6, 138.0, 135.0, 131.9, 130.6, 129.8, 128.7, 128.3, 128.2, 127.9, 
126.7, 122.8, 114.0, 82.5, 71.7, 55.4, 21.8, 21.3; HRMS (ESI, positive): m/z calcd. for 
C24H23NNaO3S [M + Na]
+ 428.1290, found 428.1291. 
 
N-(4-Methoxybenzyl)-4-methyl-N-(o-tolylethynyl)benzenesulfonamide (1m) 
Synthesized by Method A. Isolated by flash silica gel column chromatography (hexane/EtOAc = 
7/3). The title compound was obtained as pale yellow oil, 95%; 1H NMR δ 7.84 (d, J = 8.4 Hz, 2H), 
7.35 (d, J = 7.9 Hz, 2H), 7.31-7.27 (m, 2H, overlapped with CHCl3), 7.22 (d, J = 7.5 Hz, 1H), 
7.18-7.13 (m, 2H), 7.11-7.07 (m, 1H), 6.86 (d, J = 8.4 Hz, 2H), 4.56 (s, 2H), 3.82 (s, 3H), 2.47 (s, 
3H), 2.22 (s, 3H); 13C NMR δ 159.9, 144.7, 139.6, 135.0, 131.3, 130.6, 129.9, 129.4, 127.9, 127.7, 
126.7, 125.5, 122.8, 114.1, 86.5, 70.7, 55.4, 55.4, 21.8, 20.7; HRMS (ESI, positive): m/z calcd. for 
C24H23NNaO3S [M + Na]
+ 428.1291, found 428.1291. 
 
N-(4-Methoxybenzyl)-N-((4-methoxyphenyl)ethynyl)-4-methylbenzenesulfonamide (1n) 
Synthesized by Method A. Isolated by flash silica gel column chromatography (hexane/EtOAc = 
7/3). The title compound was obtained as a white solid, 92%; mp 73-74 °C; 1H NMR δ 7.78 (d, J = 
8.2 Hz, 2H), 7.30 (d, J = 7.9 Hz, 2H), 7.25 (d, J = 8.4 Hz, 2H, overlapped with CHCl3), 7.20 (d, J = 
8.4 Hz, 2H), 6.82 (d, J = 8.6 Hz, 2H), 6.78 (d, J = 8.6 Hz, 2H), 4.50 (s, 2H), 3.78 (s, 3H), 3.78 (s, 
3H), 2.44 (s, 3H); 13C NMR δ 159.8, 159.5, 144.6, 135.0, 133.3, 130.5, 129.8, 127.9, 126.8, 115.0, 
114.0, 114.0, 81.4, 71.2, 55.5, 55.4, 21.8; HRMS (ESI, positive): m/z calcd. for C24H23NNaO4S [M 
+ Na]+ 444.1239, found 444.1240. 
 
N-(4-Methoxybenzyl)-4-methyl-N-(pyridin-3-ylethynyl)benzenesulfonamide (1o) 
Synthesized by Method A. Isolated by flash silica gel column chromatography (hexane/EtOAc = 
7/3). The title compound was obtained as brown oil, 70%; 1H NMR δ 8.46-8.42 (m, 2H), 7.79 (d, J 
= 8.2 Hz, 2H), 7.54-7.50 (dt, J = 8.0, 2.0 Hz, 1H), 7.34 (d, J = 8.3 Hz, 2H), 7.24 (d, J = 8.8 Hz, 2H), 
7.20-7.15 (m, 1H), 6.84 (d, J = 8.8 Hz, 2H), 4.53 (s, 2H), 3.80 (s, 3H), 2.45 (s, 3H); 13C NMR δ 
160.0, 151.9, 148.1, 145.0, 138.0, 134.8, 130.6, 130.0, 127.9, 126.3, 123.0, 120.3, 114.1, 85.9, 68.8, 
55.4, 55.3, 21.8; HRMS (ESI, positive): m/z calcd. for C22H20N2NaO3S [M + Na]
+ 415.1085, found 
415.1087. 
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N-(2,4-Dimethoxybenzyl)-N-(phenylethynyl)-p-toluenesulfonamide (1p) 
Synthesized by Method B. Isolated by flash silica gel column chromatography (hexane/EtOAc = 
7/3). The title compound was obtained as a off-white solid, 32% (2 steps); mp 81 °C; 1H NMR δ 
7.80 (d, J = 8.4 Hz, 2H), 7.29 (d, J = 8.4 Hz, 2H), 7.22-7.17 (m, 6H), 6.42 (dd, J = 8.2, 2.4 Hz, 1H), 
6.37 (d, J = 2.4 Hz, 1H), 4.58 (s, 2H), 3.76 (s, 3H), 3.65 (s, 3H), 2.41 (s, 3H); 13C NMR δ 161.4, 
159.0, 144.4, 135.2, 131.9, 131.0, 129.7, 128.3, 127.9, 127.4, 123.4, 115.1, 104.1, 98.5, 83.3, 71.0, 
55.5, 55.4, 50.5, 21.8 (a pair of peaks on the aromatic region is overlapped); HRMS (ESI, positive): 
m/z calcd. for C24H23NNaO4S
 [M + Na]+ 444.1240, found 444.1241.. 
 
N-(4-Methoxynaphthylmethyl)-N-(phenylethynyl)-p-toluenesulfonamide (1q) 
Synthesized by Method B. Isolated by flash silica gel column chromatography (hexane/EtOAc = 
7/3). The title compound was obtained as a white solid, 45% (2 steps); mp 141 °C; 1H NMR δ 8.29 
(d, J = 8.3 Hz, 1H), 8.15 (d, J = 8.3 Hz, 1H), 7.86 (d, J = 8.4 Hz, 2H), 7.60-7.46 (m, 2H), 7.38-7.31 
(m, 3H), 7.22-7.16 (m, 3H), 7.12-7.06 (m, 2H), 6.72 (d, J = 8.0 Hz, 1H), 4.89 (s, 2H), 3.99 (s, 3H), 
2.45 (s, 3H); 13C NMR δ 156.6, 144.8, 134.3, 132.9, 131.1, 129.9, 129.7, 128.2, 128.0, 127.6, 127.4, 
126.0, 125.5, 123.6, 123.0, 122.7, 121.5, 102.9, 82.8, 71.9, 55.7, 53.7, 21.8; HRMS (ESI, positive): 
m/z calcd. for C27H23NNaO3S [M+Na
+] 464.1291, found 464.1293. 
 
N-(2-Methoxynaphthylmethyl)-N-(phenylethynyl)-p-toluenesulfonamide (1r) 
Synthesized by Method B. Isolated by flash silica gel column chromatography (hexane/EtOAc = 
7/3). The title compound was obtained as a pale yellow solid, 54% (2 steps); mp 130 °C; 1H NMR 
δ 8.07 (d, J = 8.6 Hz, 1H), 7.91 (d, J = 8.3 Hz, 2H), 7.82 (d, J = 8.9 Hz, 1H), 7.75 (d, J = 7.8 Hz, 
1H), 7.51-7.43 (m, 1H), 7.37-7.30 (m, 3H), 7.19 (d, J = 8.9 Hz, 1H), 7.12-7.06 (m, 3H), 6.89-6.82 
(m, 2H), 5.08 (s, 2H), 3.76 (s, 3H), 2.42 (s, 3H); 13C NMR δ 156.8, 144.6, 134.5, 133.7, 131.4, 
130.6, 129.9, 129.1, 128.5, 128.1, 128.1, 127.5, 127.1, 123.8, 123.3, 123.2, 114.1, 113.0, 82.8, 71.0, 
56.6, 45.2, 21.8; HRMS(ESI, positive): m/z calcd. for C27H23NNaO3S [M+Na
+] 464.1291, found 
464.1292. 
 
N-(3-Bromo-4-methoxybenzyl)-N-(phenylethynyl)-p-toluenesulfonamide (1s) 
Synthesized by Method B. Isolated by flash silica gel column chromatography (hexane/EtOAc = 
7/3). The title compound was obtained as a pale yellow solid, 68% (2 steps); mp 108 °C; 1H NMR δ 
7.78 (d, J = 8.2 Hz, 2H), 7.42 (s, 1H), 7.34-7.20 (m, 7H), 6.80 (d, J = 8.5 Hz, 2H), 4.47 (s, 2H), 
3.84 (s, 3H), 2.42 (s, 3H); 13C NMR δ 156.0, 144.9, 134.7, 134.0, 131.3, 129.9, 129.5, 128.4, 128.0, 
127.9, 127.8, 122.8, 111.8, 111.6, 82.5, 71.8, 56.4, 54.7, 21.8; HRMS(ESI, positive): m/z calcd. for 
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C23H20
79BrNNaO3S [M+Na
+] 492.0239, found 492.0241. 
 
N-(4-tert-Butoxybenzyl)-N-(phenylethynyl)-p-toluenesulfonamide (1t) 
Synthesized by Method B from p-tert-butoxybenzaldehyde.20 Isolated by flash silica gel column 
chromatography (hexane/EtOAc = 7/3). The title compound was obtained as pale-yellow oil, 74%; 
1H NMR δ 7.78 (d, J = 8.3 Hz, 2H), 7.31 (d, J = 8.3 Hz, 2H), 7.26-7.20 (m, 7H), 6.92 (d, 8.4 Hz, 
2H), 4.54 (s, 2H), 2.44 (s, 3H), 1.33 (s, 9H); 13C NMR δ 155.7, 144.7, 134.9, 131.2, 129.9, 129.8, 
129.3, 128.3, 127.9, 127.8, 124.1, 122.9, 82.8, 78.8, 71.5, 55.4, 28.9, 21.8; HRMS(ESI, positive): 
m/z calcd. for C26H27NNaO3S [M+Na
+] 456.1604, found 456.1603. 
 
2-Tosyl-2-azaspiro[4.5]deca-6,9-diene-3,8-dione (2a) 
Isolated by PTLC (hexane/DCM/EtOAc = 5/4/1). The title compound was obtained as a white solid, 
53%; mp 165 °C; 1H NMR δ 7.95 (d, J = 8.3 Hz, 2H), 7.40 (d, J = 8.3 Hz, 2H), 6.80 (d, J = 10.1 Hz, 
2H), 6.35 (d, J = 10.1 Hz, 2H), 3.92 (s, 2H), 2.62 (s, 2H), 2.48 (s, 3H); 13C NMR δ 184.4, 169.7, 
147.6, 146.1, 134.6, 130.4, 130.1, 128.3, 53.8, 42.1, 40.9, 21.9; HRMS (ESI, positive): m/z calcd. 
for C16H15NNaO4S [M + Na]
+ 340.0614, found 340.0614. 
 
4-Phenyl-2-tosyl-2-azaspiro[4.5]deca-6,9-diene-3,8-dione (2b) 
Isolated by flash silica gel column chromatography (hexane/DCM/EtOAc = 4/5/1). The title com-
pound was obtained as a pale pink solid, 85%; mp 188 °C; 1H NMR δ 8.01 (d, J = 8.4 Hz, 2H), 7.41 
(d, J = 8.2 Hz, 2H), 7.25-7.18 (m, 3H), 6.91-6.85 (m, 3H), 6.63 (dd, J = 10.2, 3.1 Hz, 1H), 6.36 (dd, 
J = 10.1, 1.8 Hz, 1H), 6.09 (dd, J = 10.2, 1.8 Hz, 1H), 4.01 (d, J = 10.4 Hz, 1H), 3.94 (d, J = 10.4 
Hz, 1H), 3.91 (s, 1H), 2.49 (s, 3H); 13C NMR δ 184.6, 170.4, 147.2, 146.2, 145.5, 134.7, 132.0, 
131.0, 131.0, 130.2, 129.2, 128.8, 128.7, 128.4, 58.6, 52.1, 47.1, 21.9; HRMS (ESI, positive): m/z 
calcd. for C22H19NNaO4S [M + Na]
+ 416.0925, found 416.0927. 
 
N-(4-Methoxybenzyl)-N-tosyl-2-oxo-2-phenylacetamide (2b’)21 
The NMR data of the title compound were accorded with those in the literature. 
 
4-(4-Fluorophenyl)-2-tosyl-2-azaspiro[4.5]deca-6,9-diene-3,8-dione (2c) 
Isolated by flash silica gel column chromatography (hexane/DCM/EtOAc = 5/4/1). The title com-
pound was obtained as a pale pink solid, 68%; mp >198 °C decomp.; 1H NMR δ 8.00 (d, J = 8.2 Hz, 
2H), 7.41 (d, J = 8.4 Hz, 2H), 6.95-6.88 (m, 4H), 6.86 (dd, J = 9.9, 3.0 Hz, 1H), 6.65 (dd, J = 10.1, 
3.0 Hz, 1H), 6.37 (dd, J = 10.1, 1.8 Hz, 1H), 6.12 (dd, J = 10.2, 1.8 Hz, 1H), 4.01 (d, J = 10.4 Hz, 
1H), 3.96-3.90 (m, 2H), 2.49 (s, 3H); 13C NMR δ 184.4, 170.1, 146.9, 146.3, 145.1, 134.6, 132.4, 
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131.2, 131.0, 131.0, 130.2, 128.4, 126.6 (d, JC-F = 3.6 Hz, 1C), 115.8 (d, JC-F = 21.8 Hz, 1C), 57.8, 
52.0, 47.3, 21.9; HRMS (ESI, positive): m/z calcd. for C22H18FNNaO4S [M + Na]
+ 434.0833, found 
434.0833. 
 
4-(4-Chlorophenyl)-2-tosyl-2-azaspiro[4.5]deca-6,9-diene-3,8-dione (2d) 
Isolated by PTLC (hexane/DCM/EtOAc = 5/4/1). The title compound was obtained as a pale yellow 
solid, 79%; mp 154-155 °C; 1H NMR δ 8.00 (d, J = 8.4 Hz, 2H), 7.42 (d, J = 8.2 Hz, 2H), 7.20 (d, J 
= 8.4 Hz, 2H), 6.87-6.83 (m, 3H), 6.64 (dd, J = 10.0, 3.0 Hz, 1H), 6.40-6.36 (m, 1H), 6.14-6.10 (m, 
1H), 4.01 (d, J = 10.4 Hz, 1H), 3.93 (d, J = 10.4 Hz, 1H), 3.91 (s, 1H), 2.49 (s, 3H); 13C NMR δ 
184.2, 169.7, 146.6, 146.2, 144.8, 134.7, 134.4, 132.4, 131.1, 130.4, 130.1, 129.2, 128.9, 128.3, 
57.8, 51.9, 47.1, 21.8; HRMS (ESI, positive): m/z calcd. for C22H18ClNNaO4S [M + Na]
+ 450.0539, 
found 450.0537. 
 
4-(4-Bromophenyl)-2-tosyl-2-azaspiro[4.5]deca-6,9-diene-3,8-dione (2e) 
Isolated by PTLC (hexane/DCM/EtOAc = 5/4/1). The title compound was obtained pale yellow 
solid, 85%; mp 133 °C; 1H NMR δ 8.00 (d, J = 8.4 Hz, 2H), 7.41 (d, J = 7.9 Hz, 2H), 7.35 (d, J = 
8.4 Hz, 1H), 6.85 (dd, J = 10.0, 3.1 Hz, 1H), 6.79 (d, J = 8.4 Hz, 1H), 6.63 (dd, J = 10.3, 3.1 Hz, 
1H), 6.38 (dd, J = 10.0, 1.8 Hz, 1H), 6.12 (dd, J = 10.3, 1.8 Hz, 1H), 4.00 (d, J = 10.6 Hz, 1H), 3.93 
(d, J = 10.6 Hz, 1H), 3.89 (s, 3H), 2.49 (s, 3H); 13C NMR δ 184.3, 169.8, 146.7, 146.3, 144.9, 134.5, 
132.5, 132.0, 131.3, 130.8, 130.2, 129.8, 128.4, 123.0, 58.0, 52.0, 47.2, 21.9; HRMS (ESI, posi-
tive): m/z calcd. for C22H18
79BrNNaO4S [M + Na]
+ 494.0034, found 494.0032. 
 
4-(3-Chlorophenyl)-2-tosyl-2-azaspiro[4.5]deca-6,9-diene-3,8-dione (2f) 
Isolated by PTLC (hexane/DCM/EtOAc = 5/4/1). The title compound was obtained as a pale yellow 
solid, 82%; mp 156-157 °C; 1H NMR δ 8.01 (d, J = 8.2 Hz, 2H), 7.42 (d, J = 8.2 Hz, 2H), 7.24-7.21 
(m, 1H), 7.16 (t, J = 7.8 Hz, 1H), 6.90-6.85 (m, 2H), 6.82-6.78 (m, 1H), 6.63 (dd, J = 10.2, 3.1 Hz, 
1H), 6.39 (dd, J = 10.1, 1.8 Hz, 1H), 6.14 (dd, J = 10.2, 1.8 Hz, 1H), 4.00 (d, J = 10.5 Hz, 1H), 3.94 
(d, J = 10.5 Hz, 1H), 3.90 (s, 1H), 2.49 (s, 3H); 13C NMR δ 184.3, 169.6, 146.6, 146.2, 144.8, 134.5, 
134.4, 132.7, 132.3, 131.1, 130.1, 129.9, 129.0, 128.9, 128.3, 127.4, 57.9, 52.0, 47.0, 21.8; HRMS 
(ESI, positive): m/z calcd. for C22H18
35ClNNaO4S [M + Na]
+ 450.0538, found 450.0537. 
 
4-(4-Bromo-2-fluorophenyl)-2-tosyl-2-azaspiro[4.5]deca-6,9-diene-3,8-dione (2g) 
Isolated by PTLC (hexane/DCM/EtOAc = 5/4/1). The title compound was obtained as a pale yellow 
solid, 69%; mp 182-183 °C; 1H NMR δ 7.99 (d, J = 8.3 Hz, 2H), 7.41 (d, J = 7.9 Hz, 2H), 7.19 (dd, 
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J = 8.3, 1.8 Hz, 1H), 7.15 (dd, J = 9.6, 1.8 Hz, 1H), 6.90-6.82 (m, 2H), 6.76-6.72 (m, 1H), 6.34 (dd, 
J = 10.1, 1.8 Hz, 1H), 6.17 (dd, J = 10.2, 1.8 Hz, 1H), 4.20 (s, 1H), 4.03 (d, J = 10.5 Hz, 1H), 3.96 
(d, J = 10.5 Hz, 1H), 2.49 (s, 3H); 13C NMR δ 184.2, 168.9, 160.5 (d, JC-F = 252.4 Hz, 1C), 146.7, 
146.2, 144.3 (d, JC-F = 1.5 Hz, 1C), 134.3, 132.3 (d, JC-F = 4.8 Hz, 1C), 132.0, 131.3, 130.1, 128.3, 
127.7 (d, JC-F = 3.3 Hz, 1C), 123.3 (d, JC-F = 9.2 Hz, 1C), 119.5 (d, JC-F = 25.6 Hz, 1C), 117.5 (d, 
JC-F = 15.2 Hz, 1C), 52.2, 52.1, 47.1, 21.8; HRMS (ESI, positive): m/z calcd. for 
C22H17
79BrFNNaO4S [M + Na]
+ 511.9940, found 511.9938. 
 
Methyl 4-(3,8-dioxo-2-tosyl-2-azaspiro[4.5]deca-6,9-dien-4-yl)benzoate (2h) 
Isolated by PTLC (hexane/DCM/EtOAc = 5/4/1). The title compound was obtained as a brown sol-
id, 86%; mp >100 °C decomp.; 1H NMR δ 8.01 (d, J = 8.4 Hz, 2H), 7.89 (d, J = 8.2 Hz, 2H), 7.42 
(d, J = 8.4 Hz, 2H), 7.00 (d, J = 8.2 Hz, 2H), 6.88 (dd, J = 10.0, 3.0 Hz, 1H), 6.64 (dd, J = 10.1, 3.0 
Hz, 1H), 6.37 (dd, J = 10.0, 2.1 Hz, 1H), 6.08 (dd, J = 10.1, 2.1 Hz, 1H), 4.04-3.94 (m, 3H), 3.88 (s, 
3H), 2.00 (s, 3H); 13C NMR δ 184.2, 169.6, 166.4, 146.6, 146.3, 144.8, 135.7, 134.4, 132.4, 131.1, 
130.4, 130.2, 129.8, 129.2, 128.4, 58.2, 52.3, 52.1, 47.1, 21.9; HRMS (ESI, positive): m/z calcd. for 
C24H21NNaO6S [M + Na]
+ 474.0983, found 474.0982. 
 
2-Tosyl-4-(4-(trifluoromethyl)phenyl)-2-azaspiro[4.5]deca-6,9-diene-3,8-dione (2i) 
Isolated by PTLC (/DCM/EtOAc = 4/1). The title compound was obtained as a white solid, 98%; 
mp 93-94 °C; 1H NMR δ 8.01 (d, J = 8.2 Hz, 2H), 7.49 (d, J = 8.2 Hz, 2H), 7.43 (d, J = 8.2 Hz, 2H), 
7.06 (d, J = 8.2 Hz, 2H), 6.90 (dd, J = 10.1, 3.0 Hz, 1H), 6.64 (dd, J = 10.2, 3.0 Hz, 1H), 6.40 (dd, J 
= 10.1, 1.8 Hz, 1H), 6.12 (dd, J = 10.2, 1.8 Hz, 1H), 4.05-3.95 (m, 3H), 2.50 (s, 3H); 13C NMR δ 
184.1, 169.5, 146.5, 146.3, 144.5, 134.8, 134.7 (q, JC-F = 1.2 Hz, 1C), 132.6, 131.3, 130.8 (q, JC-F = 
32.8 Hz, 1C), 130.2, 129.7, 128.4, 125.6 (q, JC-F = 3.6 Hz, 1C), 123.7 (q, JC-F = 272.4 Hz, 1C), 58.0, 
52.1, 47.2, 21.9; HRMS (ESI, positive): m/z calcd. for C23H18F3NNaO4S [M + Na]
+ 484.0801, 
found 484.0802. 
 
2-Tosyl-4-(2-(trifluoromethyl)phenyl)-2-azaspiro[4.5]deca-6,9-diene-3,8-dione (2j) 
Isolated by PTLC (hexane/toluene/DCM/EtOAc = 3/2/4/1). The title compound was obtained as a 
pale yellow solid, 35%; mp 72 °C; 1H NMR δ 8.01 (d, J = 8.4 Hz, 2H), 7.63 (dd, J = 7.6, 1.6 Hz, 
1H), 7.46-7.38 (m, 3H), 6.95 (d, J = 7.6 Hz, 2H), 6.87-6.82 (m, 1H), 6.60 (dd, J = 10.3, 3.2 Hz, 1H), 
6.30 (dd, J = 10.1, 1.8 Hz, 1H), 6.20 (dd, J = 10.3, 1.8 Hz, 1H), 4.32 (s, 1H), 4.06 (d, J = 10.6 Hz, 
1H), 3.97 (d, J = 10.6 Hz, 1H), 2.50 (s, 3H); 13C NMR δ 184.3, 170.3, 147.1, 146.3, 144.7, 134.4, 
132.0, 131.5, 131.2, 130.7, 130.3 (q, JC-F = 1.5 Hz, 1C), 130.2, 129.0, 128.5, 127.0 (q, JC-F = 5.4 Hz, 
1C), 124.8, 122.6, 54.8, 52.5, 46.6, 21.9; HRMS (ESI, positive): m/z calcd. for C23H18F3NNaO4S 
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[M + Na]+ 484.0801, found 484.0801. 
 
4-(p-Tolyl)-2-tosyl-2-azaspiro[4.5]deca-6,9-diene-3,8-dione (2k) 
Isolated by flash silica gel column chromatography (hexane/DCM/EtOAc = 5/4/1). The title com-
pound was obtained as a pale yellow solid, 51%; mp 86-87 °C; 1H NMR δ 8.01 (d, J = 8.3 Hz, 2H), 
7.41 (d, J = 8.3 Hz, 2H), 7.01 (d, J = 7.9 Hz, 2H), 6.85 (dd, J = 10.1, 3.1 Hz, 1H), 6.77 (d, J = 7.9 
Hz, 2H), 6.63 (dd, J = 10.1, 3.1 Hz, 1H), 6.35 (dd, J = 10.1, 1.8 Hz, 1H), 6.10 (dd, J = 10.3, 1.8 Hz, 
1H), 3.99 (d, J = 10.4 Hz, 1H), 3.90 (d, J = 10.4 Hz, 1H), 3.86 (s, 1H), 2.49 (s, 3H), 2.26 (s, 3H); 
13C NMR δ 184.7, 170.5, 147.3, 146.1, 145.7, 138.5, 134.7, 132.0, 131.0, 130.1, 129.5, 129.0, 
128.4, 127.9, 58.4, 52.0, 47.2, 21.9, 21.2; HRMS (ESI, positive): m/z calcd. for C23H21NNaO4S [M 
+ Na]+ 430.1085, found 430.1084. 
 
4-(m-Tolyl)-2-tosyl-2-azaspiro[4.5]deca-6,9-diene-3,8-dione (2l) 
Isolated by flash silica gel column chromatography (hexane/DCM/EtOAc = 5/4/1). The title com-
pound was obtained as a pale yellow solid, 52%; mp 143-144 °C; 1H NMR δ 8.02 (d, J = 8.3 Hz, 
2H), 7.41 (d, J = 8.1 Hz, 2H), 7.12-7.06 (m, 1H), 7.04 (d, J = 7.5 Hz, 1H), 6.88 (dd, J = 10.1, 3.1 
Hz, 1H), 6.66 (d, J = 8.1 Hz, 2H), 6.61 (dd, J = 10.2, 3.1 Hz, 1H), 6.36 (dd, J = 10.0, 1.8 Hz, 1H), 
6.12 (dd, J = 10.2, 1.8 Hz, 1H), 4.00 (d, J = 10.4 Hz, 1H), 3.91 (d, J = 10.4 Hz, 1H), 3.84 (s, 1H), 
2.49 (s, 3H), 2.22 (s, 3H); 13C NMR δ 184.7, 170.6, 147.4, 146.1, 145.7, 138.5, 134.7, 131.7, 131.0, 
131.0, 130.2, 129.6, 129.5, 128.7, 128.5, 126.2, 58.6, 52.1, 46.9, 21.9, 21.4; HRMS (ESI, positive): 
m/z calcd. for C23H21NNaO4S [M + Na]
+ 430.1083, found 430.1084. 
 
4-(o-Tolyl)-2-tosyl-2-azaspiro[4.5]deca-6,9-diene-3,8-dione (2m) 
Isolated by flash silica gel column chromatography (hexane/DCM/EtOAc = 5/4/1). The title com-
pound was obtained as a pale yellow solid, 49%; mp 87-88 °C; 1H NMR δ 8.03 (d, J = 8.2 Hz, 2H), 
7.43 (d, J = 8.1 Hz, 2H), 7.17-7.08 (m, 2H), 7.03-6.98 (m, 1H), 6.95 (dd, J = 10.1, 3.1 Hz, 1H), 
6.60-6.57 (m, 1H), 6.46 (dd, J = 10.3, 3.2 Hz, 1H), 6.33 (dd, J = 10.1, 1.8 Hz, 1H), 6.17 (dd, J = 
10.3, 1.8 Hz, 1H), 4.09 (s, 1H), 4.01 (d, J = 10.6 Hz, 1H), 3.92 (d, J = 10.6 Hz, 1H), 2.51 (s, 3H), 
2.09 (s, 3H); 13C NMR δ 184.5, 171.7, 163.8, 147.9, 146.2, 145.8, 137.2, 134.7, 131.4, 131.3, 130.8, 
130.4, 130.2, 128.7, 128.5, 126.6, 55.0, 52.3, 46.0, 21.9, 20.2; HRMS (ESI, positive): m/z calcd. for 
C23H21NNaO4S [M + Na]
+ 430.1083, found 430.1084. 
 
4-(4-Methoxyphenyl)-2-tosyl-2-azaspiro[4.5]deca-6,9-diene-3,8-dione (2n) 
Isolated by flash silica gel column chromatography (hexane/DCM/EtOAc = 5/4/1). The title com-
Chapter 3 
 106 
pound was obtained as a vermilion solid, 14%; mp 70 °C; 1H NMR δ 8.01 (d, J = 8.2 Hz, 2H), 7.41 
(d, J = 8.1 Hz, 2H), 6.85 (dd, J = 9.9, 2.8 Hz, 1H), 6.82 (d, J = 8.7 Hz, 2H), 6.73 (d, J = 8.7 Hz, 2H), 
6.64 (dd, J = 10.2, 2.8 Hz, 1H), 6.36 (dd, J = 9.9, 1.7 Hz, 1H), 6.11 (dd, J = 10.2, 1.7 Hz, 1H), 4.00 
(d, J = 10.6 Hz, 1H), 3.90 (d, J = 10.6 Hz, 1H), 3.87 (s, 1H), 3.74 (s, 3H), 2.49 (s, 3H); 13C NMR δ 
184.5, 170.5, 159.5, 147.2, 146.0, 145.6, 134.6, 132.0, 130.9, 130.2, 130.0, 128.3, 122.7, 114.0, 
57.9, 55.2, 51.8, 47.3, 21.8; HRMS (ESI, positive): m/z calcd. for C23H21NNaO5S [M + Na]
+ 
446.1033, found 446.1033. 
 
4-(Pyridin-3-yl)-2-tosyl-2-azaspiro[4.5]deca-6,9-diene-3,8-dione (2o) 
Isolated by PTLC (hexane/DCM/EtOAc = 5/4/1). The title compound was obtained as a brown sol-
id, 67%; mp 75-76 °C; 1H NMR δ 8.49 (dd, J = 4.8 1.6 Hz, 1H), 8.19 (d, J = 2.2 Hz, 1H), 8.00 (d, J 
= 8.4 Hz, 2H), 7.42 (d, J = 8.2 Hz, 2H), 7.34-7.30 (m, 1H), 7.21-7.17 (m, 1H), 6.89 (dd, J = 9.9, 3.1 
Hz, 1H), 6.67 (dd, J = 10.2, 3.1 Hz, 1H), 6.40 (dd, J = 9.9, 1.7 Hz, 1H), 6.13 (dd, J = 10.2, 1.7 Hz, 
1H), 4.04 (d, J = 10.4 Hz, 1H), 4.01-3.97 (m, 2H), 2.50 (s, 3H); 13C NMR δ 184.1, 169.3, 150.3, 
150.0, 146.4, 146.2, 144.3, 136.8, 134.5, 133.0, 131.6, 130.3, 128.4, 126.8, 123.4, 56.2, 52.2, 47.5, 
21.9; HRMS (ESI, positive): m/z calcd. for C21H18N2NaO4S [M + Na]
+ 417.0879, found 417.0879. 
 
6-Methoxy-4-phenyl-2-tosyl-2-azaspiro[4.5]deca-6,9-diene-3,8-dione (2p) 
Isolated by PTLC (hexane/DCM/EtOAc = 5/4/1). The title compound was obtained as a pale-brown 
solid, 78%; diastereomeric mixture; 1H NMR δ 8.08-7.98 (m, 2H), 7.46-7.36 (m, 2H), 7.24-7.12 (m, 
3H), 6.96-6.86 (m, 2H), 6.69 (d, J = 9.9 Hz, 0.85H), 6.41 (d, J = 10.2 Hz, 0.15H), 6.28 (dd, J = 9.9, 
1.5 Hz, 0.85H), 5.99 (dd, J = 10.1, 1.5 Hz, 0.15H), 5.66 (d, J = 1.5 Hz, 0.15H), 5.10 (d, J = 1.3 Hz, 
0.85H), 4.32-3.88 (m, 3H), 3.79 (s, 0.45H), 3.14 (s, 2.55H), 2.49 (s, 3H); 13C NMR δ 186.5, 186.2, 
173.0, 171.1, 170.3, 170.0, 146.0, 145.5, 143.7, 142.2, 135.4, 134.8, 131.3, 131.1, 130.2, 130.1, 
129.8, 129.6, 129.1, 129.0, 128.8, 128.6, 128.5, 128.5, 128.5, 128.4, 105.2, 103.3, 56.9, 56.7, 56.3, 
55.1, 51.7, 51.4, 49.2, 48.5, 21.9, 21.9; HRMS (ESI, positive): m/z calcd. for C23H21NNaO5S [M + 
Na]+ 446.1033, found 446.1036. 
 
2'-Phenyl-1'-tosyl-4H-spiro[naphthalene-1,3'-pyrrolidine]-4,5'-dione (2q) 
Isolated by PTLC (hexane/DCM/EtOAc = 5/4/1). The title compound was obtained as yellow oil, 
85%; diastereomeric mixture; 1H NMR δ 8.13 (d, J = 7.4 Hz, 0.61H), 8.11-8.03 (m, 2H), 7.86-7.80 
(m, 0.39H), 7.74-7.41(m, 4H), 7.29-7.27 (m, 0.39H), 7.24-7.11 (m, 1H), 7.11-6.98 (m, 2H), 
6.97-6.90 (m, 0.78H), 6.77-6.60 (m, 2H), 6.59-6.50 (m, 1.22H), 6.24 (d, J = 10.4 Hz, 0.61H), 4.50 
(d, J = 10.8 Hz, 0.39H), 4.39 (s, 0.61H), 4.35 (d, J = 10.8 Hz, 0.61H), 4.28 (d, J = 10.8 Hz, 0.39H), 
4.18-4.09 (m, 1H), 2.55-2.49 (m, 3H); 13C NMR δ 183.4, 183.3, 170.5, 170.3, 149.0, 146.2, 146.1, 
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146.0, 141.7, 141.7, 134.8, 134.7, 133.5, 132.9, 132.6, 131.5, 131.3, 131.0, 130.2, 130.1, 130.0, 
129.9, 129.5, 128.8, 128.7, 128.6, 128.6, 128.5, 128.5, 128.4, 128.1, 128.0, 127.6, 127.3, 125.8, 
124.7, 61.4, 59.9, 55.3, 55.1, 47.3, 46.9, 21.9 (a pair of peaks on alkyl region is overlapped); 
HRMS (ESI, positive): m/z calcd. for C26H21NNaO4S [M + Na]
+ 466.1084, found 466.1086. 
 
2'-Phenyl-1'-tosyl-2H-spiro[naphthalene-1,3'-pyrrolidine]-2,5'-dione (2r) 
Isolated by PTLC (hexane/DCM/EtOAc = 5/4/1). The title compound was obtained as a brown 
solid, 54%; diastereomeric mixture (d.r. = 1.4:1); mp >200 °C decomp; 1H NMR δ 8.15-8.03 (m, 
2H), 7.76-7.69 (d, J = 7.9 Hz, 0.58H), 6.64-7.54 (m, 0.58H), 7.47-7.39 (m, 3H), 7.33-7.27 (m, 1H), 
7.25-7.01 (m, 4H), 6.99-6.89 (m, 0.84H), 6.63-6.53 (m, 2H), 6.18 (d, J = 9.9 Hz, 0.42H), 5.66-5.58 
(d, J = 9.9 Hz, 0.58H), 4.71 (d, J = 10.3 Hz, 0.42H), 4.39 (d, J = 10.8 Hz, 0.58H), 4.36-4.30 (m, 
1H), 4.30-4.23 (m, 1H), 2.54-2.48 (m, 3H); 13C NMR δ 199.9, 199.3, 170.3, 169.8, 147.0, 145.9, 
145.5, 145.3, 140.6, 140.2, 135.2, 134.7, 131.5, 131.2, 130.9, 130.8, 130.7, 130.3, 130.2, 130.0, 
129.9, 129.9, 129.8, 129.3, 128.7, 128.7, 128.6, 128.5, 128.3, 128.1, 127.9, 127.6, 126.8, 126.3, 
124.8, 124.7, 63.2, 62.7, 56.4, 55.6, 54.1, 53.4, 22.0, 21.9 (two pairs of peaks on the aromatic re-
gion are overlapped); HRMS (ESI, positive): m/z calcd. for C26H21NNaO4S [M + Na]
+ 466.1084, 
found 466.1085. 
 
1-(4-Hydroxyphenyl)-1-methoxycarbonyl-1-phenylmethane (3)22 
Isolated by PTLC (hexane/DCM/EtOAc = 5/4/1). The title compound was obtained as colorless oil, 
91%; 1H NMR δ 7.40-7.21 (m, 5H, overlapped with CHCl3), 7.16 (d, J = 8.7 Hz, 2H), 6.76 (d, J = 
8.7 Hz, 2H), 5.10 (s, 1H), 4.97 (s, 1H), 3.74 (s, 3H); 13C NMR δ 173.6, 155.0, 139.0, 130.9, 130.0, 
128.8, 128.6, 127.4, 115.6, 56.3, 52.5; HRMS (ESI, positive): m/z calcd. for C15H14NaO3 [M + 
Na]+ 265.0835, found 265.0834. 
 
8-Hydroxy-4-phenyl-2-azaspiro[4.5]decan-3-one (4) 
The title compound was obtained as a white solid, quant.; diastereomeric mixture; mp 95 °C; 1H 
NMR (CD3OD) δ 7.37-7.23 (m, 3H), 7.22-7.18 (m, 0.6H), 7.17-7.10 (m, 1.4H), 3.41-3.26 (m, 4H), 
1.94-1.17 (m, 7H), 1.14-1.05 (m, 0.3H), 0.89-0.77 (m, 0.7H); 13C NMR δ 181.1, 180.6, 137.3, 
136.7, 130.9, 130.7, 129.5, 129.4, 128.3, 128.3, 70.2, 60.9, 50.8, 44.3, 44.1, 35.7, 32.5, 32.0, 31.2, 
31.2, 31.2, 31.1, 30.6, 30.5 (two pairs of peaks on the alkyl region are overlapped); HRMS (ESI, 
positive): m/z calcd. for C15H19NNaO2 [M + Na]
+ 268.1308, found 268.1309. 
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7-Hydroxy-4-phenyl-2-tosyl-1,2-dihydroisoquinolin-3(4H)-one (5) 
Isolated by flash silica gel column chromatography (hexane/DCM/EtOAc = 5/4/1). The title com-
pound was obtained as a white solid, 87%; mp 182 °C; 1H NMR δ 7.78 (d, J = 8.2 Hz, 2H), 
7.28-7.14 (m, 6H, ), 6.88 (d, J = 6.6 Hz, 2H), 6.81 (dd, J = 8.2, 2.4 Hz, 1H), 6.56 (d, J = 2.4 Hz, 
1H), 5.79 (brs, 1H), 5.09 (d, J = 15.2, 1H), 4.69 (s, 1H), 4.55 (d, J = 15.2 Hz, 1H), 2.46 (s, 3H); 13C 
NMR δ 170.0, 156.5, 145.1, 136.0, 135.5, 134.2, 129.5, 129.0, 128.6, 127.9, 127.7, 127.7, 124.0, 
115.4, 115.1, 55.6, 48.0, 21.8; HRMS (ESI, positive): m/z calcd. for C22H19NNaO4S [M + Na]
+ 
416.0927, found 416.0925. 
 
4-Methyl-4-phenyl-2-tosyl-2-azaspiro[4.5]deca-6,9-diene-3,8-dione (6) 
Isolated by flash silica gel column chromatography (hexane/DCM/EtOAc = 5/4/1). The title com-
pound was obtained as a white solid, 96%; mp 135 °C; 1H NMR δ 8.05 (d, J = 8.3 Hz, 2H), 7.46 (d, 
J = 8.3 Hz, 2H), 7.26-7.17 (m, 3H), 6.87 (d, J = 7.3 Hz, 2H), 6.80 (dd, J = 10.3, 3.0 Hz, 1H), 6.41 
(dd, J = 10.3, 1.7 Hz, 1H), 6.23 (dd, J = 10.3, 1.7 Hz, 1H), 6.17 (dd, J = 10.3, 3.0 Hz, 1H), 3.84 (d, 
J = 10.5Hz, 1H), 3.80 (d, J = 10.5 Hz, 1H), 2.53 (s, 3H), 1.34 (s, 3H); 13C NMR δ 184.6, 174.4, 
146.7, 146.5, 146.2, 137.2, 134.6, 131.5, 131.1, 130.2, 129.0, 128.5, 128.4, 126.6, 58.5, 50.9, 48.6, 
22.0, 20.0; HRMS (ESI, positive): m/z calcd. for C23H21NNaO4S [M + Na]
+ 430.1084, found 
430.1084. 
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In this thesis, the author explained the gold(I)-catalyzed construction of nitrogen-containing me-
dium-sized rings and azaspirocyclic compounds. 
In Chapter 2, the author disclosed 7-endo-dig-selective cycloisomerization of 
2-alkynydiphenylamines and 8-exo-dig-selective cycloisomerization of 
2-propargylaminotriphenylamines, which gave dibenzazepines and dibenzodiazocines, respectively. 
The reaction of carbazole-containing 2-alkynyldiphenylamine derivatives gave π-conjugated mul-
ticyclic compounds. The consecutive cycloisomerization and oxidation of indoline-containing 
2-alkynyldiphenylamine derivatives provided tetracyclic indole-containing compounds under mild 
conditions. This strategy was applied for the reaction of 2-alkynyl-N-methyldiphenylamine to give 
N-methyldibenzazepine. On the other hand, the reaction of 2-propargylaminotriphenylamines pos-
sessing a terminal alkyne moiety proceeded via 8-exo-dig cyclization under mild conditions using 
Ph3PAuCl. In contrast, the use of IPrAuCl was important for the reaction of internal alkynes. 
In Chapter 3, the author disclosed dearomative spirocyclization of phenol derivatives using gold 
carbenoid species derived from ynamides and N-oxide, which provided azaspirocyclohexadienones. 
The reaction proceeded even under air without the use of hazardous diazo compounds. The use of 
IPr as the ligand and water as the co-solvent surppressed the formation of diketone by-products. 
Some of the obtained products were transformed into synthetically important compounds.  
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Dibenzodiazocine Derivatives” 
XXVIII International Conference on Organometallic Chemistry, Florence (Italy), July 2018, 
P246. 
Asahi Takaki, Daisuke Inoue, Mamoru Ito, Kyalo Stephen Kanyiva, Takanori Shibata 
 
「カチオン性金触媒による環化異性化反応を用いた含窒素中員環合成」 
第 113 回有機合成シンポジウム, 名古屋大学（愛知）, 2018 年 6 月, A-16. 
伊藤守, 川崎涼介, 井上大輔, 高木朝日, Kyalo Stephen Kanyiva, 柴田高範 
 
「金(Ⅰ)触媒を用いた 8-exo-dig 選択的環化異性化によるジベンゾジアゾシン誘導体の合
成」 
日本化学会第 98 春季年会, 日本大学（千葉）, 2018 年 3 月, 2H2-16. 
高木朝日, 井上大輔, 伊藤 守, カニヴァ ステイヴィン キャロ, 柴田高範 
 
「イナミドから調製される α-オキソ金カルベノイド種を用いたフェノール類の脱芳香化
を伴う触媒的スピロ環化反応」 
日本化学会第 98 春季年会, 日本大学（千葉）, 2018 年 3 月, 2H2-15. 
伊藤 守, 川崎涼介, カニヴァ ステイヴィン キャロ, 柴田高範 
 
“Construction of Dibenzazepine Skeleton via Au(I)-Catalyzed Cycloisomerization on 7-Position 
of Indoline” 
26th ISHC Congress, Regensburg (Germany), September 2017, TUE-P56 
Daisuke Inoue, Mamoru Ito, Ryosuke Kawasaki, Kyalo Stephen Kanyiva, Takanori Shibata 
 
「カチオン性金触媒による環化異性化反応を用いたジベンゾアゼピン誘導体の合成」 
第 73 回有機合成化学協会関東支部シンポジウム, 学習院大学（東京）, 2017 年 5 月, A04. 
伊藤守, 川崎涼介, Kyalo Stephen Kanyiva, 柴田高範 
 
「金(I)触媒を用いた環化異性化によるインドリン骨格を有するジベンゾアゼピン誘導体
の合成」 
日本化学会第 97 春季年会, 慶應義塾大学（神奈川）, 2017 年 3 月, 1E2-09. 
井上大輔, 伊藤 守, カニヴァ ステイヴィン キャロ, 柴田高範 
 
“Efficient Synthesis of Dibenzazepine Derivatives by Cationic Au(I)-Catalyzed 
Cycloisomerization” 
Catalysis and Fine Chemicals, Taipei (Taiwan), November 2016, YO-04. 
Mamoru Ito, Ryosuke Kawasaki, Kyalo Stephen Kanyiva, Takanori Shibata 
 
「金触媒による環化異性化反応をジベンゾアゼピン誘導体の合成」 
第 63 回有機金属化学討論会, 早稲田大学,（東京）, 2016 年 9 月, O2-16. 
伊藤 守, 川崎 涼介, カニヴァ ステイヴィン キャロ, 柴田 高範 
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“Efficient synthesis of 4-substituted tryptophan derivatives via Ir-catalyzed C-H bond activation: 
Total synthesis of cis-clavicipitic acid” 
Pacifichem, Honolulu, December 2015, Organic 2546.  
Mamoru Ito, Yuki Tahara, Takanori Shibata 
 
“Enantioselective synthesis of γ-amino acids via sp3 C-H Bond activation using by Ir(I)-catalyst” 
Pacifichem, Honolulu, December 2015, Organic 1355.  
Masamichi Michino, Mamoru Ito, Yuki Tahara, Takanori Shibata 
 
「Ir 触媒による sp3 C-H 結合活性化を用いた γ-ラクタムと γ-アミノ酸の不斉合成」 
第 45 回 複素環化学討論会, 早稲田大学（東京）, 2015 年 11 月, 1P-22.  
道野 仁理, 伊藤 守, 田原 優樹, Kyalo Stephen Kanyiva, 柴田 高範 
 
「イリジウム触媒による炭素－水素結合活性化を鍵反応とした cis-クラビシピチン酸の
全合成」 
第 45 回 複素環化学討論会, 早稲田大学（東京）, 2015 年 11 月, 2P-12.  
伊藤 守, 田原 優樹, カニヴァ キャロ ステイヴィン, 柴田 高範 
 
「遷移金属触媒を用いるC-H結合活性化反応および[2+2+2]付加環化反応を利用した新規
アミノ酸誘導体の合成」 
第 108 回 有機合成シンポジウム, 早稲田大学（東京）, 2015 年 11 月, O-01.  
田原 優樹, 伊藤 守, 大日方 秀平, 道野 仁理, Kyalo Stephen Kanyiva, 柴田 高範 
 
“Enantioselective Synthesis of γ-Amino Acid Derivatives via Iridium Catalyzed Activation of sp3 
C-H Bond” 
250th American Chemical Society National Meeting & Exposition, Boston, MA, August 2015, 
ORGN112.  
Yuki Tahara, Masamichi Michino, Mamoru Ito, Takanori Shibata 
 
「イリジウム触媒を用いる炭素－水素結合活性化を起点としたクラビシピチン酸の全合
成」 
日本化学会第 95 春季年会, 日本大学（千葉）, 2015 年 3 月, 2G3-11. 
伊藤 守, 田原優樹, 柴田高範 
 
「イリジウム触媒を用いるエナンチオ選択的C-H結合活性化を利用したγ-アミノ酸類の
不斉合成」 
日本化学会第 95 春季年会, 日本大学（千葉）, 2015 年 3 月, 2E5-12. 
道野仁理, 伊藤 守, 田原優樹, 柴田高範 
 
“Enantioselective Synthesis of γ-Amino Acid Derivatives via Ir(I)-Catalyzed sp3 C-H Bond 
Activation” 
XXVI International Conference on Organometallic Chemistry, Sapporo (Japan), July 2014, 
3P105.  
Mamoru Ito, Shun Yuzawa, Yu-ki Tahara, Takanori Shibata 
 
 
